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ABSTRACT 
 
 Biotin is an essential enzyme cofactor required by all three domains of life.  It 
functions as a covalently-bound prosthetic group, which mediates the transport of CO2 in 
many vital metabolic carboxylation, decarboxylation and transcarboxylation reactions.  
Although biotin is essential, our knowledge of its biosynthesis remains fragmentary.  
Studies suggest that most of the carbon atoms of biotin are derived from pimelic acid, a 
seven carbon dicarboxylic acid.  However, the mechanism whereby Escherichia coli 
assembles this pimelate intermediate was unclear.  Genetic analyses identified only two 
genes of unknown functions, bioC and bioH, which are required for pimelate synthesis.  
BioC is annotated as an S-adenosyl-L-methionine (SAM) dependent methyltransferase, 
whereas BioH has shown carboxylesterase activity.  The mechanism by which a 
methyltransferase and a carboxylesterase catalyze the synthesis of pimelate intermediate 
was very puzzling.  In this Thesis, I describe my approaches to delineate E. coli biotin 
synthetic pathway and to elucidate the roles of BioC and BioH in pimelate synthesis. 
 
 In Chapter 2, I unravel the synthesis of pimelate.  I report in vivo and in vitro 
evidence that the pimelate intermediate is synthesized by a modified fatty acid synthetic 
pathway.  The ω-carboxyl group of a malonyl-thioester precursor is methylated by BioC, 
as an initiation step in biotin synthesis.  The shielding by a methyl ester moiety is 
required for recognition and chain elongation of this atypical substrate by the fatty acid 
synthetic enzymes.  The malonyl-thioester methyl ester enters fatty acid synthesis as the 
primer and undergoes two reiterations of the fatty acid elongation cycle to give pimeloyl-
acyl carrier protein (ACP) methyl ester.  The methyl ester moiety is then cleaved by BioH 
to signal termination of elongation.  The product pimeloyl-ACP then enters the second 
half of biotin synthetic pathway, and becomes the substrate of BioF reaction to begin 
biotin ring assembly. 
 
 In Chapter 3, I demonstrate BioC methylation of malonyl-ACP, which is a key 
initiation reaction in E. coli biotin synthesis.  I hypothesized that BioC catalyzes the 
transfer the methyl group from SAM to the ω-carboxyl group of malonyl-ACP, creating a 
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methyl ester moiety.  The methyl ester moiety is essential to allow processing of 
malonate, a C3 dicarboxylate, into pimelate, a C7 dicarboxylate by fatty acid synthetic 
enzymes.  To demonstrate BioC activity experimentally, I cloned and purified Bacillus 
cereus BioC, which is the only amenable BioC homolog I found in several different 
bacterial species.  By using radiolabeled SAM, I show that BioC specifically selects 
malonyl-ACP for methylation.  Furthermore, this methylation activity is also susceptible 
to inhibition by molecules known to target SAM-dependent enzymes.  
 
In Chapter 4, I report a 2.0-Å resolution co-crystal structure of BioH in complex 
with its substrate, pimeloyl-ACP methyl ester.  This structure was obtained in 
collaboration with the Satish Nair lab at University of Illinois at Urbana Champaign.  
BioC methylates the free carboxyl of a malonyl-thioester which replaces the usual acetyl-
thioester primer.  This atypical primer is transformed to pimeloyl-ACP methyl ester by 
two cycles of fatty acid synthesis.  The question is what stops this C7-ACP from 
undergoing further elongation, to azelaryl (C9)-ACP methyl ester, a metabolically useless 
product.  Although BioH readily cleaves this product in vitro, as shown in Chapter 2, the 
enzyme is nonspecific which made assignment of its physiological substrate 
problematical.  The downstream enzyme BioF, which releases ACP as a byproduct, could 
theoretically also perform this “gatekeeping” function.  We utilized the structure to 
demonstrate that BioH is the gatekeeper and its physiological substrate is pimeloyl-ACP 
methyl ester.  Moreover, the binding interaction with ACP is important for BioH activity.   
 
In Chapter 5, I summarize my findings in E. coli biotin synthesis.  I discuss my 
experimental approaches and technical troubleshooting that led to successful delineation 
of this pathway.  I also describe the serendipitous discovery of pimeloyl-ACP methyl 
ester as a novel biotin intermediate.  This intermediate led to the identifications of methyl 
ester moiety and ACP, which were the two missing puzzles to a complete understanding 
of E. coli biotin synthesis.  Finally, I offer two future directions to investigate BioC 
structures, and to identify the 3-ketoacyl-ACP synthases involved in chain elongation of 
dicarboxylates.  
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CHAPTER 1 
BACKGROUND AND SIGNIFICANCE 
 
THE DISCOVERY OF BIOTIN 
Enzymes have evolved to utilize an impressive array of cofactors to expand their 
catalytic repertoire beyond what can be mediated by the side chains of amino acid 
residues.  Biotin is a fascinating cofactor that plays an indispensable role in metabolic 
fixation of CO2, a quintessential process for life.  Biotin (also known as vitamin H and 
B7) is an enzyme-bound prosthetic group which mediates the transport of CO2 in many 
vital carboxylation, decarboxylation and transcarboxylation reactions.  It was discovered 
at the dawn of vitamin era by Wildiers in 1901 as an unknown substance “Bios” which 
was required for yeast fermentation in minimum medium
122
.  As described by Wildiers, 
this “Bios” substance was organic, was destroyed by boiling in acid and base, was readily 
dialyzable through a membrane, and was present in meat extract, peptone as well as yeast 
cells.  The exact composition of Wilders’ Bios was not clear until 30 years later when 
Lash Miller and co-workers further fractionated and studied the extract
71
.  In the 
meantime, biotin continued to be discovered as an essential growth factor in different 
organisms and came to be known by several different names.  It was also isolated as a 
curative factor for egg-white injury in rats and called protective factor X
12
 and vitamin 
H
50
.  Egg-white injury is a dermatitic symptom now known as due to over-consumption 
of uncooked egg whites and inactivation of dietary biotin by its binding to avidin.  Biotin 
was also named coenzyme R, a factor that stimulated respiration and growth of rhizobia
4
.  
It was also identified as a growth factor for yeast and given the name “biotin”68.  The true 
identity of biotin finally emerged when biotin was purified and its structure 
determined
55,82,117
.  Since then the enzymatic role of biotin has gradually become clear as 
biotin-dependent enzymes were identified in fatty acid synthesis, amino acid metabolism 
and gluconeogenesis across all three domains of life
63,66,78
.   
 
THE CATALYTIC ROLE OF BIOTIN 
The role of biotin as a stable carboxyl group carrier is facilitated by its structure 
which consists of a bicyclic ring fused to a valeryl side chain
34
  (Figure 1-1).  The 
2 
 
bicyclic rings are comprised of a ureido ring fused to a tetrathiophene ring.  In the active 
state, biotin is covalently attached to its cognate enzymes via an amide bond between the 
carboxyl group of biotin and the ε-amino group of a specific lysine residue of a conserved 
protein domain of 70-80 residues
70
.  Thus the biotin valeryl side chain extends the 
bicyclic rings away from the lysine residue.  The protruding biotin moiety together with 
the rugby ball-shaped biotinylated protein domain form an elongated swinging arm that 
shuttles CO2 equivalents between the carboxylation and carboxyltransfer domains of the 
enzyme
89
.  The ureido ring N8 nitrogen carries the CO2 moiety and forms N-
carboxybiotin upon reaction either with a carboxyphosphate produced by ATP activation 
of bicarbonate or with a carboxy donor molecule
6,66
 (Figure 1-1).  The ureido ring is 
essentially planar whereas the tetrathiophene ring has the sulfur atom pointing out of the 
plane
34
.  The overall structure resembles a slightly reclining chair with the ureido ring as 
the back of the chair and the tetrathiophene ring as the seat.  The geometry of the bicyclic 
rings helps to prevent the N8 nitrogen from achieving the tetrahedral geometry required 
for decarboxylation, making N8 carboxybiotin a much more stable carbamate than 
monocyclic or acyclic carboxylureas
66
.  Decarboxylation is triggered by rotation of the 
carboxy group out of plane of the ureido ring
111
.  This enzyme-mediated rotation provides 
proper polarization to weaken the bond and to release carbon dioxide in the carboxyl 
transfer reaction. 
 
BIOTIN SYNTHESIS 
The structure and chemistry of biotin and its physiological roles are now well 
understood; however, we still lack a complete understanding of biotin synthesis in any 
biotin-producing organism.  Biotin synthesis is limited to microbes, fungi and plants.  
Mammals are incapable of biotin synthesis and obtain biotin from the diet and/or 
intestinal microflora.  The structures of the late intermediates in the pathway were 
determined as the result of the extensive genetic studies on biotin-requiring mutants of 
Escherichia coli initiated by Eisenberg, Campbell and their coworkers in the late 
1960s
25,33,99
.   This foundation greatly facilitated molecular and biochemical studies of 
the biotin synthetic enzymes that allowed several novel chemistries of biotin synthesis to 
be unraveled.     
3 
 
Comparative genomic analysis indicates that the synthetic pathway is largely 
conserved among biotin-producing organisms and can be readily divided into two stages: 
synthesis of the pimelate moiety and assembly of the bicyclic rings.  Until recently little 
was known about pimelate synthesis; whereas the enzymes of ring assembly have been 
extensively characterized.  Supplementation with pimelic acid (α,ω-heptanedioic acid) 
has been known to stimulate biotin production in certain fungi and bacteria
36,38,84,86,118
.  
However, most biotin-producing organisms are unable to convert pimelic acid to biotin 
and contain unusual pathways for de novo synthesis of pimelate moiety.  The synthesis of 
pimelate, which contributes to most of the biotin carbon atoms, is catalyzed by at least 
two different pathways (Figure 1-1).  The best understood pathways, the E. coli BioC-
BioH pathway and the B. subtilis BioI-BioW pathway, are discussed in detail later.  The 
intermediate between the first and second stages of biotin synthesis is a pimelate thioester 
linked to either coenzyme A (CoA) or acyl carrier protein (ACP).  The thioester linkage 
not only is essential for pimelate synthesis but also provides the activated intermediate 
required in the subsequent synthesis of 7-keto-8-aminopelargonic acid (KAPA).  In 
contrast to the diversity seen in pimelate synthesis, the assembly of the bicyclic rings in 
all known biotin synthetic pathways is evolutionarily conserved, and the enzymes share 
nearly identical chemistry.  In a four-step pathway, a pimelate thioester is first converted 
to KAPA.  The pathway then proceeds through two more intermediates - 7,8-
diaminonopelargonic acid (DAPA) and dethiobiotin (DTB) - to form biotin (Figure 1-1).  
All of the E. coli enzymes involved in assembly of the bicyclic rings have known x-ray 
crystal structures and are well studied mechanistically.  I shall first discuss these 
enzymes. 
 
7-Keto-8-Aminopelargonic Acid Synthase 
The first step in the assembly of the bicyclic rings is the conversion of the 
pimelate thioester to KAPA by KAPA synthase (BioF) encoded by the bioF gene.  BioF 
is a pyridoxal 5’-phosphate (PLP)-dependent enzyme of subclass II of the 
aminotransferase family and has the conserved active-site architecture of PLP-dependent 
acyl-CoA α-oxoamine synthases3,91.  Each monomer of the homodimeric BioF resembles 
an open left hand with the thumb being the flexible N-terminal domain, the heel being the 
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C-terminal domain and the remainder of the palm and fingers representing the central 
domain
3
.  The PLP cofactor is covalently attached to a conserved lysine residue through 
an imine linkage and participates as both proton acceptor and donor in the reaction
120
.  
Several positively charged residues thought to facilitate binding of the acidic groups of 
CoA
3
 (or ACP) surround the active site.  KAPA is formed in a decarboxylative 
condensation reaction between L-alanine and a pimelate thioester with concomitant 
release of CO2 and cleavage of the thioester bond.  This reaction follows standard Schiff 
base chemistry.  In the presence of the substrate, L-alanine, an alanine-bound external 
aldimine complex is formed and rearranged into a quinonoid intermediate by the binding 
of the second substrate, pimelate thioester
120
.  The second half reaction is in principle the 
reversal of the first half reaction.  The quinonoid intermediate is converted back to the 
lysine-bound internal aldimine that subsequently attacks the thioester carbonyl forming a 
3-ketoacid aldimine complex
120
.   The synthesis of KAPA is completed by 
decarboxylation of the 3-ketoacid aldimine intermediate back into the quinonoid species 
and reformation of Schiff base linkage between PLP and the lysine residue
120
.  The end 
result of the BioF reaction is the extension of the seven carbons of pimelate with two 
carbon atoms and a nitrogen atom derived from L-alanine, which become the C8, C9 and 
N8 moieties of biotin. 
 
7,8-Diaminopelargonic Acid Synthase 
The next step in the pathway is transamination of KAPA at C7 to produce DAPA.  
The DAPA synthase (encoded by the bioA gene) of E. coli, B. sphaericus and 
Mycobacterium tuberculosis surprisingly use SAM as the amino donor
10,35,41,79
.   This is 
the only known example of use of SAM, a common methyl donor, as an amino donor.  
The product of deamination, S-adenosyl-2-oxo-4-thiomethylbutryate, spontaneously 
degrades in vitro
109
, and thus it seems likely that the three ATP equivalents required to 
synthesize SAM are consumed in what is an otherwise simple transamination reaction.  
B. subtilis BioA avoids this seemingly profligate loss of an expensive activated 
intermediate by using a more mundane amino donor, lysine
119
.  Like BioF, BioA is also a 
PLP-dependent enzyme belonging to the subclass III aminotransferase family
109
.  Each 
subunit of this homodimeric enzyme consists of a small N-terminal domain essential for 
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dimerization and a large β-sheet rich central domain where the critical PLP-binding 
lysine residue is located
65
.  The striking similarity of the amino acid sequences, the 
overall structures, and the active site architectures of BioF and BioA suggest that the two 
enzymes are evolutionarily related and possibly derived from a common ancestor
87,109
.  
Therefore it is not surprising that the BioA reaction is mechanistically similar to the BioF 
reaction.  The first half reaction proceeds through a transaldimination process from which 
an external aldimine complex is formed between SAM and PLP
65
.  The external aldimine 
complex is rearranged to a quinonoid intermediate before being processed through a 
ketimine intermediate to give S-adenosyl-2-oxo-4-thiomethylbutryate and pyridoxamine 
phosphate.  In the second half reaction, DAPA accepts the amino group from 
pyridoxamine phosphate and the enzyme-bound PLP complex is restored
65
.  The result is 
the introduction of the N7 amino group essential for formation of the ureido ring. 
 
Dethiobiotin Synthetase 
The penultimate step of biotin synthesis is the conversion of DAPA to DTB by 
DTB synthetase (encoded by the bioD gene).  This enzyme catalyzes a mechanistically 
unusual reaction, the ATP-dependent insertion of CO2 between the N7 and N8 nitrogen 
atoms of DAN to form an ureido ring.  Thus BioD represents an enzymatic carboxylation 
mechanism distinct from those of biotin-dependent carboxylases and ribulose 
bisphosphate carboxylase
57
.  Each subunit of the BioD homodimer is composed of seven 
parallel β-sheets interconnected by α-helices with the active sites located at the dimer 
interface
57
.  Similar to ATP- and GTP-binding proteins, BioD contains a classical P-loop 
motif (Gly-X-X-Gly-X-Gly-Lys-Thr/Ser) that binds the nucleotide phosphate groups
56
.  
The carboxylation reaction catalyzed by BioD consists of three steps.  The first step is the 
regiospecific formation of carbamate at N7 of DAPA through reaction with CO2, a highly 
coordinated event at the enzyme active site
47,57
.  The enzyme initiates nucleophilic attack 
of the N7 nitrogen by polarizing CO2 and abstracting a proton from the N7 nitrogen.  The 
resulting carbamate intermediate is partially buried in the enzyme, rendering it 
inaccessible to solvent, and is further stabilized by a number of hydrogen bonding and 
ionic interactions
57
 (Figure 1-2). Stabilization of the carbamate allows the reaction to 
proceed even at low CO2 concentrations.  The second step is formation of carbamic-
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phosphoric anhydride by nucleophilic attack of the ATP γ-phosphate by the carbamate 
oxygen atom
64
.  The final step is the closure of the ureido ring and release of inorganic 
phosphate.  This last step awaits further clarification.  The proposed mechanism begins 
with nucleophilic attack at the carbamate carbon by N8 to form a tetrahedral 
intermediate
57
 (Figure 1-2).  To complete formation of the ureido ring, the carbon-oxygen 
bond is cleaved to release inorganic phosphate and the N8 nitrogen is deprotonated by a 
nearby base, possibly Glu12 residue or a phosphate oxygen atom
57
 (Figure 1-2). 
 
Biotin Synthase 
The final step of biotin synthetic pathway is the insertion of a sulfur atom at the 
C6 methylene and C9 methyl groups of DTB to form a tetrathiophane ring.  This reaction 
is catalyzed by biotin synthase (encoded by the bioB gene) whose intriguing SAM-
dependent radical chemistry, despite extensive research, is still not fully understood.  
Active biotin synthase is a homodimeric iron-sulfur enzyme.  Each monomer has the fold 
of a triosephosphate isomerase (TIM) type (α/β)8 barrel containing a surface exposed, air-
sensitive [4Fe-4S]
2+
 cluster and a deeply buried, air-stable [2Fe-2S]
2+
 cluster
9,115
.  The 
topology of biotin synthase resembles the general architecture of SAM radical enzymes; 
however, the location of the iron-sulfur clusters in the TIM barrel is unusual, hinting at a 
design for unique chemistry.  The [4Fe-4S]
2+
 cluster is essential for radical generation
115
.  
This cluster is located at the top of the TIM barrel far from the dimer interface and is 
coordinated by a CxxxCxxC motif conserved in SAM radical enzymes
9,106
.  The fourth 
ligand to this cluster is the substrate SAM which binds a specific Fe atom via its amino 
nitrogen and carboxyl oxygen
9
 (Figure 1-3).  SAM binding is greatly enhanced by the 
presence of DTB which becomes sandwiched between SAM and the [2Fe-2S]
2+
 cluster
9
.  
The [2Fe-2S]
2+
 cluster is deeply buried at the bottom of the barrel
9
 and is the source of 
sulfur atom for tetrathiophane ring formation, as verified by labeling studies with 
isotopes of sulfur
113
 and selenium
114
. 
 
The biotin synthase reaction consists of three main steps: the SAM-dependent 
abstraction of hydrogen from DTB, the derivation of a sulfur atom from the [2Fe-2S]
2+
 
cluster, and a complex regeneration of active enzyme that is poorly understood.  
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Although a complete mechanism awaits further biochemical studies, the proposed 
reaction begins with transfer of an electron from reduced flavodoxin, via the [4Fe-4S]
2+
 
cluster, to the SAM sulfonium
49
 (Figure 1-3).  The one-electron reduction of the 
sulfonium group spontaneously generates methionine and a 5’-deoxyadenosyl radical 
which is required for C-H bond homolytic cleavage and abstraction of a hydrogen atom 
from the C9 methyl group of DTB
43
.  This reaction produces a carbon radical at C9 
which attacks the bridging sulfide of the [2Fe-2S]
2+
 cluster, yielding a [2Fe-2S]
2+
 linked 
DTB intermediate
115
 (Figure 1-3).  A second 5’deoxyadenosyl radical generated by the 
same reduction mechanism abstracts a hydrogen atom from the C6 methylene group, 
producing another carbon radical that attacks the same [2Fe-2S]
2+
 cluster sulfur atom
43
.  
Insertion of the sulfur atom at C6 and C9 of DTB creates the tetrathiophane ring and 
consequently destroys the [2Fe-2S]
2+
 cluster
116
.  The biotin synthase reaction also 
requires Mtn, a 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase to cleave 
5’-deoxyadenosine to alleviate product inhibition20.  
 
The sacrifice of the [2Fe-2S]
2+
 cluster for sulfur insertion renders biotin synthase 
inactive after each round of catalysis.  This explains why biotin synthase has generally 
been reported to catalyze only a single turnover per subunit in vitro, although evidence 
for multiple turnovers has very recently been reported
44
.  To achieve multiple turnovers, 
the reconstitution of the [2Fe-2S]
2+
 cluster must be considered as an obligatory part of 
catalytic cycle.  Reconstitution of the deeply buried [2Fe-2S]
2+
 cluster is not an easy 
process.  Some researchers have proposed that biotin synthase might have evolved to be a 
stoichiometric substrate rather than an enzyme
9
.  However, in vivo biotin synthase is 
capable of up to 20 turnovers where Fe-S cluster assembly systems such as the Isc and 
Suf systems are available
9,21
 .  Moreover the regeneration of biotin synthase requires 
partial unfolding of the protein, mediated by HscA, a molecular chaperone of the Hsp70 
family, which renders biotin synthase susceptible to proteolysis and eventual 
degradation
21,94,95
.  Since the biological requirement for biotin is so low (~100 
molecules/cell in E. coli)
21
, continuous synthesis of biotin synthase could readily 
compensate for its short half-life.  
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THE SYNTHESIS OF PIMELATE 
Until very recently little was known about the synthesis of the biotin pimelate 
moiety, and much of the available literature was only conjecture.  Using radioactive 
pimelic acid, Eisenberg and colleagues demonstrated direct incorporation of pimelic acid 
into biotin by the fungi Phlycomyces blakesleeanus
37
 and Penicillium chrysogenum 
39
.  
These workers proposed a mechanism of incorporation in which pimelic acid was 
activated via a thioester linkage to CoA to give pimeloyl-CoA
40
.  Pimeloyl-CoA would 
then be converted into KAPA by BioF in a reaction analogous to the synthesis of δ-
aminolevulinic acid from glycine and succinyl-CoA
105
.  The enzymatic formation of 
KAPA from pimeloyl-CoA and L-alanine was subsequently demonstrated in cell-free 
extracts of E. coli, suggesting that pimelate could serve as an entry point into biotin 
synthesis
40
.   
 
In 1994 two groups reported studies tracing the origin of the E. coli biotin carbons 
atoms by 
13
C-NMR
58,104
.  The 
13
C-NMR spectra of biotin extracted from E. coli cultures 
grown on acetate differentially labeled with 
13
C indicated that three intact acetate units 
are incorporated into the pimelate moiety of biotin.  The labeling pattern matches the 
head-to-tail condensation pathways of fatty acid and polyketide syntheses.  The C3, C5 
and C7 carbon atoms of pimelate are derived from C1 of acetate, whereas the C2, C4 and 
C6 are derived from C2 of acetate.  The C1 of pimelate could be labeled with both [1-
13
C]- and [2-
13
C]-acetate, suggesting that the carboxyl group originated from 
13
CO2 
produced by the citric acid cycle and subsequently fixed into malonyl-CoA by acetyl-
CoA carboxylase
58,104
.  The labeling patterns demonstrated that the two carboxyl groups 
of pimelate are metabolically distinct, thereby ruling out the symmetrical pimelic acid as 
a biotin synthetic intermediate in E. coli
104
.  Moreover, these studies eliminated other 
plausible sources of pimelate from oxidation of octanoate, by elongation of 2-
ketoglutarate or derivation from the tryptophan, lysine or diaminopimelate pathways.  
However, the patterns precisely matched those predicted by the model of biotin synthesis 
put forth in 1963 by Lynen and coworkers, in which pimeloyl-CoA synthesis was 
postulated to proceed by a head-to-tail condensation process mechanistically similar to 
fatty acid synthesis
75
.  In that model three molecules of malonyl-CoA would be coupled 
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by two successive rounds of fatty acid synthesis to produce pimeloyl-CoA (Figure 1-4).  
This reaction sequence would retain the ω-carboxyl group of the primer malonyl moiety 
such that odd numbered carbon chains would be produced.  This model has a precedent in 
type III polyketide synthesis, in which the synthases catalyze decarboxylative Claisen 
condensations of multiple malonyl-CoA molecules to form long chain ω-carboxylacyl-
CoA species
45
 (Figure 1-4).  The keto groups introduced by the Claisen condensations are 
retained or remodeled in subsequent cyclization reactions of the carbon chain to form the 
final polyketide (Figure 1-4).  In contrast, the synthesis of pimeloyl-CoA by the Lynen 
pathway requires that the keto groups become fully reduced to methylene groups, by the 
reduction and dehydration reactions of fatty acid synthesis. 
 
The Lynen model of pimeloyl-CoA synthesis raised three major biochemical 
challenges.  First, fatty acid synthesis utilizes ACP as a carrier rather than CoA which is 
generally associated with the fatty acid degradation pathway (ACP was unknown when 
the Lynen proposal was put forth).  If pimelate is synthesized as an ACP thioester, either 
an acyl transfer reaction would be required to transfer the pimelate moiety from ACP to 
CoA for KAPA synthesis, or pimeloyl-ACP must be a BioF substrate.  A serious 
challenge to the model is the presence of the ω-carboxyl group.  In the initiation step of 
normal fatty acid synthesis, acetyl-CoA is condensed with malonyl-ACP by 3-ketoacyl-
ACP synthase (FabH, FabB or FabF) to give acetoacetyl-ACP, the methyl end of which is 
derived from the primer acetyl moiety (Figure 1-4).  In contrast, the Lynen model would 
result in a negatively-charged, hydrophilic ω-carboxyl group derived from the primer 
malonyl moiety in place of the hydrophobic methyl group.  The ω-carboxyl group would 
be poorly tolerated, if not totally occluded, from the hydrophobic active sites of the fatty 
acid synthetic enzymes
121
.  The final challenge is the preservation of the ω-carboxyl 
group of the 3-ketoglutaryl intermediate.  Prior to reduction of the 3-keto group the ω-
carboxyl group would in theory be prone to spontaneous decarboxylation and therefore 
might require stabilization.   
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BioC-BioH Pathway of Escherichia coli 
The isotopic labeling data mentioned above plus the extensive genetic analyses of 
its biotin synthetic pathway made E. coli the obvious choice to approach the question of 
how the pimelate moiety might be assembled using the fatty acid synthetic pathway.  
Another advantage was that the fatty acid synthetic pathway of this bacterium has been 
studied in great detail.  Genetic studies in E. coli identified bioC and bioH as the only 
genes with unassigned functions essential for biotin synthesis.  Strains having inactive 
bioC or bioH genes require biotin for growth, but biotin can be replaced by KAPA or any 
of the later pathway intermediates, indicating that the bioC and bioH gene products 
catalyze reactions required for KAPA synthesis
33,99
.  Moreover, neither bioC nor bioH 
mutant strains excrete any detectable intermediate, suggesting that the intermediates of 
pimelate synthesis might be protein bound
33
.  Various workers had proposed confusing 
and contradictory pictures of the roles of BioC and BioH in biotin synthesis.  BioC was 
hypothesized to actively catalyze the condensation of malonyl-CoA or to function as an 
ACP dedicated to pimeloyl-CoA synthesis
72
; whereas BioH was proposed to act as an 
acyltransferase that transferred the pimeloyl moiety from BioC to CoA
1
.  It was also 
proposed that BioH could function as a pimeloyl-CoA synthetase and somehow attach 
pimelic acid to CoA, perhaps with the help of BioC
103
.  However, these models not only 
lacked supporting data but also failed to address the fundamental problems of how α,ω-
dicarboxylic acyl chains are assembled.  
 
BioC and BioH were the two missing pieces of the puzzle to a complete 
understanding of the biotin synthetic pathway.  The primary sequence of BioC showed 
SAM binding motifs that are well conserved in the SAM-dependent methyltransferase 
family, although no methyltransferase activity had been demonstrated.  On the other hand 
BioH had been shown to have carboxylesterase activity of broad substrate specificity. 
BioH hydrolyzes the ester bonds of short acyl chain ρ-nitrophenyl esters1,103 and also the 
methyl ester of dimethylbutyryl-S-methyl mercaptopropionate, a precursor of the 
cholesterol-lowering agent, Simvastatin
124
.  Moreover, the BioH X-ray crystal structure 
showed a catalytic triad (Ser82, His235, Asp207) often found in hydrolase superfamily 
enzymes
103
.  A BioH:CoA complex was also observed when purified BioH was incubated 
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with excess of CoA
112
.  These attributes of BioC and BioH made the assignment of their 
functions in biotin synthesis puzzling.  Why does E. coli biotin synthetic pathway require 
a SAM-dependent methyltransferase when the origins of all biotin carbons are accounted 
for and none originates from methionine?  Why is an esterase required when pimelate 
assembly must require a series of condensation reactions? 
 
We recently proposed a model in which E. coli BioC and BioH hijack fatty acid 
synthetic enzymes for biotin synthesis
76
.  In this model BioC and BioH do not directly 
catalyze the synthesis of pimelate but instead provide the means to allow fatty acid 
synthesis to assemble the pimelate moiety (Figure 1-5).  Such circumvention of the 
normal fatty acid synthesis pathway involves O-methylation and demethylation events 
and produces pimeloyl-ACP, instead of pimeloyl-CoA, as the KAPA synthetic precursor.  
In this model, BioC (a putative O-methyltransferase) converts the ω-carboxyl group of 
malonyl-CoA into a methyl ester by transferring a methyl group from SAM.  The 
shielding of the carboxyl group by conversion to a methyl ester neutralizes the negative 
charge and provides a methyl carbon that mimics the methyl ends of normal fatty acyl 
chains.  The malonyl-CoA methyl ester then enters fatty acid synthetic pathway where it 
is condensed with malonyl-ACP by a 3-ketoacyl-ACP synthase to give 3-ketoglutaryl-
ACP methyl ester, an intermediate stabilized by the methyl ester moiety.  The methyl 
ester shielding allows the 3-keto group to be processed into a methylene group by the 
standard fatty acid reductase-dehydratase-reductase reaction sequence (Figure 1-5).  The 
glutaryl-ACP methyl ester product would then be elongated to the C7 species and another 
round of the reductase-dehydratase-reductase cycle would give pimeloyl-ACP methyl 
ester.  Given the hydrophobicity of the active sites of the fatty acid synthetic enzymes, 
the methyl ester moiety would remain essential throughout this process.  Once synthesis 
of the pimeloyl chain is complete, the methyl ester moiety is no longer required and is 
removed to terminate chain elongation.  The termination reaction is catalyzed by BioH, 
which hydrolyzes the methyl ester bond to expose the ω-carboxyl group to prevent 
further elongation by the fatty acid synthetic enzymes (Figure 1-5).  BioF converts 
pimeloyl-ACP into KAPA, the first intermediate in assembly of the bicyclic rings of 
biotin.  Note that the BioF reaction could provide an equally effective termination of the 
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chain elongation process due to cleavage of the thioester linkage between pimeloyl chain 
and ACP.   
 
BioI-BioW Pathway of Bacillus subtilis 
B. subtilis is the only organism other than E. coli in which we have an 
understanding of how the pimelate moiety is synthesized.  However, the genetic and 
biochemical analyses of this pathway are not as well developed as in E. coli.  B. subtilis is 
thought to have two routes to obtain pimelate thioesters: a pimeloyl-CoA synthetase 
encoded by the bioW gene, and an enzyme of the cytochrome P450 family encoded by 
the bioI gene
14
.  Pimeloyl-CoA synthetase allows B. subtilis to incorporate exogenous 
pimelic acid into the biotin synthetic pathway.  Homologous enzymes have also been 
characterized in Bacillus megaterium
59
, B. sphaericous
90
 and Pseudomonas mendocina
11
.  
However, the origin of pimelic acid (or pimeloyl-CoA) remains elusive, because the 
molecule is neither found in central metabolism nor is abundant in known environments.  
The only reported source of pimeloyl-CoA is benzene degradation by 
Rhodopseudomonas
53
; however, other biotin-producing organisms lack this pathway, 
suggesting the existence of pimelate synthetic pathway(s) dedicated for biotin synthesis.  
 
 In contrast, BioI is believed to provide de novo synthesis of pimeloyl-ACP by 
catalyzing oxidative C-C bond cleavage of long chain acyl-ACPs
108
 (Figure 1-6).  Like 
other cytochrome P450 enzymes, BioI uses the cysteine-ligated active-site heme to 
activate O2 by two flavodoxin-mediated reductions with NAD(P)H to produce one 
equivalent of the Fe(V)-oxo species and a H2O molecule
108
.  The highly reactive Fe(V)-
oxo species is responsible for acyl chain C-C bond cleavage , although several cycles of 
oxidation are needed to achieve cleavage
30
.  The first intermediate is thought to be a 
monohydroxylated acyl chain, which upon further oxidation would become a vicinal diol.  
A third round of oxidation would cleave the vicinal diol.  Although free fatty acids can be 
processed by BioI in vitro, acyl-ACPs are thought to be the physiological substrates
30,108
.  
No ω-oxidation of fatty acid by BioI was observed, ruling out the possibility of direct 
conversion of octanoyl-ACP to pimeloyl-ACP. 
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The regiospecificity of BioI oxidation of long chain acyl-ACPs is attributed to the 
enzyme active-site architecture and interaction of the protein with ACP.  Both are 
important in dictating the position of oxidative cleavage.  Expression of the bioI gene in 
E. coli resulted in a portion of the BioI protein being found in complexes with 14- and 
18-carbon acyl-ACPs
108
.  The recent elegant crystal structures of BioI-acyl-ACP 
complexes show that the fatty acyl chain together with the 4’-phosphopantetheine 
prosthetic group is inserted into the BioI substrate pocket with ACP bound to the BioI 
surface
31
 (Figure 1-6). This arrangement resembles insertion of a key into a lock, with 
ACP representing the knob of the key.  However, in this case the “lock” is a hydrophobic, 
U-shaped tunnel.  The inserted acyl chain is forced to adopt a kinked U-shaped 
conformation that positions C7-C8 atoms at the bend of the “U”, which is immediately 
above the heme iron
31
.  BioI is thought to hold the acyl chain at the active site for 
hydroxylation at C7 and then at C8 to form the vicinal diol, which is subsequently 
cleaved to give pimeloyl-ACP.  The hydrophobic tunnel extends beyond the heme group 
to accommodate varying acyl chains lengths (C14-C18)
31
.  Hence, the geometry of the 
active site allows precise cleavage of the C7-C8 bond independent of acyl chain length, 
producing pimeloyl-ACP and a monocarboxylic acid from the methyl end.  The 
nonspecific cleavage observed with free fatty acid substrates is explained by the lack of 
ACP to anchor the acyl chain.  The lack of anchoring would allow the acyl chain to slide 
back and forth in the hydrophobic tunnel, resulting in the diversity of products 
observed
31
.   Although this picture is satisfying, it should be noted that BioI has not yet 
been shown to be catalytic with acyl-ACP substrates.  Cleavage of acyl-ACP substrates 
has only been demonstrated for acyl-ACPs that co-purified with BioI, and less than 
stoichiometric production of pimelate was observed
108
.   
 
Several B. subtilis BioI-BioW pathway questions remain unanswered.  It is 
unclear whether or not both BioI and BioW are required for biotin synthesis.  The 
straightforward hypothesis is that BioI is essential for producing pimeloyl-ACP, while 
BioW scavenges pimelic acid from the environment or possibly from nonspecific 
cleavage of free fatty acids by BioI
14
.  A mutation in the bioI gene causes B. subtilis to 
grow poorly, suggesting that pimelic acid may be produced by other metabolic pathways 
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and become converted to pimeloyl-CoA by BioW
14
.  Another question is the substrate for 
KAPA synthesis in B. subtilis.  Since both pimeloyl-CoA and pimeloyl-ACP are 
produced, does B. subtilis BioF recognize both CoA and ACP substrates?  The question 
of CoA versus ACP substrates in the BioF reaction needs to be addressed.  Although CoA 
is a good in vitro analogue of ACP, ACP may not readily mimic CoA.  The active site of 
BioF would need to accommodate additional protein-protein interactions and overcome 
the dynamic sequestration of the acylated 4-phosphopantetheine moiety within the four 
helix structure of the protein
101
.  Since BioW has not been tested with ACP as the thiol 
acceptor and BioI catalysis has not been tested with acyl-CoAs, the identity of the 
physiological pimeloyl carrier(s) remains to be determined.  
 
Other Pathways of Pimelate Synthesis 
Genomic analysis of biotin synthetic genes suggests the presence of alternative 
pathways for pimelate synthesis.  Most of the pathways seem likely to be variations of the 
BioC-BioH pathway found in E. coli, where the two proteins operate as a functional pair.  
Although the bioC gene is widely distributed in bacteria, homologues of the bioH gene 
seem to be missing from many bioC-containing genomes
97
.   In those genomes bioC is 
often found within a bio gene cluster immediately downstream of a gene called bioG that 
may replace BioH function.  It is interesting to note that Neisseria meningitis has both 
bioC-bioH and bioC-bioG gene pairs, whereas Bacteroides fragilis has a gene that seems 
to encode a BioC-BioG fusion protein that potentially catalyzes both the BioC O-
methylation reaction and the BioH demethylation reaction
97
.  In cyanobacteria another 
gene, bioK, is found upstream of bioC, and thus there may be a second means to replace 
BioH function
97
.  The function of bioH has been shown to be replaced by the 
Mesorhizobium loti bioZ gene
110
.  The primary sequence of BioZ bears significant 
homology to the FabH 3-ketoacyl-ACP synthase of fatty acid synthesis, which catalyzes 
the initiation condensation of acetyl-CoA with malonyl-ACP.  Therefore, BioZ may be a 
dedicated biotin synthetic 3-ketoacyl-ACP synthase that catalyzes the condensation of 
two malonyl moieties required to introduce the ω-carboxyl moiety110.  The most 
intriguing biotin synthetic pathway is encoded in the Desulfovibrio vulgaris and D. 
desulfuricans genomes
98
.  These genomes contain a large insertion of five new genes 
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within the standard bioA, bioB, bioD and bioF gene cluster.  These genes share sequence 
homology to ACP, 3-ketoacyl-ACP synthase, 3-ketoacyl-ACP reductase and 3-
hydroxyacyl-ACP dehydratase.  Since Desulfovibrio lacks the known genes for the 
synthesis of pimelate (bioC, bioH, bioI and bioW), the new genes could encode a 
modified fatty acid synthetic pathway committed to pimelate production. 
 
The biotin synthetic genes of the yeast, Saccharomyces cerevisiae, have long been 
used to bioassay biotin and the late intermediates of the pathway have an unusually 
convoluted history.  Many S. cerevisiae strains isolated from the wild cannot synthesize 
biotin but still encode functional analogues of the E. coli bioA, bioD and bioB genes 
called BIO3, BIO4 and BIO2, respectively; whereas some S. cerevisiae strains grow well 
without biotin supplementation. A third class of strains can grow without biotin but 
supplementation of biotin stimulates growth
123
.  These diverse phenotypes produced a 
conflicting literature dating back to Pasteur.  Indeed, even S. cerevisiae laboratory strains 
are variable (e.g., S288c the strain from which the genome sequence was obtained, 
requires biotin for growth whereas A364a, a strain used in much of the cell cycle 
research, does not).  The work of Hall and Dietrich
51
 argues that a yeast ancestor lost its 
biotin synthetic pathway and subsequently reacquired the pathway by two processes, one 
of which was by lateral gene transfer from bacteria.  In the second reacquisition process, 
yeast gene duplication was followed by acquisition of a biotin synthetic function by one 
of the duplicated copies
51
.  Those S. cerevisiae strains that are defective in biotin 
synthesis lack either BIO6 (an BioF acquired from a duplicated yeast gene) or both BIO6 
and a gene of unknown function called BIO1.  The differing growth rates seen in strains 
that do not require biotin are thought due to the variations in the copy numbers of BIO6 
and BIO1
51
.  BIO1 has been proposed to encode a pimeloyl-CoA synthetase
51
.  Although 
this proposal seems to fit its physiological role in the pathway, the encoded Bio1 protein 
has no sequence similarities to any known pimeloyl-CoA synthetase and lacks a 
recognizable ATP binding site.  Hence, either BIO1 encodes a very unusual acyl-CoA 
synthetase or the protein has another function.  As in B. subtilis the S. cerevisiae pimelate 
source is also unknown.  Genes encoding proteins that resemble the bacterial enzymes 
involved in pimelate synthesis have yet to be identified in S. cerevisiae. 
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THE AIM AND SCOPE OF THIS THESIS 
The aim of this thesis is to elucidate the roles of BioC and BioH in the E. coli 
biotin synthetic pathway.  At the early stage of my project, I had an interesting 
observation that pimeloyl-ACP methyl ester could be converted into biotin in both in vivo 
and in vitro experiments.  This substrate is surprisingly different, and yet so similar, to 
pimeloyl-CoA, the only known in vitro biotin precursor reported.  Both substrates share 
the same pimelate moiety and thioester linkage, but one is attached to ACP whereas the 
other is linked to CoA.  The choice of carrier molecule offers an important clue to what 
the other synthetic pathway may be involved in pimelate synthesis.  ACP is the 
physiological carrier in fatty acid synthesis, whereas CoA is the physiological carrier in 
fatty acid degradation (β-oxidation).  Dr. Cronan and I hypothesize that ACP is the 
physiological carrier for the synthesis of pimelate.  There are two reasons to support this 
hypothesis.  First, it has already been known that genetic disruption of fatty acid 
degradation pathway does not affect biotin synthesis.  Therefore, pimelate are not derived 
from β-oxidation acyl-CoA intermediates.  Secondly, acyl-CoA is often a good in vitro 
analog of acyl-ACP because its 4’-phosphopantetheine group offers the minimum 
recognition moiety of ACP to fatty acid synthetic enzymes.  It is plausible in the BioF 
reaction that pimeloyl-CoA acts as an analog of pimeloyl-ACP.  With this hypothesis in 
mind, I decided to ignore pimeloyl-CoA and focus on the synthesis of pimeloyl-ACP and 
the involvement of fatty acid synthetic pathway in biotin synthesis. 
 
The biggest breakthrough came from discovery of the methyl ester moiety, a 
second critical feature of pimeloyl-ACP methyl ester.  This methyl ester moiety is 
essential for bypass of BioC function and also chain elongation process by fatty acid 
synthetic enzymes.  Furthermore, this moiety is specifically cleaved by BioH but not by 
any other hydrolases in E. coli.  Together, my preliminary results hinted at an important 
connection between the methyl ester moiety and BioC, BioH and fatty acid synthesis.  In 
Chapter 2, I delineate the synthesis of pimeloyl-ACP in the early biotin synthetic 
pathway.  I provide experimental evidence to show that BioC and BioH orchestrate the 
synthesis of pimeloyl-ACP by hijacking fatty acid synthetic pathway.  Furthermore, the 
methyl ester moiety is introduced by BioC O-methylation and removed by BioH 
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demethylation, which operates as a switch to control pimelate synthesis.  Chapter 3 
focuses on the biochemical characterization of the BioC methyltransferase.  BioC is 
annotated as a SAM-dependent methyltransferase; however, its activity had not been 
demonstrated and its methyl acceptor substrate was unknown.  By using 
3
H-SAM and 
Bacillus cereus BioC, I have identified malonyl-ACP as the target molecule of BioC 
methylation.  Over-expression of BioC also reduced cell growth - probably by elevated 
levels of malonyl-ACP methylation - which thereby starves fatty acid synthesis for 
malonyl-ACP.  Chapter 4 centers on BioH, which cleaves the methyl ester moiety to 
terminate chain elongation and to liberate the essential ω-carboxyl group of biotin.  I 
present a three-dimensional structure of BioH in complex with pimeloyl-ACP methyl 
ester.  This crystal structure of enzyme-ACP complex was obtained in collaboration with 
the Satish Nair lab.  We have identified four surface arginine residues that are essential 
for BioH binding to the ACP substrate.  Mutation of these arginine residues disrupts the 
binding interaction of BioH to its ACP substrate and therefore decreases BioH activity.  
Finally, in Chapter 5 I summarize the current understanding of E. coli biotin synthesis 
and use this knowledge to propose biotin synthetic pathways in other organisms.
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FIGURES 
 
 
Figure 1-1.   The second stage of biotin synthesis, the assembly of the bicyclic rings, 
consists of four reactions catalyzed by 7-keto-8-aminopelargonic acid (KAPA) synthase, 
7,8-diaminonopelargonic acid (DAPA) synthase, dethiobiotin (DTB) synthase and biotin 
synthase.  Pimelate thioester is a dedicated precursor of the second stage of pathway and 
provides the majority of the biotin backbone carbon atoms.  The R group indicates either 
CoA or acyl carrier protein (ACP).  Biotin is covalently attached to a specific lysine 
residue of biotin-dependent protein by biotin protein ligase.  The ureido ring N8 atom 
carries the CO2 moiety.  Abbreviations: SAM, S-adenosyl-L-methionine; AMTOB, S-
adenosyl-2-oxo-4-thiomethylbutryate; 5’-DOA, 5’-deoxyadenosine.  
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Figure 1-2.   The reaction scheme of DTB synthase, which catalyzes the ATP-dependent 
insertion of CO2 between the N7 and N8 nitrogen atoms of DAPA to form the ureido 
ring, is modified from Huang et al 
57
.  The regiospecific carboxylation of N7 produces a 
carbamate intermediate which is held in place via a number of ionic and H-bonding 
interactions, particularly involving the e-amino groups of residues Lys15 and Lys37.  The 
carbamate intermediate and the γ-phosphate group of ATP are aligned in the active site 
for nucleophilic attack on the phosphorus atom, an event facilitated by Lys37 which 
stabilizes the resulting negatively charged carbonyl oxygen. Upon deprotonation of N8 
by residue Glu12 or one of the phosphate oxygen atoms, the formation of the ureido ring 
is complete.  
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Figure 1-3.   The proposed reaction of biotin synthase begins with the reduction of 
sulfonium group of SAM by transferring an electron from reduced flavodoxin via the 
[4Fe-4S]
2+
 cluster.  This reduction generates methionine plus a 5’-deoxyadenosyl radical 
(5’-DOA•) that abstracts a hydrogen atom from the C9 methyl group of DTB.  The C9 
carbon radical attacks the bridging sulfide of the [2Fe-2S]
2+
 cluster.  A second 5’-DOA 
radical is then generated which abstracts a hydrogen atom from the C6 methylene group.  
The C6 carbon radical attacks the same sulfur atom of the [2Fe-2S]
2+
 cluster resulting in 
the insertion of a sulfur atom between C6 and C9 atoms and the formation of the 
tetrathiophane ring of biotin.  This figure is adapted from the reviews by Jarrett
60
 and 
Lotierzo et al 
77
.  
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Figure 1-4.  Decarboxylative Claisen condensation with malonyl-ACP (or CoA) is 
common to fatty acid synthesis, type III polyketide synthesis and in the proposed model 
of pimeloyl-CoA synthesis.  However, these pathways differ significantly with respect to 
the processing of the internal keto groups.  In fatty acid synthesis, the keto group is 
eliminated by a series of reduction-dehydration-reduction reactions, whereas in type III 
polyketide synthesis [using DpgA
45
 as an example], the keto groups are retained or 
remodeled during the subsequent cyclization of carbon chain.  The proposed model of 
pimeloyl-CoA synthesis
75
 from condensation of three molecules of malonyl-CoA would 
produce an keto group at each of the two chain elongation steps which must be 
eliminated in order to produce pimeloyl-CoA.  
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Figure 1-5.  The proposed E. coli BioC-BioH pathway for pimelate synthesis comprises 
three main steps.  The initiation step is catalyzed by BioC O-methyltransferase which 
transfers a methyl group from SAM to the ω-carboxyl group of malonyl-ACP (or CoA), 
to give malonyl-ACP (or CoA) methyl ester as a primer dedicated to biotin synthesis.  
The second step is the chain elongation cycle by fatty acid synthesis using ACP as the 
acyl chain carrier.  The methyl ester moiety allows elongation of a malonate to a pimelate 
after two cycles of synthesis.  Once the desired chain length is achieved, BioH terminates 
chain elongation by cleaving the methyl ester moiety to produce pimeloyl-ACP, a 
substrate for BioF in the second stage of biotin synthesis. Abbreviation: SAH, S-
adenosylhomocysteine.  
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Figure 1-6.  The interactions of BioI with ACP and 4’-phosphopantetheine group (PPant) 
provide the regiospecificity needed for precise cleavage of C7-C8 bond of the acyl chain.  
(a) In the crystal structure of BioI in complex with E. coli hexadec-9Z-enoyl-ACP (PDB 
code 3EJD), the acyl chain adapts a U-shaped conformation with C7 and C8 atoms 
becoming situated at the bend of the “U” immediately above the heme iron.  The U-
shaped tunnel extends beyond the heme group to accommodate varying acyl chain 
lengths.  For simplicity only a ribbon diagram is shown.  However, numerous BioI-ACP 
contacts involving salt bridges between acidic residues of ACP and basic residues of BioI 
are found.  In addition, a number of hydrogen bonds are formed by backbone amide 
groups of several non-polar residues of both ACP and BioI
31
.  (b) Cleavage of the C7-C8 
bond, independent of the acyl chain length, produces pimeloyl-ACP and a 
monocarboxylic acid from the methyl end.  Each arrow indicates oxidation, but the 
stoichiometry of these reactions is not known.  Color codes: blue, ACP; yellow, PPant; 
green, hexadec-9Z-enoate; red, heme; orange, iron; grey, BioI.   
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CHAPTER 2 
BIOTIN SYNTHESIS PROCEEDS BY HIJACKING THE FATTY ACID 
SYNTHETIC PATHWAY 
 
INTRODUCTION 
In my proposed model of biotin synthesis, the role of BioC is to convert the ω-
carboxyl group of a malonyl-thioester to its methyl ester by transfer of a methyl group 
from SAM.  Methylation would both cancel the charge of the carboxyl group and provide 
a methyl carbon to mimic the methyl ends of normal fatty acyl chains.  The esterified 
malonyl-thioester would enter the fatty acid synthetic pathway as proposed by Lynen
78
.  
Two reiterations of the elongation cycle would produce pimeloyl-ACP methyl ester. 
BioH would then cleave the methyl ester to give pimeloyl-ACP that BioF would utilize to 
make KAPA, the first intermediate in biotin ring assembly.  In this scenario, introduction 
of the methyl ester disguises the biotin synthetic intermediates such that they become 
substrates for the fatty acid synthetic pathway.  When synthesis of the pimeloyl moiety is 
complete and disguise is no longer needed, the methyl group is removed to free the 
carboxyl group that will eventually be used to attach biotin to its cognate metabolic 
enzymes.   
In this chapter, I report two experiments that were used to delineate the early steps 
of biotin synthetic pathway, leading to the synthesis of pimeloyl-ACP.  The first 
experiment is an in vivo bypass assay mediated by acyl-ACP synthetase (AasS) from 
Vibrio harveyi.  Expression of AasS enables ligation of the methyl ester of 
dicarboxylates, which are supplemented in growth medium, with cytoplasmic ACP.  This 
assay demonstrates that the monomethyl esters of malonate, glutarate and pimelate allow 
growth of a ∆bioC strain in the absence of biotin, but fail to allow growth of ∆bioC 
∆bioH strains.  The second experiment is an in vitro cell-free extract system that allows 
de novo synthesis of DTB, which is the last intermediate in the pathway, from malonyl-
CoA, a substrate for fatty acid synthesis.  This system allows systematic dissection of the 
precursor requirements of fatty acid and biotin synthetic pathways.  I also used inhibitors, 
which target fatty acid synthetic enzymes and SAM-dependent methyltransferases, to 
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disrupt DTB synthesis.  Reduction in DTB synthesis by the inhibitors suggests that fatty 
acid synthesis and methylation reaction are indispensable to biotin synthesis. 
 
MATERIALS AND METHODS 
Materials 
The defined medium was M9
83
 supplemented (final concentrations) with 0.2 % 
glucose, 0.1 % Vitamin Assay Casamino Acids, 1 mM MgSO4 and 1 μg/ml thiamine, 
except when 0.2 % arabinose replaced glucose.  Agar was added to 1.5 %.  Antibiotics 
were used at the following concentrations (in μg/ml): sodium ampicillin, 100; kanamycin 
sulfate, 50; chloramphenicol, 30.  Assay Buffer is 50 mM 3-(N-morpholino) 
propanesulfonic acid (MOPS) pH7.5, 200 mM NaCl, 10 % glycerol and 5 mM 2-
mercaptoethanol.  ACP (holo form) and AasS were prepared from strains DK574 and 
YFJ239, respectively, strictly according to the detailed protocols given previously
20,43
. 
 
Construction of plasmids  
Bacterial strains, plasmids and primers are listed in Table 2-2.  The bioC and bioH 
genes were PCR amplified from MG1655 genomic DNA using oligonucleotide sets A07-
A08 and A11-A12, respectively.  The bioC PCR product was digested with NcoI and 
XhoI whereas the bioH PCR products were digested with BspHI and XhoI.  The DNA 
fragments were ligated into pET28b+ digested with NcoI and XhoI to give plasmids 
pSTL4 and pSTL6 carrying the bioC and bioH genes, respectively.  Plasmid pSTL13 
encodes a mutant version of bioH in which codon 82 was changed from serine to alanine 
by site-directed mutagenesis using oligonucleotides A39 and A40 and the QuikChange 
procedure (Stratagene).  Plasmid pSTL20 carrying the Bacillus subtilis bioW gene was 
constructed by amplification of bioW from B. subtilis genomic DNA using 
oligonucleotides A41 and A55.  The resulting PCR product was digested with NcoI and 
XhoI and ligated into pBAD322 digested with NcoI and SalI.  Plasmid pCY123 which 
carries the entire bio operon (bioABFCD) was constructed by digestion of plasmid 
pLC25-23
24
 with HindIII and EcoRI and ligation of the 6.6 kb bio fragment to pBR329 
digested with the same enzymes.  An in-frame ∆bioC derivative of plasmid pCY123 was 
constructed by digestion with BglII and religation of the plasmid, removing 46 amino 
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acid residues between codon 24 and 70.  The resulting plasmid pSTL25 complemented a 
∆bioD strain but not a ∆bioC strain.  The HindIII site lies in the phage λ att region (the 
original clone was made from a λ lysogen).  Plasmid DNAs were extracted by QIAprep 
Miniprep (Qiagen).  The constructs were verified by DNA sequencing conducted by the 
Core sequencing Facility of the Carver Biotechnology Center of University of Illinois at 
Urbana-Champaign.  
 
Construction of bacterial strains 
The strains used in this study were derivatives of the sequenced E. coli K-12 
strain MG1655 unless stated otherwise.  Chromosomal deletions of bio genes in strain 
BW25113 were constructed by the λ recombination system of Datsenko et al.32.  The kan 
cassette was amplified from pKD13 using the following oligonucleotides A70-A71 (bioA 
deletion), A15-A16 (bioC deletion), A68-A69 (bioF deletion) and A17-A18 (bioH 
deletion).  Essentially the entire center of the coding sequences of each the genes was 
deleted in frame leaving <20 residues at the termini.  This was essential for function of 
the genes upstream and downstream of bioF and bioC because the coding sequences 
overlap.  The kan cassette plus the flanking chromosomal segments was transduced into 
MG1655 using phage P1vir and the cassette subsequently eliminated by the FLP helper 
plasmid
32
.  Strains STL23, STL24, STL112 and STL115 carrying in-frame deletions of 
bioC, bioH, bioA and bioF, respectively, were verified as biotin auxotrophs by testing on 
glucose minimum media plus or minus biotin. The lack of any polarity was demonstrated 
by complementation with plasmids carrying the gene deleted from the chromosome.  
Strain STL25 carrying deletions of both the bioC and bioH genes was constructed by 
transduction of strain STL23 to kanamycin resistance with a P1 phage stock grown on 
strain STL29.  The kan cassette in bioH was eliminated by the FLP helper plasmid
32
.  The 
bypass strains STL32, STL33 and STL34 were constructed by transforming strains 
STL23, STL24 and STL25, respectively, with pYFJ84 which encodes aasS under control 
of a T7 promoter.  Strain STL74 was made by transforming STL25 with plasmid 
pSTL20, which carried the Bacillus subtilis bioW gene under control of an araBAD 
promoter. 
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Esterification of dicarboxylic acid and analysis   
Compounds used are listed in Table 2-2.  The dicarboxylic acids and most of their 
esters were obtained commercially.  Those monoesters that were not commercially 
available were synthesized by one of three methods.  Diesters were partially hydrolyzed 
under basic conditions that gave hydrolysis and transesterification, whereas dicarboxylic 
acid monoesters were synthesized from the dicarboxylic acid by ion exchange resin-
catalyzed esterification in a two-phase solution that gives selective monesterification
102
 or 
by a more robust procedure in which acid-catalyzed esterification/transesterification was 
performed by dissolving the acid to 0.1 M in the anhydrous alcohol plus 0.1 % (v/v) 
concentrated HCl
46
.  These reactions gave mixtures of diester and monoester together 
with the free dicarboxylic acid with at least half of the products being the monoester as 
determined by gas chromatography mass spectrometry (GC-MS) at the Roy J. Carver 
Metabolomics Center at University of Illinois at Urbana-Champaign (Figure 2-1).  
Samples of 1 µl were injected with a split ratio of 150:1 on the Agilent GC-MS system 
consisted of a 5973 MSD, a 7683B autosampler and a 6890N gas chromatograph 
equipped with a 30 m ZB-WAX capillary column, 0.25 mm I.D. and 250 µm film 
thickness (Phenomenex).  Injection temperature and the MSD transfer line were set to 
280 
º
C, the ion source and MS quadrupole were adjusted to 230 
°
C and 150 
°
C 
respectively.  The helium carrier gas was set at a constant flow rate of 2 ml min
-1
.  The 
temperature program was: 140 
°
C for 5 min, 40 
°
C min
-1
 to 260 
°
C, 265 
°
C for 10 min.  
Acquired GC-MS spectra were recorded in the m/z 50-800 scanning range and processed 
using AMDIS (NIST) and MSD ChemStation D.02.00.275 (Agilent) software and 
compared with standard mass spectrum libraries NIST08 (NIST), WILEY8n (Palisade), 
and a custom library.  The concentrations of the monoester compounds we synthesized 
were determined by adding a known concentration of an internal standard monoester 
having a chain length that differed from the monoester of interest by one methylene 
group. 
 
Enzymatic synthesis of pimeloyl-ACP methyl ester   
Acyl-ACP synthesis and purification was adapted from the method of Jiang et 
al.
61
.  Briefly, the acylation reaction contained 50 mM Tris-HCl (pH 8.5), 10 mM MgCl2, 
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0.5 mM dithiothreitol (DTT), 2 mM ATP, 2 mM pimelate methyl ester, 100 µg/ml ACP 
and 10 μg/ml AasS.  The reactions were incubated at 37 °C for 2 h.  Pimeloyl-ACP 
methyl ester was purified by ion exchange chromatography using Vivapure D spin 
columns (GE Healthcare Life Sciences).  The reaction mixtures were loaded in Binding 
Buffer (25 mM 4-morpholineethanesulfonic acid (MES), pH 6, 10 % glycerol and 1 mM 
DTT) containing 100 mM LiCl and the column was washed with Binding Buffer 
containing 250 mM LiCl.  Pimeloyl-ACP was eluted in Binding Buffer containing 500 
mM LiCl, desalted and analyzed in a conformationally-sensitive electrophoretic mobility 
assay
43
 in 20 % polyacrylamide gels containing 2.5 M urea at 130 V for 3 h (Figure 2-
2a).  Glutaryl-ACP methyl ester and other acyl-ACPs were prepared by the same method.  
The molecular masses of the products were verified by mass spectrometry with MALDI-
MS (Figure 2-3) at the Mass Spectrometry Laboratory of University of Illinois at Urbana-
Champaign.  The ACP products were dialyzed in 3,500 molecular weight cut-off 
membrane against 2 mM ammonium acetate at 4
 °
C for 15 h.  Samples were mixed with 
α-cyano-4-hydroxycinnamic acid as matrix and analysis was performed using a Voyager-
DE STR mass spectrometer (Applied Biosystems) using a UV laser (337 nm N2 laser).  
All measurements were made using the linear mode and positive ions were recorded 
(Figure 2-3). 
 
BioH purification  
The C-terminal His-tagged versions of BioH and BioH S82A were over-expressed 
from strains STL14 and STL47, respectively.  The proteins were purified by 
immobilized-metal affinity chromatography using a nickel-nitrilotriacetic acid column 
(Ni-NTA) from Qiagen according to the manufacturer’s protocol.  The cells were 
resuspended in Loading Buffer (50 mM MOPS, pH 7.5, 500 mM NaCl, 10 % glycerol 
and 5 mM 2-mercaptoethanol) containing 10 mM imidazole and lysed by French Press at 
17,500 psi.  The Ni-NTA column was washed with 20 column volumes of 50 mM 
imidazole in Loading Buffer.  The protein was eluted with 250 mM imidazole in Loading 
Buffer.  The purified proteins were dialyzed in Loading Buffer in Pierce Slide-A-Lyzer 
dialysis cassette (7000-Da MWCO) and stored at -80 
°
C.  The protein concentration was 
estimated by Bio-Rad protein assay using bovine gamma globulin (Pierce) as standard.  
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The purified proteins were analyzed in sodium dodecyl sulfate 10 % polyacrylamide gel 
electrophoresis (SDS-PAGE) (Figure 2-4). 
 
BioC purification and refolding  
The C-terminal His-tagged version of BioC was over-expressed as inclusion 
bodies from strain STL11.  The cells were lysed in Lysis Buffer (50 mM MOPS, pH 7.5, 
300 mM NaCl, 10 mM 2-mercaptoethanol, 10 % glycerol, 10 µg/ml of RNase, 10 µg/ml 
of DNaseI and 10 µg/ml lysozyme) by French Press treatment at 17,500 psi.  The 
insoluble fraction of the cell extract was washed five times in Isolation Buffer (50 mM 
MOPS, pH 7.5, 1 M NaCl, 0.5 M guanidine-HCl, 10 mM 2-mercaptoethanol, 10 % 
glycerol, and 5 % Triton X-100) to partially purify BioC inclusion bodies.  BioC was 
solubilized in Solubilization Buffer (50 mM MES, pH 6, 1 M NaCl, 4 M guanidine-HCl, 
10 % glycerol, 5 mM 2-mercaptoethanol, 5 % sorbitol, 0.05 % Tergitol NP-40, and 10 
mM imidazole), purified under denatured condition in Ni-NTA column, and eluted in 
Solubilization Buffer containing 250 mM imidazole.  The denatured BioC was adjusted 
to 100 µg/ml in 30 ml of Solubilization Buffer and transferred to a 250-ml beaker 
containing a stir bar.  Refolding of BioC was performed by titration by adding 300 ml of 
Refolding Buffer (Solubilization Buffer lacking guanidine-HCl) to BioC at 25 
°
C at a rate 
of approximately 1 drop/sec with constant stirring.  The refolded BioC was purified by 
Ni-NTA column and eluted with Refolding Buffer containing 250 mM imidazole.  BioC 
was dialyzed and stored in Dialysis Buffer (25 mM MES, pH 6, 200 mM NaCl, 10 % 
glycerol and 1 mM 2-mercaptoethanol) (Figure 2-4). 
 
AasS-mediated bypass assay  
The chemical structures and sources of dicarboxylates and derivatives used in this 
study are summarized in Table 2-2.  Strains STL32, STL33 and STL34 were constructed 
by transformation with pYFJ84.  The strains were grown at 37 
°
C on minimal agar 
containing 0.1 mM of a dicarboxylate or a derivative plus 0.1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) to induce AasS expression.  Bypass of bio gene function 
was observed as growth in the absence of biotin.  Avidin (0.1 units/ml, Calbiochem) was 
also added to the medium to prevent cross-feeding and neutralize any biotin or DTB 
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contamination.  To verify the permeability of E. coli to pimelate, strain STL74 carrying a 
plasmid encoding B. subtilis bioW gene was streaked on M9 defined agar supplemented 
with 0.1 mM of sodium pimelate and 0.2 % arabinose for induction (Figure 2-5). 
 
Preparation of ΔbioC cell-free extracts   
Strain STL96 was grown at 37 
°
C to OD at 600 nm of 0.8 in 250 ml of M9 defined 
medium containing 2 nM biotin.  The cells were washed in M9 medium to remove biotin 
and subcultured into 1 L of M9 medium at 37 
°
C for 5 h to derepress bio operon 
transcription by starvation for biotin.  The cells were collected by centrifugation and 
lysed in Assay Buffer by French Press treatment at 17,500 psi followed by centrifugation 
at 20,000 g for 20 min to obtain the soluble fraction of the cell extract.  Ammonium 
sulfate was added slowly to 85 % of saturation to the soluble cell extract in a beaker on 
ice under constant stirring until completely dissolved.  This step was intended to remove 
small molecules and delete the extracts of ACP which remains soluble in such 
ammonium sulfate solutions
96
. The protein precipitant was collected by centrifugation at 
10,000 g and stored at -80 
°
C.  The precipitant was solubilized before use by dialysis in 
7,000 molecular weight cut-off membranes against Assay Buffer at 4 
°
C for 3 h to 
remove ammonium sulfate and any remaining small molecules.  Extracts of the other 
deletion strains were prepared by the same procedure. 
 
In vitro DTB synthesis   
This assay allows in vitro conversion of ACP-bound substrate into DTB using 
enzymes in cell-free extracts.  A 100 μl reaction in Assay Buffer contained 2.5 mg cell-
free extract protein, 1 μmol MgCl2, 0.5 μmol DTT, 0.01 μmol pyridoxal-5'-phosphate 
(PLP), 50 μg ACP, 2 μg BioC, 0.1 μmol L-alanine, 0.1 μmol KHCO3, 0.1 μmol NADPH, 
0.1 μmol ATP, 0.1 μmol glucose-6-phosphate and 0.1 μmol SAM.  Malonyl-CoA was 
used at 0.2 μmol whereas pimeloyl-ACP methyl ester or another acyl-ACP substrate was 
added at 50 μg.  The reactions were incubated at 37 °C for 3 h and quenched by 
immersion in boiling water for 10 min.  DTB production was bioassayed as follows.  
Strain ER90 (∆bioF bioC bioD) was grown in 5 ml of M9 medium containing 2 nM 
biotin at 30 
°
C overnight.  The cells were washed with M9 medium and subcultured in 
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100 ml of M9 medium at 37 
°
C for 5 h to starve the cells for biotin.  The cells were 
collected by centrifugation, washed again in M9 medium and mixed into 150 ml of 
minimal agar containing the redox indicator 2,3,5 triphenyl tetrazolium chloride (0.1 %) 
to a final OD at 600 nm of approximately 0.1.  Six ml of the mixture was poured into 
petri dishes sectored with plastic walls to prevent cross-feeding.  A 6 mm paper disk 
(BBL) was placed upon the agar and the disk was spotted with 10 μl of a reaction to be 
tested.  After incubation of the plates at 30 
°
C overnight, growth of strain ER90 was 
visualized as a red deposit of formazan.  KAPA synthesis was performed similarly using 
extracts of strain STL112 followed by bioassay on strain STL115. 
 
RESULTS 
Dicarboxylate monoesters allow growth of a ∆bioC strain  
I propose that the intermediates of pimelate synthesis are acyl carrier protein 
(ACP) thioesters.   To obtain such substrates we tested malonic, glutaric and pimelic 
acids and their monomethyl esters as substrates for acyl-ACP synthetase (AasS) from 
Vibrio harveyi
61
 (Figure 2-2a).  AasS was completely inactive with the diacids probably 
due to the inability of the terminal carboxyl groups to enter the hydrophobic tunnel where 
the substrate acyl chain resides
61
.  In contrast, the three monomethyl esters were readily 
converted to their ACP thioesters.  Given these data and prior success in using this 
enzyme to insert exogenous fatty acids into the fatty acid synthetic pathway in vivo
62
, I 
tested whether or not expression of AasS in E. coli ∆bioC, ∆bioH or ∆bioC ∆bioH strains 
would allow growth in the absence of biotin when the medium was supplemented with 
one of the three monomethyl esters.  Note that essentially the entire coding sequences 
were deleted in construction of the ∆bioC and ∆bioH strains. 
 
Supplementation of biotin-free medium with any of the three monomethyl esters 
allowed AasS-dependent growth of the ∆bioC strain whereas the ∆bioH and ∆bioC 
∆bioH strains failed to grow under these conditions (Figure 2-6).  Supplementation with 
malonic, glutaric and pimelic acids also failed to support growth, although the last of 
these could be shown to enter E. coli (Figure 2-5).  This was demonstrated by expression 
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of the BioW pimeloyl-CoA synthetase of Bacillus subtilis in a ∆bioC ∆bioH strain which 
upon supplementation with pimelic acid allows growth of these mutant strains in the 
absence of biotin
14
.  Putative intermediates in the pathway, the enoyl, 3-keto and 3-
hydroxy derivatives of the monomethyl ester of glutarate and the 3-keto and 3-hydroxy 
derivatives of the monomethyl ester of pimelate allowed growth whereas the 2-keto, 2-
hydroxy and 4-keto derivatives did not (Table 2-2).  The specificity of the in vivo system 
was also demonstrated by the failure of the monomethyl esters of C4, C6, C8, C9 and 
C11 dicarboxylates to support growth of the ∆bioC strain.  The compounds active as 
monomethyl esters were also active as their monoethyl, monopropyl and monobutyl 
esters (Table 2-2).  In the case of malonic acid, monoesterification with the longer 
alcohols resulted in better growth than seen with the monomethyl ester, perhaps due to 
increased activity with AasS.  Growth with the longer esters indicated that the enzyme 
catalyzing cleavage of the ester linkages tolerates the larger alcohol moieties (see below).  
The fact that either AasS plus the monomethyl ester of pimelate or BioW plus pimelate 
allowed growth of ∆bioC strains argues that BioF can accept either thioester.  This is not 
unprecedented, a number of fatty acid synthetic enzymes accept acyl-CoA substrates in 
vitro, albeit these are generally less efficient substrates than the cognate acyl-ACPs. 
 
Fatty acid synthesis-dependent DTB production in vitro 
To further test the proposed pathway, I developed an in vitro system in which 
DTB synthesis was coupled to the fatty acid synthetic pathway.  DTB (the last 
intermediate of the pathway) was assayed rather than biotin because BioB (biotin 
synthase), the last enzyme of the pathway, is a notoriously unstable and oxygen-sensitive 
protein that has not been demonstrated to be catalytic in vitro
22
.  The in vitro system 
consisted of cell-free extracts of wild type or ∆bio strains that had been subjected to 
ammonium sulfate precipitation (where ACP remains soluble) followed by dialysis; 
manipulations designed to remove small molecules and deplete the extracts of ACP.  The 
strains sometimes carried extra copies of the bio operon genes on a multicopy plasmid.  
The in vitro system allowed us to test which precursors are required for DTB synthesis, 
show that SAM is required for KAPA synthesis, and that the methyl group is required for 
elongation of the C5 species. 
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DTB synthesis was determined by bioassay with E. coli strain ER90 (∆bioF bioC 
bioD), which carries an insertion-deletion mutation within bioF that also inactivates the 
downstream genes, bioC and bioD, by transcriptional polarity
21
.  Hence, strain ER90 is 
defective in synthesis of KAPA, DAPA and DTB, but proficient in conversion of DTB to 
biotin
21
.  Detection by bioassay was required because biotin synthesis is an extremely low 
capacity synthetic pathway (E. coli requires only about 100 biotin molecules per cell).  In 
the bioassay, which can reliably detect 1 ρmol of DTB (Figure 2-7a), the test solution 
diffuses from a filter disk into biotin-free minimal medium agar seeded with an 
appropriate DTB (or biotin)-requiring E. coli strain.  If growth proceeds, a redox 
indicator becomes reduced and forms a bright red, insoluble deposit with the area of the 
red spot being proportional to the concentration of the biotin pathway intermediate. 
 
DTB synthesis was obtained upon supplementation of extracts of a wild type 
strain with the cofactors (malonyl-CoA, NADPH and ACP) required for in vitro fatty 
acid synthesis
73
 plus those required for the late steps of the biotin synthetic pathway (L-
alanine, ATP and SAM).  In contrast, parallel assays of extracts of ∆bioC, ∆bioH or 
∆bioA strains produced no detectable DTB.  DTB synthesis was observed when malonyl-
CoA was added to the reaction whereas the structurally related compounds, acetyl-CoA, 
succinyl-CoA and malonate, were inactive (Figure 2-7b).  The requirements for DTB 
synthesis were then examined in extracts of the ∆bioC strain STL96 (Figure 2-7c).  The 
extracts were inactive, but activity was restored upon addition of BioC purified from 
inclusion bodies and refolded into a soluble form (Figure 2-7c).  NADPH was required in 
addition to malonyl-CoA.  Thus, two essential components of the fatty acid synthetic 
pathway were required for DTB synthesis (Figure 2-7c).  Omission of ACP from the 
reaction reduced, but did not abolish DTB synthesis, probably due to residual ACP in the 
extracts.  As expected, DTB synthesis also required ATP and SAM, the respective 
substrates of BioD and BioA (Figure 2-7c).  In the absence of BioC, pimeloyl-ACP 
methyl ester (synthesized using V. harveyi AasS) was converted to DTB (Figure 2-7c).  
Bypass of the BioC requirement was also observed when malonyl-ACP methyl ester and 
glutaryl-ACP methyl ester were used as substrates (Figure 2-2c).  However, unlike 
pimeloyl-ACP methyl ester, DTB synthesis from these substrates required the presence of 
34 
 
malonyl-CoA (Figure 2-2c).  In agreement with the in vivo results, the methyl esters of 
succinyl-ACP, adipyl-ACP, suberyl-ACP and azelayl-ACP lacked activity in vitro.  
 
The methyl ester moiety is essential for chain elongation 
I postulated that methylation of the ω-carboxyl group of the malonyl thioester was 
catalyzed by BioC and was essential for accessing the fatty acid elongation cycle 
enzymes.  To test this hypothesis, the assay was modified to specifically ask whether or 
not KAPA synthesis requires SAM.  The in vitro KAPA assay used malonyl-CoA as the 
starting substrate and an extract from the ∆bioA strain STL112.  Since in the absence of 
BioA KAPA cannot be converted to DAPA, KAPA would accumulate in the reaction.  
KAPA was detected by bioassay using the ∆bioF strain, STL115 that required KAPA (or 
a later intermediate) for growth.  SAM was clearly required for in vitro KAPA synthesis 
(Figure 2-8a).  Moreover, the requirement for SAM was bypassed when pimeloyl-ACP 
methyl ester was added in place of malonyl-CoA (Figure 2-8a).   
 
To directly test whether or not the methyl ester was required for chain elongation 
by the fatty acid synthetic pathway, I synthesized glutaryl-ACP methyl ester using AasS 
and removed the ester group by BioH treatment to obtain glutaryl-ACP (Figure 2-3).  
Purified samples of glutaryl-ACP methyl ester and glutaryl-ACP were tested for the 
ability to support DTB synthesis in a ∆bioC extract.  In the presence of glutaryl-ACP 
(which lacked the methyl ester moiety) no DTB was produced (Figure 2-8b) whereas 
DTB was synthesized in the presence of glutaryl-ACP methyl ester, but only when 
malonyl-CoA was available for elongation (Figure 2-8b).  Therefore, the methyl ester 
moiety was essential for the conversion of the glutaryl moiety to DTB.  
 
Inhibitors of fatty acid synthesis block in vitro DTB synthesis   
The proposed pimelate synthetic pathway was further tested by use of the 
antibiotics, cerulenin and thiolactomycin plus the microbiocide, triclosan, to block fatty 
acid synthesis in vitro (Figure 2-9).  Cerulenin inhibits the β-ketoacyl-ACP synthases, 
FabB and FabF, whereas thiolactomycin inhibits FabB and FabF plus the short chain β-
ketoacyl-ACP synthase, FabH
17
.  Triclosan inhibits FabI, the sole E. coli enoyl-ACP 
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reductase
17
.  Addition of any of these three inhibitors severely reduced the levels of DTB 
synthesized from malonyl-CoA in a concentration-dependent manner (Figure 2-9).  
Moreover, the effects of triclosan were shown to be due to inhibition of FabI because 
addition of purified Vibrio cholerae FabV, a naturally triclosan-resistant enoyl-ACP 
reductase
80
, largely restored DTB synthesis to triclosan-treated extracts.  The fatty acid 
synthesis inhibitors had no effect on DTB synthesis when pimeloyl-ACP methyl ester 
was the substrate indicating that their effects were due to inhibition of synthesis of the 
pimeloyl moiety.   
 
Sinefungin, a SAM analog and a potent inhibitor of SAM-dependent 
methyltransferases
92
, also inhibited DTB synthesis when malonyl-CoA was the substrate.  
No inhibition was seen when pimeloyl-ACP methyl ester was the substrate (Figure 2-9) 
indicating that the blockage of DTB synthesis was not due to inhibition of BioA, the step 
later in the pathway where SAM is used as an amino donor.  
 
DTB synthesis from pimeloyl-ACP methyl ester requires BioH 
My in vivo results indicated that BioH activity was required for conversion of the 
pimeloyl methyl ester moiety to biotin.  To explore this in more detail, a cell-free extract 
of the ∆bioH strain STL98 was prepared and was found to be unable to convert pimeloyl-
ACP methyl ester to DTB unless the extract was supplemented with purified BioH 
(Figure 2-8c).  I synthesized various ω-carboxyl acyl-ACP esters and tested the ability of 
BioH in vitro to cleave the ester moieties of these substrates.  BioH hydrolyzed the 
methyl, ethyl, propyl and butyl esters of pimeloyl-ACP (Figure 2-10), confirming our in 
vivo bypass assay results.  BioH also readily hydrolyzed the methyl esters of adipyl-, 
pimeloyl-, suberyl- and azelayl-ACPs, but failed to cleave malonyl-ACP methyl ester and 
succinyl-ACP methyl ester whereas glutaryl-methyl ester seemed to cleave less 
efficiently (Figure 2-10).  As a control, I expressed and purified a BioH S82A mutant 
protein.  This protein was expected to be inactive because in the BioH crystal structure
103
 
Ser82 had been modified by reaction with phenylmethylsulfonyl fluoride added as a 
proteolysis inhibitor.  Since this inhibitor inhibits serine proteases and esterases by 
forming a covalent adduct with the active site nucleophile, there seemed little doubt that 
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the S82A substitution would inactivate BioH.  As expected the mutant protein was 
inactive in the in vitro hydrolysis assay (Figure 2-10) and failed to support DTB synthesis 
in a ∆bioH extract (Figure 2-8c).  Moreover, expression of BioH S82A in a ∆bioH strain 
failed to allow growth on biotin-free medium whereas expression of wild type BioH 
supported robust growth (Figure 2-11).  These results, together with the biotin 
requirement of ∆bioH strains, indicate that the methyl ester moiety is specifically cleaved 
by BioH and not by other E. coli hydrolases. 
 
DISCUSSIONS 
The early steps of biotin synthesis in E. coli have long been an enigma.  Indeed, 
more than 40 years after the discovery of the two genes, my data are the first to 
demonstrate that BioC precedes BioH in the pathway.  It has been argued that BioH is not 
involved in pimelate synthesis
85
 and also that it is intimately involved
72
.  BioC and BioH 
were postulated
72
 to catalyze Claisen condensations and to transfer the pimeloyl moiety 
from a BioC active site thiol to CoA, respectively.  A more recent proposal was that BioH 
would somehow condense CoA and pimelic acid to produce pimeloyl-CoA perhaps with 
the help of BioC
103
. 
 
I have demonstrated that these hypotheses are incorrect and that the roles of BioC 
and BioH are to allow E. coli to synthesize pimeloyl-ACP via the fatty acid synthetic 
pathway.  The pimeloyl-ACP synthetic pathway differs from normal fatty acid synthesis 
in that the ω-carboxyl group of a malonyl-thioester is converted to its methyl ester by 
SAM-dependent methyl transfer catalyzed by BioC.  I expect that the malonyl-thioester is 
malonyl-CoA because FabH, which uses acetyl-CoA rather than acetyl-ACP
17,121
, seems 
likely to catalyze the first condensation.  Moreover, E. coli FabH is known to accept 
propionyl-CoA, a reasonable analogue of malonyl-CoA methyl ester although it cannot 
accept bulkier branched-chain acyl-CoAs as substrates
23
.  However, I could not 
determine in this chapter whether the methyl acceptor is malonyl-CoA or malonyl-ACP 
(or both).  This is because E. coli BioC (as well as the BioCs of Salmonella enterica, 
Pseudomonas putida, Bacillus cereus and Kurthia sp.) is an extremely recalcitrant 
protein.  E. coli BioC invariably formed inclusion bodies under a wide range of 
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expression conditions both in native form and as a fusion protein.  Others have 
encountered the same problem with BioC
112
.  Although we have recovered traces of 
activity by refolding denaturated BioC, the activities are too low to detect methyl transfer 
by direct means (e.g., transfer of the methyl group from [methyl-
3
H]-SAM).  It should 
also be noted that native BioC might be an intrinsically poor catalyst.  E. coli requires 
only trace quantities of biotin and thus catalytic efficiency is not required of the biotin 
pathway enzymes.  Indeed, the enzymes late in the pathway are notably poor catalysts 
(kcat values of 0.1-0.01 s
-1
).  Moreover, a catalytically efficient BioC might compromise 
fatty acid synthesis, by depleting the substrate malonyl-ACP.  
 
Methyl transfer to a carboxyl group is an unusual reaction for a SAM-dependent 
methyltransferase and thus it is interesting that data base searches using several BLAST 
algorithms indicate that the closest relative of BioC is a known carboxyl 
methyltransferase, the E. coli trans-aconitate methyltransferase (Tam) that converts 
trans-aconitate to its 6-methyl ester
15,16
.  The E. coli Tam and BioC proteins align with 
28 % identity over the full lengths of the proteins with only a few small gaps.   
 
The pimeloyl-ACP synthetic pathway also requires BioH.  I believe that the 
physiological role of BioH is to remove the methyl group introduced by BioC when the 
pimeloyl moiety is complete.  If so, this would prevent further chain elongation to 
azelayl-ACP methyl ester, a physiologically useless product. However, we find that BioH 
is a rather promiscuous hydrolase that also cleaves various esters of pimeloyl-ACP and 
the methyl esters of the C5 through C9 acyl-ACPs (Figure 2-10) although the thioester 
bonds of these substrates are not cleaved.  Others report that BioH cleaves an ester
124
 and 
acyl p-nitrophenyl esters
69,103
.  One possibility is that the specificity of BioH for 
pimeloyl-ACP depends on acyl-ACP structure.  Early work demonstrated that the first 6-
8 carbon atoms of the acyl chain are sequestered from solvent by the protein
26
.  This 
picture has been borne out by X-ray structures
101
 and molecular dynamics simulations
18
 
indicating that the protected carbon atoms reside within a hydrophobic tunnel formed by 
a bundle of four helices.  Hence, the ester groups of the shorter intermediates would be 
38 
 
largely or completely protected from BioH and only upon chain elongation to the 
pimeloyl moiety would the ester group become fully exposed to solvent and BioH.  
 
I believe that pimeloyl-ACP rather than pimeloyl-CoA is the physiological 
substrate of BioF.  Pimeloyl-CoA was the first substrate tested based on analogy to the 
synthesis of δ-aminolevulinic acid from glycine and succinyl-CoA and the ability of 
pimelate to bypass the biotin requirements of certain bacteria and fungi
40
.  However, 
pimeloyl-CoA seems the only acyl donor tested and it is possible that it acts as a mimic 
of pimeloyl-ACP or that the enzyme can accept either pimeloyl-thioester.  The suggestion 
that pimeloyl-ACP is the physiological acyl donor for BioF is consistent with recent 
reports on the BioI of Bacillus subtilis, a bacterium that makes the pimeloyl moiety by a 
mechanism entirely different from that of E. coli.  BioI, which appears restricted to this 
organism and its close relatives, is a cytochrome P450 family member that binds long 
chain acyl-ACPs both in vivo and in vitro and cleaves the acyl chains to generate 
pimeloyl-ACP
31,108
.  B. subtilis BioI functionally replaces both BioC and BioH in E. 
coli
14
 which argues strongly that pimeloyl-ACP is a physiological BioF acyl donor and 
eliminates models in which BioH is involved in transfer of the pimeloyl moiety from 
ACP to CoA.  
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TABLES 
Table 2-1.  Bacterial strains, plasmids and PCR primers. 
 
Strain Relevant Characteristics Reference 
   MG1655 E. coli K-12   CGSC
a
 
BM2511
3 
lacI
q 
rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 ΔrhaBADLD78 
32
  
BL21 
(DE3) 
F
-
 ompT hsdSB (rB
-
mB
-
) gal dcm (DE3) Invitrogen 
STL11 BL21 (DE3) / pSTL4 This chapter 
STL14 BL21 (DE3) / pSTL6 This chapter 
STL23 MG1655 ΔbioC::FRT This chapter 
STL24 MG1655 ΔbioH::FRT This chapter 
STL25 MG1655 ΔbioC::FRT ΔbioH::FRT This chapter 
STL29 MG1655 ΔbioH::kan This chapter 
STL32 MG1655 ΔbioC::FRT / pYFJ84 This chapter 
STL33 MG1655 ΔbioH::FRT / pYFJ84 This chapter 
STL34 MG1655 ΔbioC::FRT ΔbioH::FRT / pYFJ84 This chapter 
STL47 BL21 (DE3) / pSTL13 This chapter 
STL49 
 
MG1655 ΔbioH::FRT / pSTL6 This chapter 
STL50 MG1655 ΔbioH::FRT / pSTL13 This chapter 
STL74 MG1655 ΔbioC::FRT ΔbioH::FRT / pSTL20 This chapter 
STL78 MG1655 ΔbioC::FRT / pET16b This chapter 
STL96 MG1655 ΔbioC::FRT / pSTL25 This chapter 
STL98 MG1655 ΔbioH::FRT / pCY123 This chapter 
STL112 MG1655 ΔbioA::FRT This chapter 
STL115 MG1655 ΔbioF::FRT This chapter 
ER90 MG1655 ΔbioF::cat 21 
YFJ239 BL21 (DE3) / pYFJ84 
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DK574 / 
pJT93 
E. coli holo-ACP over-expression strain 
29
 
  
Plasmid Relevant Characteristics Primers Reference 
    pET28b
+ 
Kan
R
 T7 expression vector  Novagen 
pET16b Amp
R
 T7 expression vector  Novagen 
pBAD3
22 
Amp
R
 arabinose-inducible expression vector  
28
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Table 2-1.  (Continued) 
  
pSTL4 pET28b+ encoding C-terminal His-tagged E. coli BioC A07-A08 This chapter 
pSTL6 pET28b+ encoding C-terminal His-tagged E. coli BioH A11-A12 This chapter 
pSTL13 pSTL6 derivative carrying the S82A bioH mutation  A39-A40 This chapter 
pSTL20 pBAD322 encoding B. subtilis bioW A41-A55 This chapter 
pSTL25 bioC in-frame deletion (∆BglII) of pCY123   This chapter 
pYFJ84 pET16b encoding N-terminal His-tagged V. harveyi AasS  
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pCY123 pBR329 carrying the bioABFCD operon  This chapter 
   
Primers Sequence (5’ to 3’) 
A07  GGTGCTCCATGGCAACGGTTAATAAAC  
A08  GGTGACAAAATAACTCGAGCTCACGAGCAATC  
A11  AGAGAACAATAGCTCATGAATAACATCTGGTGG 
A12  ATTTCAAAAGCCTCGAGCACCCTCTGC  
A15  
GAAATGCAGGATATCGACCGTCTGCTGGAGGTGCTGCATGGCAACGGTT
AAGTGTAGGCTGGAGCTGCTTC 
A16  
TTACTCACGAGCAATCACTCCCAAAAAAAGATGATACGTCAGAGGATAT
CGATTCCGGGGATCCGTCGACC 
A17  
ATGAATAACATCTGGTGGCAGACCAAAGGTCAGGGGAATGTTCATCCTG
TGATTCCGGGGATCCGTCGACC 
A18  
CTACACCCTCTGCTTCAACGCCACCAGCAGGTGACAAAACTCGGCCGGA
TGGTGTAGGCTGGAGCTGCTTC 
A39  CCATTTGGTTAGGCTGGGCTCTGGGC 
A40  CACCAGCCCGCCCAGAGCCCAGCC 
A41 GAAAGGGCGAGCCATGGTGCAAGAAGAAAC  
A55 CTTTTTTCTCTCGAGTCATGCGTCATGATCTTCCTC  
A68  
GCGCTGATGACCCCGGACACCGACGAATCTTACAACGCGGCAGCATAAT
GAGTGTAGGCTGGAGCTGCTTC 
A69  
ATTAACCGTTGCCATGCAGCACCTCCAGCAGACGGTCGATATCCTGCAT
TTATTCCGGGGATCCGTCGACC 
A70  
TTCTTGTTTGCAGAAAGTGTAGCCAGAAACCCTCACGCGGACTTCTCGTT
AGTGTAGGCTGGAGCTGCTTC 
A71  
ATGACAACGGCAGATCTTGCCTTTGACCAACGCCATATCTGGCACCCAT
ACATTCCGGGGATCCGTCGACC 
a
CGSC, Coli Genetic Stock Center, Yale University. 
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Table 2-2.  Compounds tested for bypass of the ∆bioC mutation in the presence of AasS.  
The data set we obtained for each of the compounds tested matched that for the 
compound given in the mass spectral and NMR databases. 
 
Compound Structure Source Analysis Bypass 
Malonic acid 
 
SAa NMR No 
Malonate  
methyl ester 
 
SA NMR Yes 
Malonate  
ethyl ester 
 
This 
chapter 
GC-MS Yes 
Malonate  
propyl ester 
 
This 
chapter 
GC-MS Yes 
Malonate  
butyl ester 
 
This 
chapter 
GC-MS Yes 
Succinic acid 
 
SA NMR No 
Succinate  
methyl ester 
 
This 
chapter 
GC-MS No 
Glutaric acid 
 
SA 
NMR  
GC-MS 
No 
Glutarate  
methyl ester 
 
SA 
NMR 
GC-MS 
Yes 
Glutarate  
ethyl ester 
 
This 
chapter 
NMR 
GC-MS 
Yes 
 
Glutarate  
propyl ester  
 
 
This 
chapter 
NMR 
GC-MS 
Yes 
Glutarate  
butyl ester 
 
This 
chapter 
GC-MS Yes 
3-Ketoglutarate 
methyl ester 
 
Derivative 
from SAb 
NMR Yes 
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Table 2-2.  (Continued)  
3-Hydroxyglutarate 
methyl ester 
 
Derivative 
from SA 
NMR Yes 
Glutaconate  
methyl ester 
 
Derivative 
from SA 
GC-MS Yes 
2-Ketoglutarate 
methyl ester 
 
Derivative 
from SA 
GC-MS No 
Adipic acid 
 
SA GC-MS No 
Adipate  
methyl ester 
 
SA GC-MS No 
Adipate  
ethyl ester 
 
This 
chapter 
GC-MS No 
Hexanoic acid 
 
SA GC-MS No 
Pimelic acid 
 
SA 
NMR 
GC-MS 
No 
Pimelate  
methyl ester 
 
This 
chapter 
NMR 
GC-MS 
Yes 
Pimelate  
ethyl ester 
 
This 
chapter 
GC-MS Yes 
Pimelate  
propyl ester 
 
This 
chapter 
NMR Yes 
Pimelate  
butyl ester  
This 
chapter 
GC-MS Yes 
3-Ketopimelate 
ethyl ester 
 
Derivative 
from TCIc 
NMR Yes 
4-Ketopimelate 
ethyl ester 
 
Derivative 
from SA 
GC-MS No 
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Table 2-2.  (Continued) 
Heptanoic acid 
 
SA NMR No 
3-Ketoheptanoic 
acid 
 
Derivative 
from SAd 
GC-MS No 
Suberic acid 
 
SA NMR No 
Suberate  
methyl ester 
 
This 
chapter 
GC-MS No 
Azelaic acid 
 
SA NMR No 
Azelate  
methyl ester 
 
This 
chapter 
GC-MS No 
Sebacic acid 
 
SA NMR No 
Sebacate  
methyl ester 
 
This 
chapter 
GC-MS No 
Undecanedioic acid 
 
SA NMR No 
Undecanedioate 
methyl ester 
 
This 
chapter 
GC-MS No 
 
a 
Sigma-Aldrich 
b 
Purchased from Sigma-Aldrich as diester and hydrolyzed to monoester. 
c 
Purchased from TCI America as diester and hydrolyzed to monoester. 
d 
Purchased from Sigma-Aldrich as methyl ester and hydrolyzed to acid. 
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FIGURES 
 
Figure 2-1.  Products of the esterification of pimelate with methanol as determined by 
GC-MS.  Monomethyl adipate was added as internal standard at 14 mM to the 
synthesized monomethyl pimelate mixture.  Monomethyl pimelate was 68.9 % of the 
total pimelate as calculated from the peak areas of the monomethyl esters of adipate and 
pimelate.  
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Figure 2-2.  Acylation of ACP with monomethyl esters of various dicarboxylates was 
carried out using V. harveyi AasS (a).  The migration rate of an acyl-ACP in this system 
is dependent on the length of the acyl chain until a maximum is reached.  The gel was 
stained with Coomassie Blue R250 (b).  The purified acyl-ACP species of panel B were 
tested for the ability to support DTB synthesis in vitro in the absence of BioC.  The acyl-
ACPs are numbered as in panel B.  (c) Only malonyl-ACP methyl ester (2), glutaryl-ACP 
methyl ester (4) and pimeloyl-ACP methyl ester (5) supported DTB synthesis.  
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Figure 2-3.  Analysis of pimeloyl-ACP and glutaryl-ACP and their methyl esters by 
MALDI-MS.  A portion of the ACP retains the N-terminal N-fomylmethionine or 
methionine of the primary translation product presumably due to titration of peptide 
deformylase or methionine aminopeptidase upon ACP ove-rexpression. 
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Figure 2-3.  (Continued) 
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Figure 2-3.  (Continued) 
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Figure 2-3.  (Continued) 
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Figure 2-3.  (Continued) 
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Figure 2-4.  Analysis of purified proteins by sodium dodecyl sulfate 10 % 
polyacrylamide gel electrophoresis.  Lane 1, protein standards (Bio-Rad); lane 2, AasS; 
lane 3, BioC; lane 4, BioH; and lane 5, BioH S82A.  The proteins were visualized by 
staining the gel with Coomassie Blue R250.  
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Figure 2-5.  The permeability of derivatives E. coli strains STL32 and STL74 carrying 
plasmids encoding either AasS or the B. subtilis BioW were tested.  Four random 
colonies of the each strain were streaked on minimal agar supplemented with 0.1 mM 
pimelate sodium salt and 0.2 % arabinose for induction.  The expression of BioW, a 
pimeloyl-CoA synthetase, allows bypass of both bioC and bioH in the presence of 
pimelic acid whereas pimelic acid was unable to support growth of strain STL32 because 
pimelic acid is not a substrate for AasS.  
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Figure 2-6.  AasS-mediated bypass of the ∆bioC mutation by supplementation with 
monomethyl esters of dicarboxylates.  Each minimal agar plate contained 0.1 mg/ml 
sodium ampicillin and 1 mM IPTG.  The strain lacking AasS expression carried the 
empty vector plasmid to provide ampicillin resistance.  The methyl esters were tested at 
nominal concentrations of 0.1 mM except for malonate methyl ester which had a nominal 
concentration of 1 mM (growth was weak on 0.1 mM).  Biotin was added at 4 nM.  The 
plates were incubated overnight at 37 
o
C.  The strains tested were STL78, STL32, STL33 
and STL34.  Note that the concentrations given are based on the total dicarboxylate of the 
preparation because the various preparations contain variable levels of the dimethyl esters 
(which are insoluble in the medium) and the free dicarboxylic acids (which are inactive 
as AasS substrates).  However, the monomethyl ester was the major species in all cases 
(Figure 2-1).  
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Figure 2-7.  Requirements for DTB synthesis from malonyl-CoA.  The cell free extract 
was prepared from the ∆bioC strain STL96 which carries multiple copies of all the bio 
operon genes except bioC.  Purified and refolded BioC was added to all reactions except 
as shown.  Bioassays were done using strain ER90 (∆bioF) as described in Experimental 
Procedures.  (a) Standard DTB was bioassayed and reliably detected in levels as low as 1 
pmol.  (b) DTB synthesis specifically required malonyl-CoA as substrate.  Structurally 
related compounds such as acetyl-CoA, succinyl-CoA and malonate were inactive.  (c) 
DTB synthesis required malonyl-CoA, BioC, NADPH and all other reactions components 
as given for in vitro DTB synthesis in Experimental Procedures.  When pimeloyl-ACP 
methyl ester was added, both BioC and malonyl-CoA were omitted.  
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Figure 2-8.  SAM and the methyl ester moiety are both required for synthesis of the 
pimeloyl moiety.  (a) KAPA synthesis in an extract lacking BioA with malonyl-CoA as 
substrate.  The product was detected by bioassay on the ∆bioF strain STL115. When 
pimeloyl-ACP methyl ester was added both SAM and malonyl-CoA were omitted.  (b) 
Requirement for the methyl ester moiety in conversion of glutaryl-ACP to DTB.  The 
extract lacked BioC and the bioassay was performed on strain ER90 (∆bioF bioC bioD).  
Glutaryl-ACP methyl ester was added to the reactions assayed in the two left hand 
quadrants whereas the reactions of the two right hand quadrants received glutaryl-ACP.  
(c) The requirement for active BioH in conversion of pimeloyl-ACP methyl ester to DTB.  
The extract lacked BioH with pimeloyl-ACP methyl ester as the substrate and the 
bioassay was performed using strain ER90.  Either purified wild type BioH or the mutant 
BioH S82A protein (which lacks the active site nucleophile) was added to 20 μg/ml.  The 
reaction of the lower right quadrant lacked extract, but contained both the wild type and 
mutant BioH proteins.  
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Figure 2-9.  Inhibition of DTB synthesis by inhibitors of fatty acid synthesis and SAM-
dependent methyltransferases.   The microbiocide, triclosan, or the antibiotics cerulenin, 
thiolactomycin and sinefungin were added to the in vitro DTB synthesis with either 
malonyl-CoA (○) or pimeloyl-ACP methyl ester (■) as substrate. The level of DTB 
produced was estimated based on the area of the bioassay red zone and was standardized 
to the control reactions containing no inhibitor (100 % DTB synthesis was approximately 
30 ρmol).  The lack of inhibition seen when pimeloyl-ACP methyl ester was the substrate 
demonstrated that the amounts of inhibitor transferred to the assay disks were insufficient 
to inhibit growth of the bioassay strain ER90 (∆bioF bioC bioD).  Inhibition by triclosan 
was reduced when FabV, a triclosan resistant enoyl-ACP reductase, was added to 50 
μg/ml in the reaction (●).  The protein synthesis inhibitor, kanamycin, was tested with 
malonyl-CoA as the substrate and gave no inhibition over the same range of 
concentrations.  A bioassay plate showing the effects of thiolactomycin on DTB synthesis 
is given at the lower right of the figure.  
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Figure 2-10.  (a) BioH catalyzed hydrolysis of the ester bonds of pimeloyl-ACP esters.  
The reactions contained 50 mM Tris-HCl (pH 7.0), 5 % glycerol, 5 μg/ml BioH and 2 
mM pimeloyl-ACP esters and were incubated at 37 °C for 1 h.  Hydrolysis results in the 
slower migrating pimeloyl-ACP as demonstrated in a conformationally-sensitive 
electrophoretic mobility assay as described in Experimental Procedures.  Mutant BioH 
S82A lacked the catalytic nucleophile (see text) and was unable to hydrolyze the ester 
bonds (lane 4).  (b) BioH cleavage of the methyl ester moieties of other ω-carboxyl acyl-
ACP methyl esters of acyl chain length of 3 to 9 carbon atoms.   Hydrolysis of the methyl 
ester bond results in the slower migrating ω-carboxyl acyl-ACPs in all cases.  
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Figure 2-11.  Complementation by expression of BioH or BioH S82A from multi-copy 
plasmids in a ∆bioH strain.  Four random colonies of the each strain were streaked on 
minimal agar supplemented with 0.1 mM IPTG for induction.  The expression of the wild 
type BioH allowed growth on biotin-free medium whereas the expression of BioH S82A 
failed to restore growth.  
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CHAPTER 3 
METHYLATION OF MALONYL-ACYL-CARRIER PROTEIN BY BACILLUS 
CEREUS BIOC O-METHYLTRANSFERASE 
 
INTRODUCTION 
In Chapter 2, I delineated E. coli biotin synthetic pathway to reveal BioC as the 
first enzyme in the pathway.  I hypothesized that BioC catalyzes transfer of the methyl 
group from SAM to the ω-carboxyl group of malonyl-ACP (or CoA) to form a methyl 
ester.  The product malonyl-ACP (or CoA) methyl ester would then become a primer 
molecule for the synthesis of pimeloyl-ACP.  The shielding of the negatively charged ω-
carboxyl group is essential for elongation of the malonyl moiety (C3), via two rounds of 
fatty acid synthesis, to a pimeloyl moiety (C7).  The methyl ester moiety neutralizes the 
negative charge and mimics the methyl end of monocarboxylates normally found in fatty 
acid synthesis.  BioC methylation reaction is therefore critical for processing 
dicarboxylates, which are rather unusual substrates but carry the essential biotin carboxyl 
group, by fatty acid synthetic enzymes.    
 
E. coli BioC is notorious for its insolubility upon over-expression
112
.  To 
demonstrate the methyltransferase activity, I cloned and tried to purify recombinant E. 
coli BioC.  However, the protein remained highly insoluble in various growth conditions, 
in low concentrations of IPTG and different expression hosts.  Additives such as 
glycylglycine, betaine, sorbitol, surcrose and benzoyl alcohol, which are reported to 
improve protein solubility when supplemented in growth medium, did not improve BioC 
solubility.  Fusion to maltose-binding protein and glutathione S-transferase significantly 
reduced the expression level of BioC and also led to degradation of the protein.  In vitro 
protein synthesis, by using PURExpress system (NEB), also failed to yield detectable 
amount of BioC.  Since I was neither able to obtain soluble E. coli BioC nor detect any 
methyltransferase activity from the refolded enzyme, I decided to search for BioC 
homologs in other bacteria.  BioC homolog from Salmonella typhimurium had the same 
solubility problem as the E. coli protein due to high level of sequence homology.  On the 
other hand, homologs from Kurthia species, Pseudomonas putida and Chlorobium 
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tepidum were highly toxic to host cells and could not be expressed to high levels.  The 
only amenable BioC homolog was found in Bacillus cereus 10987.  B. cereus has a 
unidirectional bio operon which contains all six bio genes, including bioH (Figure 3-1a).  
The bioC gene is the fourth gene in the operon and is located downstream of bioF and 
immediately upstream of bioH.  This arrangement is different from that of E. coli in 
which the bio operon is bidirectional and the the bioH gene is located elsewhere in the 
chromosome.  The primary sequence of B. cereus BioC shares only 26.5% identity and 
48.2% similarity with E. coli BioC (Figure 3-2).  To ensure maximum expression in E. 
coli, the genetic codon of B. cereus bioC has been optimized (Figure 3-1b).  This protein 
was heterologously expressed in E. coli in soluble form, and remained stable throughout 
purification and in vitro experiments.   
 
In this chapter, I describe purification of the native form of B. cereus BioC, and 
present an in vitro assay, using [methyl-
3
H] SAM, to study BioC SAM-dependent 
methyltransferase activity.  Since commercial SAM is only ~40 % active due to 
contamination by impurities and degraded products
44
, I enzymatically synthesized SAM 
using E. coli SAM synthetase (MetK).  By use of this assay, I determined that malonyl-
ACP is a much better substrate for BioC than malonyl-CoA.  Furthermore, the 
methylation activity of BioC could be blocked by SAH, a demethylated product,  or by 
sinefungin
13
, a potent inhibitor of SAM-dependent methyltransferase.  Finally, I provide 
in vivo and in vitro evidence that over-expression of BioC blocks fatty acid synthesis.  It 
has been previously reported that over-expression of E. coli BioC impaired cell growth
74
.  
However, the exact mechanism was unclear at the time, due to the lack of knowledge of 
BioC activity.  I hypothesized that BioC compromises cell growth by disrupting fatty acid 
synthesis.  Active fatty acid synthesis is required for the synthesis of phospholipids, 
which provides cell membrane biogenesis.  Since malonyl-ACP is an essential substrate 
for fatty acid synthesis, high level of BioC methylation would deplete malonyl-ACP by 
converting malonyl-ACP into its methyl ester.  To monitor fatty acid synthesis, I 
supplemented [
14
C] acetate in the growth medium and extracted phospholipids to 
determine incorporation of 
14
C radioactivity.  Over-expression of B. cereus BioC 
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diminished the incorporation of [
14
C] acetate into phospholipids, suggesting that fatty 
acid synthesis was inhibited. 
 
MATERIALS AND METHODS 
Materials  
The defined medium was M9
83
 supplemented (final concentrations) with 0.2 % 
glucose, 0.1 % Vitamin Assay Casamino Acids, 1 mM MgSO4 and 1 μg/ml thiamine 
except when 0.2 % arabinose replaced glucose.  RB medium contained 10 g of tryptone, 
1 g of yeast extract and 5 g of NaCl per liter of H2O.  2XYT medium contained 16 g of 
tryptone, 10 g of yeast extract and 5 g of NaCl per liter of H2O.  M9 was added as a 
buffer to LB, RB and 2XYT media give LB-M9, RB-M9 and 2XYT-M9 media 
respectively.  Agar was added to 1.5 %.  Phenylmethanesulfonylfluoride (PMSF, Sigma-
Aldrich) was dissolved in ethanol to 100 mM.  E. coli ACP (apo form), Mtn (E. coli 5'-
methylthioadenosine/S-adenosylhomocysteine nucleosidase) and Sfp (B. subtilis 
phosphopantetheinyl transferase) were prepared from strains DK574, ER103 and NRD4-
33, respectively, strictly according to the detailed protocols given previously
21,61,93
.   
 
Construction of plasmids  
Plasmids and oligonucleotides are listed in Table 3-1.  The E. coli metK gene was 
PCR amplified from MG1655 genomic DNA using oligonucleotides B24 and B25.  The 
DNA product was digested with NcoI and XhoI and ligated into pET28b+ vector, which 
was also digested by the same enzymes, to give plasmid pSTL27.  The B. cereus ATCC 
10987 bioC gene was codon optimized, synthesized and provided as plasmid 37454 by 
DNA2.0 Inc (see Figure 3-1b for optimized sequence).  For high level expression, the 
gene was PCR amplified from plasmid 37454 using oligonucleotides A77 and A78.  The 
DNA fragment was digested with BspHI and XhoI, and ligated into pET28b+ (digested 
with NcoI and XhoI) to give plasmid pSTL28 containing a hexahistidine-tag fusion at the 
C-terminus of bioC.  Two stop codons were added to the bioC gene by site-directed PCR 
mutagenesis using oligonucleotides B13 and B14 to give pSTL29.  For complementation 
experiments, the bioC gene was PCR amplified from plasmid 37454 using 
oligonucleotides A77 and B23.  The DNA fragment was digested BspHI and HindIII, and 
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ligated into pBAD24 (digested with NcoI and HindIII) to give pSTL30.  Mutations of the 
bioC gene were constructed by site-directed PCR mutagenesis using the following 
oligonucleotide sets: Y18F (B15 and B16), D110N (B17 and B18), E153A (B19 and 
B20) and Y256F (B21 and B22).  Plasmid DNAs were extracted by QIAprep Miniprep 
(Qiagen).  The constructs were verified by DNA sequencing conducted by the Core 
sequencing Facility of the Carver Biotechnology Center of University of Illinois at 
Urbana-Champaign. 
 
Purification of B. cereus BioC 
Native form of B. cereus BioC was overexpressed in strain STL204 as follows.  
The strain was inoculated in 5 ml of LB medium supplemented with 50 μg/ml of 
kanamycin at 30 °C overnight.  The culture was transferred to 500 ml of LB-M9 medium 
supplemented with 50 μg/ml of kanamycin and incubated at 37 °C for 6 h.  The cells 
were harvested by centrifugation and resuspended in 10 ml of LB medium supplemented 
with 50 μg/ml of kanamycin.  2.5 ml of the cell suspension was added into 1 L of 2XYT-
M9 medium containing 50 μg/ml of kanamycin and 0.5 μM of IPTG.  The culture was 
incubated at room temperature for 17 h.  The cells were harvested by centrifugation and 
the cell pellet was stored at -80 °C until use. 
 
The cells were resuspened in purification buffer (25 mM MES pH 6, 0.1 M LiCl, 
10 % glycerol and 5 mM TCEP) containing 10 mM PMSF and 5 μg/ml of DNaseI 
(Sigma).  Cells were lysed by two passages through French press at 17500 psi.  Soluble 
cell extract was obtained by centrifugation at 20,000 g and filtration through a 0.45-μm 
filter (Millipore).  All subsequent protein purification steps (Figure 3-3) were performed 
on an ACTA Purifier FPLC and columns from GE Healthcare Life Sciences at 4 °C.  The 
extract was loaded at 2 ml/min into a HiTrap SP FF column which had been equilibrated 
in purification buffer.  The column was washed with purification buffer containing 0.2 M 
LiCl.  BioC was eluted with purification buffer containing 0.3 M LiCl and the volume of 
BioC elution was adjusted to 20 ml by concentrating using an Amicon centrifugal filter 
(MWCO 10,000 Da) (Millipore).  Twenty ml of purification buffer containing 2 M of 
(NH4)2SO4 was added slowly to the BioC eluent to introduce (NH4)2SO4 to 1 M.  The 
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mixture was filtered through 0.45-μm filter before loading into a HiTrap Phenyl 
sepharose column as 2 ml/min.  The column was washed with purification buffer 
containing 1 M (NH4)2SO4.  BioC was eluted by a linear gradient to decrease the 
concentration of (NH4)2SO4 from 1 M to 0 M over 10 column volumes.  The target 
fractions were combined and the volume was reduced to about 3 ml using an Amicon 
centrifugal filter (MWCO 10,000 Da).   Finally, BioC was purified in a HiLoad 26/60 
Superdex 200 column in 25 mM MES (pH 6), 0.2 M NaCl, 10 % glycerol and 1 mM 
TCEP.  Protein concentration was determined by Bradford assay and the purity was 
analyzed by SDS-PAGE and Coomassie blue staining.  The purified protein has an 
expected mass of 31.2 kDa, and was eluted as a monomer from an analytical Superdex 
200 column, with a retention time in between protein standards chicken ovalbumin (44 
kDa) and equine myoglobin (17 kDa) (Figure 3-4). 
  
Preparation of SAM 
MetK, which carried a C-terminal fusion of hexahistidine tag, was overexpressed 
in STL 215.  The strain was inoculated in 5 ml of LB medium supplemented with 50 
μg/ml of kanamycin at 30 °C overnight.  The cells were subcultured at 1:100 ratio in 300 
ml of LB-M9 medium supplemented with 50 μg/ml of kanamycin.  The culture was 
incubated at 37 °C for 4.5 h.  Isopropyl-thiogalactopyransoide (IPTG) was added to 10 
μM to induce protein expression at 37 °C for 2 h.  The cells were harvested and 
resuspended in 9 ml of BugBuster master mix (EMD) and incubated at room temp for 40 
min for lysis.  Twenty ml of loading buffer (25 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) pH 7.5, 0.5 M NaCl, 20 % glycerol, 5 mM tris(2-
carboxyethyl)phosphine (TCEP) and 20 mM imidazole) was added, and the mixture was 
centrifuged at 20,000 g to remove cell debris.  The supernatant was incubated with 1.5 ml 
of Ni-NTA (Qiagen) at 4 °C for 30 min.  The resin was transferred to a 10-ml column.  
The column was washed once with 20 column volumes (CV) of loading buffer and then 
40 CVs of loading buffer containing 60 mM imidazole. The protein was eluted in loading 
buffer containing 500 mM imidazole and dialyzed in 25 mM HEPES (pH 7), 0.2 mM 
KCl, 10 % glycerol and 1 mM TCEP at 4 °C overnight.  Protein concentration was 
determined by Bradford assay (Bio-Rad). 
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Enzymatic synthesis of SAM was adapted from Park et al
88
 and Farrar et al
44
.  
The reaction consisted of 100 mM Tris-HCl (pH 8), 200 mM KCl, 100 mM MgCl2, 20 % 
acetonitrile, 50 mM ATP, 20 mM Met and 0.12 mM MetK at 37 °C for 2 h.  One ml of 4 
M sodium acetate (pH 4) was added and the mixture was incubated on ice for 10 min to 
precipitate MetK.  Ten ml of 0.2 M sodium acetate (pH 4) was added to the supernatant, 
and the mixture was transferred to a 1.5 ml Amberlite CG50 column which was 
equilibrated with 15 CV of 0.2 M sodium acetate.  The column was washed with 15 CV 
of 0.2 M sodium acetate.  SAM was eluted in 0.1 M H2SO4 and 10 % ethanol (pH ~1) 
and stored at -80 °C.  The concentration of SAM was determined by OD at 260 nm using 
extinction coefficient of 14700 M
-1
 cm
-1
.  The purity of SAM was analyzed on a 
Beckman System Gold HPLC.  Samples were injected on a Waters μBondapack C18 
column and eluted with a linear gradient from 0.2 M ammonium acetate to methanol for 6 
min at a flow rate of 0.7 ml/min at room temperature.  ATP, SAM and 
methylthioadenosine was monitored at 260 nm (Figure 3-5a and b).  A working solution 
of [methyl-
3
H] SAM was prepared by mixing the synthesized SAM with Perkin Elmer 
[methyl-
3
H] SAM (80.7 Ci/mmol) at approximately 720:1 molar ratio. The final 
concentration was adjusted to 1 mM with 10 mM H2SO4 (pH ~1) and 10 % ethanol.  The 
specific activity was estimated 91.26 CPM per ρmol of [methyl-3H] SAM (Figure 3-6). 
 
The LC-MS/MS analysis was performed in Metabolomics Center at University of 
Illinois at Urbana-Champaign with an Agilent mass spectrometer (MSD Trap XCT Plus) 
equipped with an 1100 Agilent LC.  Chemstation (version B.01.03) was used for data 
acquisition and processing.  The HPLC flow rate was set at 0.3 ml/min.  HPLC mobile 
phases consisted of A (15 mM ammonia formate in H2O) and B (15 mM ammonia 
formate in methanol).  The autosampler was kept at 5 °C.  The injection volume was 5 
µl.  A Phenomenex Synergy 4u Fusion column (4u, 100 x 4.6mm) was used for the 
separation with the following gradient: 0-2 min, 98 % A; 10-15 min, 0 % A.  The mass 
spectrometer was operated under positive electrospray ionization.  The electrospray 
voltage was set to 3500 V with the scan range of m/z 100-600, the drying temperature at 
350 °C, the nebulizer at 35 psi, and dry gas at 8 l/min. The results of analysis are shown 
in Figure 3-5c and d. 
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Preparation of Malonyl-ACP 
Malonyl-ACP was synthesized from ACP (apo form) and malonyl-CoA (Sigma-
Aldrich) using Sfp, a Bacillus subtilis phosphopantetheinyl transferase, as described 
perviously
93
.  The reaction consisted of 100 mM MES (pH 6), 10 mM MgCl2, 10 μM Sfp, 
0.5 mM ACP and 0.75 mM malonyl-CoA.  Acetyl-ACP, succinyl-ACP and glutaryl-ACP 
were prepared by the same procedure, from acetyl-CoA, succinyl-CoA and glutaryl-CoA, 
respectively.  Malonyl-ACP methyl ester was synthesized by BioC using malonyl-ACP 
and SAM as substrates.  The reaction contained 100 mM Tris-HCl (pH 7.5), 10 mM 
MgCl2, 10 % glycerol, 200 mM NaCl, 0.3 μM BioC, 3 μM Mtn, 0.5 mM malonyl-ACP 
and 1 mM SAM.  The reactions were incubated at 37 °C for an hour. ACP products were 
purified using Vivapure D column and analyzed by EMSA as described in Chapter 2.   
To verify BioC methylation, malonyl-ACP and malonyl-ACP methyl ester were dialyzed 
against 2 mM ammonium acetate in 3000 Da-MWCO dialysis cassette (Pierce) at 4 °C 
overnight.  The ACP was dried under vacuum, and the mass was analyzed by MALDI-
TOF/ESI massspectrometry at Univeristy of Illinois, SCS, Mass Spectrometry Lab. 
 
BioC methyltransferase assay 
A 50-μl reaction consisted of 100 mM sodium phosphate buffer (pH 7), 20 mM 
MgCl2, 100 mM NaCl, 20 % glycerol, 20 nM Mtn nucleosidase, 100 nM BioC, malonyl-
ACP and [
3
H] SAM.  To determine the kinetic parameters for malonyl-ACP and SAM, 
the concentrations of [
3
H] SAM and malonyl-ACP were fixed to 100 μM and 75 μM 
respectively.  A premix equivalent to 6.5 reactions was prepared, without BioC, and 
incubated at 37 °C for one min.  The reaction was then initiated by adding BioC.  A 50-μl 
sample was taken from the premix vial at each time point and transferred into a 1.5-ml 
tube pre chilled on dry ice to quench reaction.  ACP was subsequently purified by Macro-
Prep High Q resin (Bio-Rad) as follows.  One ml of washing buffer (50 mM sodium 
acetate, pH 4.5, and 25 mM NaCl) was added to the 50-μl reaction sample.  One hundred 
μl of the Q resin (50 % slurry in 20 % ethanol) was added and incubated for 5 min to 
capture ACP.  The resin was spun down by centrifugation at max speed and washed five 
times, each with 1 ml of washing buffer.  ACP was eluted by adding 1 ml of washing 
buffer containing 0.5 M NaCl.  The eluent was mixed thoroughly with 4 ml of Bio-Safe II 
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scintillation fluid (Research Products International Corp) and 
3
H radioactivity was 
determined in a Beckman LS6500 scintillation counter.  Other acyl-ACPs and malonyl-
CoA were assayed by the same procedure, except that in CoA purification, 25 mM MES 
(pH 6) was used in place of sodium acetate.  All the reactions were repeated three times 
and Michaelis-Menten kinetic parameters were determined by OriginPro 8.6. 
  
Phospholipid labeling assay 
E. coli strain MG1655∆araBAD::cat, carrying a plasmid-encoded bioC wild-type 
or mutant gene, was inoculated in 5 ml of RB-M9 medium supplemented with 25 μg/ml 
of tricarcillin:clavulanate (15:1) at 30 °C overnight.  One hundred μl of the cells were 
subcultured in 100 ml of RB-M9 medium supplemented with 25 μg/ml of 
tricarcillin:clavulanate (15:1) and incubated at 37 °C.  Cell growth was monitored by 
absorbance at 260 nm every 20 min. Arabinose was added to 0.2 % (w/v) to induce BioC 
expression when the OD at 260 nm reached 0.3.  For phospholipid labeling experiment, 
one ml of cells were transferred to a 15-ml tube containing 5 μCi of [14C] acetate and 
incubated at 37 °C for 20 min.  Three ml of chloroform: methanol mixture (1:2) was 
added and mixed thoroughly by vortex to lyse cells.  The sample was stored at 4 °C 
overnight.  Lipid extraction began by mixing in one ml of chloroform and then mixing in 
one ml of H2O.  The mixture was allowed to partition into two phases by centrifugation at 
4,000 g.  The bottom phase was transferred to a new tube and the solvent was evaporated 
by blowing with nitrogen.  The lipid pellet was dissolved in 50 μl of chloroform: 
methanol (2:1) and spotted on silica G plate.  Phospholipids were resolved by thin layer 
chromatography (TLC) using a solvent system which consisted of chloroform: methanol: 
acetic acid (65:25:8).  Incorporation of [
14
C] acetate into lipids was detected by 
autoradiography using a BioMax XAR film (Kodax). 
 
RESULTS 
BioC targeted malonyl-ACP for methylation 
 In my model of biotin synthesis, BioC acts as a SAM-dependent O-
methyltransferase that converts the ω-carboxyl group of malonyl-ACP (or CoA) to a 
methyl ester.  To demonstrate this activity experimentally, I obtained a soluble BioC 
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homolog from B. cereus 10986.  The B. cereus bioC gene complemented E. coli bioC 
(Figure 3-9), suggesting that B. cereus BioC could recognize E. coli ACP in vivo.  It is 
important to note that E. coli requires miniscule levels of biotin for growth, biotin 
production is kept at extremely low level, and therefore, BioC may not be a robust 
catalyst.  In this scenario, in vivo complementation is a much more sensitive measure of 
BioC activity than in vitro biochemical assay.  To ensure quantitative detection of BioC 
methyltransferase activity, I set up a direct, radioactive methylation assay using [methyl-
3
H] SAM as a methyl group donor, and either acyl-ACP or acyl-CoA as methyl acceptor 
(Figure 3-9).  Due to a lack of structural information of BioC, I purified the native form 
of B. cereus BioC to avoid potential interference with substrate binding by purification 
tags.  The purified BioC eluted as a monomer from Superdex 200 column, with a 
retention time consistent with its theoretical mass of 31.2 kDa.  The reaction also 
contained a second enzyme, Mtn
21
, which is an S-adenosylhomocysteine (SAH) 
nucleosidase, to alleviate product inhibition of BioC.  Since ACP and CoA are negatively 
charged, they can be easily purified from the reaction by anionic exchanger Q resin.  The 
transfer of methyl group to ACP or CoA was determined by the incorporation of tritium 
radioactivity, which was measured in a scintillation counter.  
 
SAM is a highly unstable molecule.  The biologically active (S,S) configuration of 
SAM is prone to spontaneous racemization at the sulfonium center to yield inactive (R,S) 
diastereomer
54
.  SAM can also spontaneously degrade, by intramolecular SN2 attack of 
the methionine carboxylate on the γ-carbon, into methylthioadenosine (MTA) and 
homocysteine (HCY)
54
.  Typical commercial SAM is extracted from cultured yeast and 
purified by HPLC.  The preparation results in only ~43% of the biologically active (S, S)-
SAM, with the other 60 % composed of the racemized and degraded products, S-
adenosylhomocysteine (SAH), and as much as 10 % of unidentified substances
44
.  These 
contaminants are difficult to remove and are known to interfere with SAM-dependent 
enzymes.  To reliably determine the KM for SAM, I enzymatically synthesized (S,S)-
SAM, from ATP and L-methionine, using E. coli SAM synthetase MetK.  SAM was 
purified to homogenous by weak ion exchange chromatography (Figure 3-5b), and 
remained stable in sulfuric acid at -80 °C.  The synthetic SAM also showed correct mass 
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fragmentations in LC-MS and LC-MS/MS (Figure 3-5c).  The synthetic SAM was 
blended with commercial [methyl-
3
H] SAM, which was also prepared enzymatically, to a 
specific activity of 91.26 CPM per ρmol of [methyl-3H] SAM (Figure 3-6). 
 
I wanted to determine whether malonyl-ACP or malonyl-CoA was the substrate 
for BioC methylation.  Surprisingly, malonyl-ACP was a much better substrate than 
malonyl-CoA (Figure 3-10a).  Holo-ACP, acetyl-ACP, succinyl-ACP and glutaryl-ACP 
were also assayed in parallel.  However, no methylation was detected, indicating that 
BioC specifically targeted malonyl-ACP.  Methylation of malonyl-CoA occurred only at 
much higher concentrations.  Given the same reaction conditions, BioC required 160-fold 
higher concentration of malonyl-CoA (8 mM), to achieve 50% of the activity obtained 
from 0.05 mM malonyl-ACP.  Since ACP is more negatively charged than CoA, it is 
logical to question the difference in binding efficiencies of ACP and CoA to the Q resin.  
Using [
14
C] malonyl-CoA, I determined binding capacity of the Q resin, which was 
sufficient to capture 400 nmol of malonyl-CoA (equivalent to 8 mM in 50-μl reaction) 
(Figure 3-10b).  After extensive washing, there was approximately 20 % loss of bound 
malonyl-CoA, suggesting that the activity on malonyl-CoA was slightly under-estimated.  
However, the leaching of CoA from the Q resin is insignificant in comparison to the 
reduction in BioC activity on malonyl-CoA. 
   
Before further kinetic analysis, the pH profile of B. cereus BioC was determined.  
The enzyme demonstrated the highest methyltransferase activity in sodium phosphate at 
pH 7.  The activity remained above 50 % within the pH range of 5 to 7.5, but decreased 
drastically outside this range (Figure 3-11a).  Furthermore, B. cereus BioC did not require 
metal ions for activity.  The addition of metal ions or EDTA to the reaction neither 
enhanced nor reduced BioC activity significantly (Figure 3-11b).  The Michaelis-Menton 
kinetic parameters were determined in sodium phosphate at pH 7 and the results are 
reported in Figure 3-11 c and d.  The KM for malonyl-ACP (10.8 ± 0.6 μM) is about five 
fold higher than that of SAM (1.9 ± 0.1 μM), indicating that BioC has lower affinity for 
malonyl-ACP.  The kcat for malonyl-ACP and SAM are 225.3 ± 3.4 s
-1
 and 173.6 ± 2.9 s
-
1
, respectively.  The catalytic efficiency (kcat/KM) for malonyl-ACP is 20.9 s
-1μM-1, which 
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is about four fold lower than that of SAM, 91.4 s
-1μM-1.  As an independent means to 
verify BioC methylation reaction, I also prepared malonyl-ACP methyl ester in a larger 
scale for MALDI-MS analyses.  And after BioC treatment, the mass of malonyl-ACP 
increased from 8934 Da to 8947 Da (Figure 3-7), corresponding to the formation of a 
methyl ester at the ω-carboxyl group of the malonyl moiety.  
 
BioC methylation is inhibited by SAH and sinefungin 
I wanted to test whether or not BioC methyltransferase activity could be blocked 
by molecules that are known to inhibit SAM-dependent enzymes.  I selected six 
molecules that either bear parts of the SAM structure or are analogs of SAM (Figure 3-
12).  5’-deoxyadenosine (DOA) is a byproduct of radical SAM reaction; whereas, a 
similar molecule, methylthioadenosine (MTA) is a spontaneously degraded product of 
SAM.  Both DOA and MTA have been reported to interfere with SAM-dependent radical 
enzymes
21,44
.  However, when added in the assay at equal molar ratio as SAM, they did 
not exhibit any inhibitory activity on BioC.  Similarly, adenosine (ADE) and 
homocysteine (HCY), which resemble the nucleoside and the amino acyl chain of SAM 
respectively, also did not affect BioC methylation activity.  The results have shown that 
these molecules are not potent inhibitors of BioC O-methyltransferase.  Neither the 
adenosine rings nor the homocysteine moiety could compete effectively against SAM for 
BioC active site.   
 
I also tested two larger analogs of SAM in parallel.  SAH is a demethylated 
product of SAM and is a competitive inhibitor of SAM-dependent methyltransferase.  
Sinefungin (SIN) is a natural antibiotic isolated from Streptomyces griseolus
13
 and is an 
approximate steric and electrostatic mimic for SAM
44
.  SIN is a potent inhibitor of 
numerous SAM-dependent enzymes and exhibits equal to or greater inhibitory activity 
than SAH
13
.  When added in BioC reaction, both SIN and SAH effectively blocked BioC 
methyltransferase activity in a concentration dependent manner (Figure 3-12).  SIN was 
clearly more potent than SAH, and completely abolished BioC activity at 10 μM, and 
reduced BioC activity by ~60% at as little as 0.1 μM.  To neutralize the inhibitory 
activity of SIN and SAH, Mtn nucleosidase was added back into the reaction (Figure 3-
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12 stripped bars).  SAH is susceptible to hydrolysis by Mtn, whereas SIN is resistant to 
Mtn.  In the absence of inhibitors, Mtn increased BioC methylation by eliminating 
inhibition by SAH, which was produced from demethylation of SAM.  Mtn also 
completely neutralized the effects of 0.1 and 1 μM of SAH, and partially rescued 
inhibition by10 μM SAH (Figure 3-12 stripped bars).  However, Mtn could not hydrolyze 
SIN.  The inhibition profile of SIN with Mtn is essentially identical to that without Mtn.  
 
Over-expression of BioC disrupted fatty acid synthesis 
It has been reported that over-expression of BioC impaired cell growth; however, 
the exact cause of BioC toxicity was unclear
74
.  Since I now had a better understanding of 
biotin synthesis, I decided to investigate this interesting toxic effect.  I suspected that 
over-expression of BioC would lead to an elevated level of BioC methylation activity, 
resulting in depletion of malonyl-ACP and accumulation of malonyl-ACP methyl ester.  
Malonyl-ACP is the quintessential building block of canonical fatty acid synthesis; 
whereas malonyl-ACP methyl ester is a dedicated biotin primer of no other known 
function.  During fatty acyl chain elongation, the ω-carboxyl group of malonyl-ACP is 
decarboxylated by 3-ketoacyl-ACP synthase to generate a deprotonated methyl end, for 
nucleophilic attack on the thioester carbon atom of incoming acyl-ACP.  Methylation at 
the ω-carboxyl group completely inactivates malonyl-ACP, rendering decarboxylative 
condensation impossible.  Exhaustion of malonyl-ACP pool shuts down fatty acid 
synthesis, which operates at high flux to sustain phospholipid synthesis and membrane 
biogenesis, during normal cell growth.  Therefore, depletion of malonyl-ACP leads to a 
series of negative effects that ultimately impairs cell growth. 
 
 To test this model of toxicity, I transformed MG1655∆araBAD with a plasmid 
carrying B. cereus bioC gene under an arabinose-inducible promoter.  As a control, I also 
included a B. cereus BioC Y18F mutant, which failed to complement E. coli BioC in vivo 
(Figure 3-8).  The effect of BioC induction on cell growth occurred rapidly.  The 
induction of wild-type B. cereus bioC impaired cell growth within an hour, and led to a 
complete blockage of growth by three hours (Figure 3-13a).  No growth defect was 
detected in the vector control or in the absence of arabinose, indicating that wild-type 
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BioC was the specific cause.  The induction of bioC Y18F mutant showed normal cell 
growth in the first three hours.  However, the strain reached stationary phase sooner and 
at lower density than the vector control and the uninduced strain (Figure 3-13a).  This 
result suggests that BioC Y18F might be partially active, and required more time to 
deplete malonyl-ACP and inhibit fatty acid synthesis.   
 
 To monitor phospholipid synthesis, I sampled cultures at different time points and 
incubated them with [
14
C] acetate for 10 min.  Phospholipids were then extracted from 
the cells, resolved on TLC, and visualized by autoradiography.  Incorporation of [
14
C] 
acetate into phospholipids, which are in the forms of cardiolipin, phosphatidylglycerol 
and phosphatidylethanolamine, requires active fatty acid synthesis (Figure 3-13b).  On 
the other hand, the lack of 
14
C radioactivity in the extracted phospholipids indicates 
disruption of this pathway, which is exactly what happened in the strain overexpressing 
wild-type BioC.  A faint spot of phosphatidylethanolamine was detected in the first hour.  
However, the labeling diminished all together in the next hours, corresponding to 
compromised cell growth.  It is interesting to note that disruption of phospholipid 
synthesis occurred more rapidly than cessation of growth.  Upon induction of BioC, 
phospholipid synthesis stopped within an hour; whereas, cell mass continued to increase 
beyond two hours.  This observation has also been reported previously with E. coli 
mutant strains blocked early in fatty acid synthesis
52
.  Although fatty acid synthesis is 
blocked, the cells will continue to synthesize proteins, resulting in increase in optical 
density.  In contrast, in vector control and uninduced strain, fatty acid and phospholipid 
syntheses continued to operate normally, resulting in steady incorporation of [
14
C] 
acetate.  The induction of bioC Y18F mutant gene resulted in reduction of phospholipid 
labeling, although not as severely as that seen with the wild-type gene.   
 
DISCUSSIONS 
 In Chapter 2, I proposed a novel methylation-demethylation directed synthesis of 
pimeloyl-ACP, an essential biotin precursor in E. coli.  This synthetic scheme is 
orchestrated by two Bio enzymes: BioC SAM-dependent methyltransferase and BioH 
carboxylesterase.  BioC introduces a protective methyl ester moiety to a malonyl 
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thioester primer molecule, allowing chain elongation of malonate to pimelate, by fatty 
acid synthesis.  BioH carboxylesterase subsequently cleaves off the methyl ester moiety 
to release pimeloyl-ACP, and to stop futile chain elongation.  These two reactions are 
crucial to my model of biotin synthesis, and I sought to characterize them experimentally.  
In the previous chapter, I demonstrated the cleavage of methyl ester moiety by BioH.  
However, I was unable to examine BioC methylation activity because E. coli BioC was 
highly insoluble.  Denaturation and refolding of E. coli BioC yielded weak enzyme 
activity that could be detected only in DTB synthesis assay in a mixture with E. coli cell 
extracts; whereas, in a defined in vitro system, with substrates [methyl-
3
H] SAM and 
malonyl-CoA, no activity was detected.  There are a few possible explanations to weak 
BioC activity.  First, the denatured enzyme might not have refolded properly, yielding 
only a small fraction of active enzyme.  Secondly, the methyltransferase assay might 
have poor sensitivity, due to inhibitory contaminants in commercial SAM
44
.  And finally, 
I suspected that BioC might be an intrinsically poor catalyst.  Since the cellular demand 
for biotin is extremely low, BioC may not have been evolutionarily selected for catalytic 
efficiency. 
 
In this chapter, I described an active BioC homolog from B. cereus 10986, which 
complemented E. coli BioC in vivo, suggesting that these two enzymes share a common 
substrate.  B. cereus BioC could be heterologously expressed in E. coli as soluble protein 
in reasonably good yield, making native purification feasible.  This soluble BioC allowed 
in vitro characterizations of SAM-dependent methyltransferase activity, which was 
previously not possible with insoluble E. coli BioC.  Using the newly optimized 
methyltransferase assay and enzymatically synthesized SAM, I demonstrated that BioC 
specifically targeted malonyl-ACP as the methyl acceptor.  In contrast, succinyl (C4)-
ACP and glutaryl (C5)-ACP were completely inactive, suggesting that BioC active site is 
highly selective towards the malony (C3) moiety.  Succinyl- and glutaryl-ACP are 
articificial substrates which are not known to exist in E. coli; however, BioH could 
potentially produce glutaryl-ACP.  As shown in vitro (Chapter 2), BioH could cleave the 
methyl ester of glutaryl-ACP, albeit at lower activity than long-chain substrates.  If 
cleavage of glutaryl-ACP methyl ester happens in vivo, presumably by elevated levels of 
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BioH, BioC would not be able to reactivate glutaryl-ACP, and pimelate synthesis would 
therefore be terminated prematurely.  This prediction correlates nicely with a previous 
study, in which over-expression of BioH not only failed to increase biotin production, but 
also significantly reduced the level of biotin and biotin intermediates
67
.   
 
Surprisingly, malonyl-CoA is a poor substrate for BioC.  Methylation of malonyl-
CoA was detected, but only at much higher substrate concentrations (Figure 3-10a).  CoA 
is often a good in vitro analog of ACP because both carrier molecules share the 4’-
phosphopantetheine group.  However, the amino acid residues of ACP may provide 
additional interactions to help binding to BioC and oriention of malonyl moiey in the 
active site.  The increased activity on malonyl-ACP is likely attributed to the lower KM 
for malonyl-ACP than malonyl-CoA.  The KM for malonyl-ACP is estimated 10.8 ± 0.6 
μM.  It is difficult to assess this value because the physiological concentration of 
malonyl-ACP is not known, although I expect a concentration similar to malonyl-CoA 
(35 μM)8.  Keep in mind that, although BioC may not have evolved for productivity, the 
enzyme still needs to compete against 3-ketoacyl-ACP synthases in canonical fatty acid 
synthesis for malonyl-ACP in order to efficiently initiate biotin synthesis.   
 
In contrast, the KM for SAM is estimated at 1.9 ± 0.1 μM which falls well within 
the physiological concentration of SAM (200 μM)8.  The KM for SAM is about five-fold 
lower than that of malonyl-ACP.  This might seem contradictory because SAM is more 
adundant than malonyl-ACP.  However, while malonyl-ACP is dedicated to fatty acid 
synthesis, SAM is used in many more metabolic processes.  BioC must compete with 
several other SAM-dependent methyltransferases and radical enzymes.  B. cereus BioC is 
also susceptible to inhibition by SAH and SIN, a classic trait of SAM-dependent 
methyltransferases.  SAH is a byproduct of SAM-dependent methylation reaction; 
whereas SIN is a natural antibiotic and an excellent mimic of SAM.  Both molecules are 
potent inhibitors of SAM-dependent enzymes other than BioC.  In contrast, other small 
derivatives of SAM, such as DOA and MTA, were not inhibitory to BioC.  These 
molecules represent only nucleoside moiety of SAM, and their inhibitory actions target 
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more specifically towards SAM-dependent radical enzymes.  To block the SAM binding 
pocket in BioC active site, the SAM nucleoside moiety is not sufficient. 
 
Biotin synthesis is an expensive biological process, which consumes four SAM, 
four NADPH and one ATP per one molecule of biotin made.  For this reason, BioC is 
tightly regulated at transcriptional level by BirA (biotin ligase and repressor), which 
represses the transcripton of bio genes in response to increased in biotin concentration.  I 
postulate that the turnover of BioC enzyme may also play an important role in 
maintaining a steady, low flux of malonyl-ACP methyl ester, without consuming too 
much malonyl-ACP.  Levy-Schill et al. reported that high level of BioC expression 
impaired E. coli cell growth
74
.  They postulated that an early precursor of the biotin 
synthetic pathway might be required by another essential metabolic pathway.  Therefore, 
they suspected that the induction of BioC led to deleterious redirection of flux 
distribution in primary metabolism, or possibly the accumulation of toxic BioC product.  
In this chapter, I have proven their prediction correct.  Over-expression of BioC rapidly 
disrupted fatty acid and phospholipid synthesis, presumably by inactivating malonyl-ACP 
by O-methylation, and as a result, effectively stopped cell growth.  I am currently in the 
progress of extracting and identifying malonyl-ACP methyl ester from BioC over-
expressing strain.  My preliminary result showed accumulation of a new ACP species in 
BioC over-expressing strain that was absence in the negative control strain. 
 
 In this study, I demonstrated that B. cereus BioC catalyzes the formation of a 
methyl ester moiety at the ω-carboxyl group of malonyl-ACP.  This simple but novel O-
methylation reaction provides an essential primer for E. coli biotin synthesis, and allows 
chain elongation of dicarboxylate by canonical fatty acid synthetic enzymes.  This 
methylation-demethylation synthetic scheme expanded our current understanding of 
metabolic synthesis.  It would certainly be interesting to see if this methylation-
demethylation synthetic scheme is used to make other natural products. 
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TABLES 
Table 3-1. Bacterial strains, plasmids and oligonucleotides. 
Strains Relevant characteristics Reference 
DK574 Apo-ACP over-expressing strain 
29
 
ER103 Mtn over-expressing strain 
21
 
NRD4-33 Sfp over-expressing strain a 
NRD 204 MG1655 ∆araBAD::cat a 
STL23 MG1655 ∆bioC::FRT Chapter 2 
STL204 Tuner (DE3) / pSTL29 BioC over-expressing strain 
This 
chapter 
STL215 Tuner (DE3) / pSTL27 MetK over-expressing strain 
This 
chapter 
Plasmids Relevant characteristics Reference 
37454 
pJexpress401 plasmid encoding the synthetic B. cereus 
bioC gene 
DNA2.0 
Inc. 
pSTL27 
pET28b+ plasmid encoding E. coli metK gene with a 
hexahistidine tag fusion at C-terminus 
This 
chapter 
pSTL28 
pET28b+ plasmid encoding B. cereus bioC gene with a 
hexahistidine tag fusion at C-terminus 
This 
chapter 
pSTL29 
pET28b+ plasmid encoding B. cereus bioC gene (native 
form) 
This 
chapter 
pSTL30 
pBAD24 plasmid encoding B. cereus bioC gene (native 
form) 
This 
chapter 
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Table 3-1. (Continued) 
Oligonucleotides Sequences 5’ to 3’ 
A77 CTC ACA ATT CCA CAA CGG TTT CCC TCT AG 
A78 CTT GGG GAC TCG AGA CGC TTA CC 
B13 GCG TTA GTA GCA CCA CCA CCA C 
B14 GGT GGT GCT ACT AAC GCT TAC CCT C 
B15 CGG TGA GCT TCG ATC AAT ACG C 
B16 GAT CGA AGC TCA CCG CAG C 
B17 CCT ACA ACG TTA TCA TTA GCA ACG C 
B18 GAT AAC GTT GTA GGT TTC TTC CAA ACG C 
B19 CCA GCA ACT GCA TGC GAG C 
B20 GCA GTT GCT GGA AAG TTT CCT G 
B21 GCT ACC TTT CAC GCG TTG TTT GTC C 
B22 GCG TGA AAG GTA GCC ATG ATG C 
B23 CCT TGG GGA AGC TTA ACG CTT ACC C 
B24 TTA GGT GAT ATT AAC CAT GGC AAA ACA CC 
B25 CGC AGG TGA AGA ACT CGA GCT TCA GAC CGG C 
 
a
 Constructed by Nicolas De Lay. 
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FIGURES 
 
Figure 3-1.  (a) The B. cereus 10987 bio operon contains all six overlapping bio genes 
under a unidirectional promoter.  The bioC gene is the fourth gene in the operon and 
locates immediately upstream of the bioH gene. (b) The B. cereus bioC gene was 
synthesized by DNA2.0 Inc and the codons were optimized to for expression in E. coli.   
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BC 2 INKTLLQKRFNVAAVSYDQYANVQKKMAHSLLSTLNRRYSTNSSIRILEL  51 
   :||..:...|..||..|:|:|::|::.|.:||:.|.:|..|:    :|:. 
EC     4 VNKQAIAAAFGRAAAHYEQHADLQRQSADALLAMLPQRKYTH----VLDA  49 
 
 
BC    52 GCGTGYVTEQLSNLFPKAQITAIDFAESMIAVAKTRQNVNNVTFYCEDIE  101 
         |||.|:::.....  ..||:||:|.:..|:..|:.:...::  :...||| 
EC    50 GCGPGWMSRHWRE--RHAQVTALDLSPPMLVQARQKDAADH--YLAGDIE  95 
 
 
BC   102 RLRL-EETYDVIISNATFQWLNDLKQVITNLFRHLSIEGILLFSTFGQET  150 
         .|.| ..|:|:..||...||..:|...:..|:|.:..:|::.|:|..|.: 
EC    96 SLPLATATFDLAWSNLAVQWCGNLSTALRELYRVVRPKGVVAFTTLVQGS  145 
 
 
BC   151 FQELHASFQRAKEEKNIQNETSIGQRFYSKNQLRHICEIETGDVHVSETC  200 
         ..|||.::|...|..:       ..||...:::    |.....||...   
EC   146 LPELHQAWQAVDERPH-------ANRFLPPDEI----EQSLNGVHYQH--  182 
 
 
BC   201 YIER----FTEVREFLHSIRKVGATNSNEESYCQSPS-LFRAMLRIYERD  245 
         :|:.    |.:....:.|::.:|||:.:|.   :.|. |.|:.|:..:.. 
EC   183 HIQPITLWFDDALSAMRSLKGIGATHLHEG---RDPRILTRSQLQRLQLA  229 
 
 
BC   246 FTGNEG-IMATYHALFVHITKE    266 
         :...:| ...|||.....|.:| 
EC   230 WPQQQGRYPLTYHLFLGVIARE    251 
 
 
Identity:      72/272 (26.5%) 
Similarity:   131/272 (48.2%) 
Gaps:          31/272 (11.4%) 
 
 
Figure 3-2.  Pair-wise sequence alignment of B. cereus 10987 BioC (BC) and E. coli 
MG1655 BioC (EC) using the program Water (EMBL-EBI).  The two sequences share 
26.5 % identity and 48.2 % similarity.  
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Figure 3-3.  Purification of the native form of B. cereus BioC consisted of three 
chromatographic steps: (a) anion exchange in a HiTrap SP FF column, (b) hydrophobic 
interaction in a HiTrap Phenyl Sepharose column and (c) size-exclusion in a HiLoad 
Superdex 200 column.  (d) Fractions containing BioC were monitored by SDS-PAGE. 
The numberings indicate the protein samples obtained during the three chromatographic 
steps.  Abbreviation: crude cell extract, Cru.  
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Figure 3-4.  Purified B. cereus BioC eluted as a monomer from Superdex 200 analytical 
size-exclusion column.  The molecular weight was estimated using protein standards 
from Bio-Rad.  
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Figure 3-5.  (a) MetK catalyzes the formation of SAM from ATP and methionine.  (b) 
The synthesis was monitored on HPLC at 260 nm. SAM is highly unstable and readily 
degrades into homoserine and methylthioadenosine which is visible at 260 nm.  SAM 
was purified by ion exchange chromatography to homogeneity to remove reactants and 
degraded products.  (c) Synthesized SAM was subjected to LC-MS and LC-MS/MS 
analyses.  The detected mass corresponded to the theoretical mass of 398.44 g/mol.  In 
LC-MS/MS, fragmentation at the sulfonium ion in MS/MS gave rise to adenosine and 
methylthioadenosine.  
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Figure 3-6.  Synthesized SAM was mixed with commercial [methyl-
3
H]-SAM (Perkin 
Elmer) and diluted in 10 mM H2SO4 (pH ~1) and 10 % ethanol to plot a standard curve.  
Each concentration contained three replicates.  The specific activity was calculated from 
the slope to 91.26 CPM per ρmol of [3H] SAM. 
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Figure 3-7.  Analysis of malonyl-ACP and malonyl-ACP methyl ester by MALDI-MS. 
Formation of a methyl ester at the ω-carboxyl group of malonyl-ACP increased the mass 
by 14 Da, which matches closely to theoretical mass of 15 Da.  
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Figure 3-8.  Complementation of an E. coli ∆bioCstrain by plasmid-encoded B. cereus 
bioC wild-type or mutant genes, was tested on M9 minimal medium.  Wild-type B. 
cereus bioC restored biotin synthesis, allowing growth of MG1655∆bioC in the absence 
of biotin. Similar growth was seen in the D110 mutant.  In contrast, Y18F, D110N and 
Y256F mutants failed to complement, suggesting that the mutation has inactivated the 
enzyme.  
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Figure 3-9.  The scheme of SAM-dependent methyltransferase assay shows that BioC 
catalyzes the transfer of methyl group from SAM to the ω-carboxyl group of malonyl-
ACP (or CoA) to form a methyl ester.  Mtn nucleosidase was added to hydrolyze SAH to 
prevent product inhibition.  Negatively charged ACP and CoA were purified from the 
reaction mixture by ion exchange Q resin.  The incorporation of tritium onto the recipient 
molecules was determined in a scintillation counter.   
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Figure 3-10.  (a) Specificity of B. cereus BioC methyltransferase activity was determined 
using different acyl-ACPs as methyl acceptor.  The results show that BioC was highly 
selective toward malonyl-ACP, whereas succinyl- and glutaryl-ACP of slightly longer 
chain length were completely inactive.  Methylation of malonyl-CoA was also detected, 
but at much higher substrate concentrations.  (b) A binding calibration curve of malonyl-
CoA to the Q resin shows an approximately 20 percent loss of bound malonyl-CoA, by 
the same extensive washing steps, across all concentrations.   
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Figure 3-11.  (a) Optimal pH of the BioC reaction was determined using malonyl-ACP 
as substrate, in buffers of sodium acetate (pH 4, 4.5 and 5), MES (pH 5.5 and 6), sodium 
phosphate (pH 6.5, 7 and 7.5), and Tris-HCl (pH 8, 8.5 and 9) at 37 °C for 10 min.  (b) 
Ion dependency was tested in either 20 mM of EDTA or 10 mM of a metal ion in sodium 
phosphate at pH 7.  The KM and kcat for malonyl-ACP (c) and SAM (d) were determined 
in sodium phosphate at pH 7.  The data were fit to classic Michaelis-Menton kinetics 
using OriginPro 8.6.  All reactions were repeated three times. Standard errors were 
presented as error bars.  
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Figure 3-12.  Inhibition of BioC activity by compounds of similar structure to SAM.  
Each compound was incubated with 100 nM BioC and 50 μM malonyl-ACP on ice for 5 
min.  Ten μM of SAM was added to initiate the reaction at 37 °C for 5 min.  BioC 
reaction was not affected by ADE, DOA, MTA or HCY, but the reaction was inhibited by 
SIN and SAH in a concentration-dependent manner.  The addition of 20 nM of Mtn 
(striped bars) enhanced BioC methylation reaction.  Mtn alleviated the inhibition by 
SAH, but not by SIN.  Standard errors were calculated from three replicate reactions and 
presented as error bars.  
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Figure 3-13.  (a) The effect of over-expressing B. cereus BioC on E. coli cell growth was 
investigated in RB medium with or without 0.2 % arabinose.  The expression of wild-
type B. cereus bioC gene, as induced by arabinose, stopped cell growth in 2 h.  The strain 
carrying Y18F mutant bioC gene showed only slight growth defect.   (b) Cells were taken 
at six time points during the growth and incubated with [1-
14
C] acetate for 10 min.  
Phospholipids were extracted from the cells, resolved on thin layer chromatography and 
visualized by autoradiography.  Incorporation of 
14
C acetate into phospholipids requires 
active fatty acid synthesis, which can be seen in vector control and uninduced strain.  
Disruption in phospholipid labeling was observed when the wild-type bioC gene was 
induced.  Labeling was also slightly affected by the expression of Y18F mutant gene.  
Abbreviations: cardiolipin, CL; phosphoglyceride, PG; phosphatidylethanolamine, PE.  
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CHAPTER 4 
CLEAVAGE OF THE METHYL ESTER MOIETY BY BIOH 
CARBOXYLESTERASE 
 
INTRODUCTION 
In Chapter 2, I demonstrate that BioH is responsible for cleavage of the methyl 
ester of pimeloyl-ACP, but the physiological substrate of the enzyme was unclear.  
Chemical logic argues that the most attractive substrate would be pimeloyl-ACP methyl 
ester because its cleavage would act as a “gatekeeper” to prevent further chain elongation 
to azelayl-ACP methyl ester, a physiologically useless product.  However, since the 
methyl ester introduced by BioC is at the far end of the pimeloyl moiety from the carbon 
atom incorporated to initiate the biotin uriedo ring, the ester could remain until later in 
the pathway.  In that case the gatekeeper function could be provided by BioF, the KAPA 
synthase that begins ring formation, because the reaction consumes the thioester required 
for further fatty acid chain elongation.  Hence, the problem distills down to the question 
of whether BioH acts before or after BioF (Figure 4-1).  This issue is further complicated 
by the findings that BioH is known to be a rather nonspecific hydrolase.  This substrate 
promiscuity may reflect recent recruitment of E. coli BioH for biotin synthesis and the 
fact that the bioH gene has not been fully integrated into the biotin synthetic pathway.  In 
E. coli bioH differs from the other genes of the pathway in that it is neither located within 
the bio operon nor regulated by the BirA repressor/biotin protein ligase
7,67
.  This is in 
contrast to other bacteria where bioH resides within the biotin operon
98
.  Thus, the E. coli 
bioH gene may encode a less specific protein than those encoded by the “domesticated” 
bioH genes.  
 
In this chapter I report experiments indicating that BioH acts before BioF (Figure 
4-2).  However, the lack of specificity of both enzymes made this experiment less than 
compelling and thus I obtained, in collaboration with the Satish Nair lab, the crystal 
structure of a complex of BioH with pimeloyl-ACP methyl ester as an independent test of 
my interpretation (Figure 4-3).  The BioH-ACP contacts identified in the structure 
(Figure 4-4) were demonstrated to be required for biotin synthesis in vivo indicating that 
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pimeloyl-ACP methyl ester is the physiological substrate of BioH and BioH is the 
gatekeeper. 
 
MATERIALS AND METHODS 
Materials   
The defined medium was M9
83
 supplemented at final concentrations with 0.8 % 
(v/v) glycerol, 0.1 % (w/v) Vitamin Assay Casamino Acids (Difco) and 1 mM MgSO4. 
The medium contained 0.4 % glucose in place of the glycerol and amino acids.  Medium 
2XYT contained 16 g of tryptone, 10 g of yeast extract and 5 g of NaCl per liter. Agar 
was added to 1.5 % (w/v). Antibiotics were used at the following concentrations (in μg 
ml
-1
): kanamycin sulfate, 50; chloramphenicol, 30; spectinomycin sulfate, 100.  
 
Cloning, protein expression and purification   
Construction of plasmids encoding C-terminally hexahistidine-tagged derivatives 
of wild type and the S82A mutant of BioH enzyme in pET28b vector have been 
described in Chapter 2.  Single, double, triple and quadruple BioH mutants designed to 
disrupt ACP binding were generated from the C-terminally hexahistidine-tagged wild 
type protein by standard site directed mutagenesis protocols.  The Arg mutations were 
constructed by Vinayak Agarwal, a Biophysics Program student in the Nair lab, using the 
oligonucleotides list in Table 4-1.  Wild type and mutant BioH enzymes used in this 
study for crystallization and biochemical assays all carried a C-terminal fusion of 
hexahistidine tag (unless stated otherwise) and were purified by Vinayak Agarwal as 
follows.  Clones were transformed into E. coli BL21 (DE3) and cultures were grown in 
LB medium supplemented with 50 µg/mL kanamycin sulfate.  Two liters of culture was 
grown at 37 °C until an OD600nm of 0.6 and protein production was induced by addition of 
0.3 mM IPTG.  The culture was then shifted to 18 °C and further grown for 16 h.  The 
cells were collected by centrifugation and resuspended in 20 mM Tris-HCl (pH 8.0), 500 
mM NaCl, 10 % glycerol buffer and lysed by multiple passages through a C5 Avestin cell 
homogenizer.  The supernatant was collected by centrifugation and applied to a 5 mL 
His-Trap (GE Biosciences) column equilibrated in the cell harvest buffer.  The column 
was extensively washed with 20 mM Tris-HCl (pH 8), 1 M NaCl, 30 mM imidazole 
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buffer and eluted by a linear gradient to 250 mM imidazole.  Protein purity was 
determined by SDS-PAGE and greater than 95 % pure fractions were applied to a 
Superdex-75 size-exclusion column equilibrated with 20 mM HEPES (pH 7.5), 100 mM 
KCl buffer.  The peak fractions corresponding to the BioH monomer were pooled and 
concentrated.  Crystallization and X-ray crystallography were performed by Vinayak 
Agarwal. 
 
Carboxylesterase assay   
BioH enzymes were assayed for their carboxylesterase activity on pimeloyl-ACP 
methyl ester.  Hydrolysis of the ester bond produces a slower migrating pimeloyl-ACP 
which can be resolved by the conformationally-sensitive electrophoretic mobility shift 
assay described in Chapter 2.  The reaction contained 100 mM sodium phosphate (pH 7), 
200 μM pimeloyl-ACP methyl ester and 5 nM BioH.  The hydrolysis reaction was 
monitored at 7 time points over a course of 20 min using the following protocol.  A 
premixed of buffer and ACP substrate, without BioH, was incubated at 37 
°
C for 1 min.  
The hydrolysis reaction was initiated by adding BioH. At each time point, the reaction 
was sampled, immediately quenched by addition of an equal volume of 10 M urea and 
stored on dry ice until analysis.  The reaction samples were mixed with loading dye (100 
mM MES (pH 6) and 70 % glycerol) at 2:1 ratio prior to loading into the gel. 
 
In vivo complementation assays  
Strain STL243 was transformed with plasmid pET28b carrying the bioH wild-
type gene or a mutant gene.  The resulting strains were maintained in spectinomycin and 
kanamycin throughout the experiment.  The strains were inoculated at 30 °C overnight in 
5 ml of M9 medium containing 0.8 % glycerol (M9-glycerol) and 1 nM biotin.  One ml 
of the cultures were collected, washed three times with M9-glycerol to remove biotin, 
and resuspended in 1 ml of M9-glycerol.  Cell density was normalized to optical density 
(OD) at 600 nm of one.  Ten μl of the cells were then used to inoculate 1.5 ml of M9-
glycerol.  The growth analysis was performed on Bioscreen C (Growth Curves USA) 
using a proprietary 100-well microplate.  Each well contained 250 μl of the cell 
suspension. Growth was monitored by OD at 600 nm at 37 °C for 24 h with high 
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agitation rate.  Growth curve of each strain was plotted based on the mean OD from five 
replicates using OriginPro 8.6.  Standard errors were all less than 2 % of mean ODs.  
Growth phenotypes were also tested by colony formation on solid medium. 
 
Construction of plasmids encoding biotinylation peptide tagged BioF and BioH; protein 
purification and the order of addition assay   
Plasmid pSTL6, encoding a version of BioH with a C-terminal hexahistidine tag 
in pET28b, was constructed in Chapter 2.  An analogous pET28b plasmid (pSTL3) 
encoding a C-terminal hexahistidine-tagged BioF was made in the same manner as the 
BioH plasmid using the oligonucleotide primers: BioF forward and BioF reverse.  Both 
genes contained an XhoI site at the junction of the coding and tag sequences which was 
used by Dr. Cronan to replace the C-terminal hexahistidine tags with a sequence 
encoding a peptide sequence (Pep-85) that becomes biotinylated by the E. coli BirA 
biotin protein ligase.  Two oligonucleotides PEP85 top and PEP85 btm were annealed to 
give a double-stranded cassette having overhanging XhoI and BlpI ends.  The BioH-
encoding plasmid was digested with BlpI (located 50 bp downstream of the termination 
codon) and XhoI and ligated to the cassette to give plasmid pCY890 which encoded the 
BioH-Pep-85 fusion.  DNA sequencing showed the construct had the expected sequence.  
Similar manipulations could not be done with the BioF plasmid, because the bioF gene 
contains a BlpI site.  Hence the BioH plasmid was digested with XhoI and ClaI (which 
cuts in the vector kanamycin resistance gene) and the smaller of the two resulting 
fragments containing the Pep-85 tag was ligated to the larger fragment of pSTL3 cut with 
the same enzymes to give the BioF-Pep-85 fusion protein expression plasmid pCY889.  
Plasmids pCY889 and pCY890 encoded active proteins as shown by their abilities to 
allow growth of ∆bioF and ∆bioH strains, respectively, in the absence of biotin.   
 
Plasmids pCY889 and pCY890 were used to transform strain Tuner (DE3) 
carrying additional copies of birA (the E. coli gene encoding biotin protein ligase) 
encoded on a second plasmid, pCY216
19
.  The resulting strains were maintained in 
chloramphenicol and kanamycin throughout the experiment.  For expression of BioF and 
BioH, the strains were inoculated in 5 ml of LB medium at 30 °C overnight, and 
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subcultured (1:100 ratio) in 250 ml of 2XYT medium.  The cells were grown at 37 
o
C 
until OD at 600 nm reached 0.6.  Arabinose was added to 0.02 % (w/v) to induce 
expression of BirA for 30 min, and then IPTG was added to 0.1 mM to induce expression 
of BioF or BioH for 3 h.  The cells were collected by centrifugation, resuspended in lysis 
buffer (100 mM sodium phosphate, pH 6.5, 150 mM NaCl, 10 % glycerol and 1 mM 
TCEP, and lysed by French press treatment at 17,500 psi. Ammonium sulfate was added 
slowly to the soluble cell extract to 55 % (w/v) saturation under constant stirring on ice.  
After 30 min of stirring, protein pellet was collected by centrifugation at 20,000 g.  The 
pellet was washed three times, each with 20 ml of lysis buffer containing 55 % 
ammonium sulfate.  The pellet was then dissolved in lysis buffer and biotin-tagged BioF 
or BioH was purified by monomeric avidin agarose (Pierce).  The agarose was washed 
with 30 column volumes of lysis buffer and the biotin-tagged protein was eluted with 
lysis buffer containing 4 mM biotin. The proteins were dialyzed extensively in lysis 
buffer to remove biotin and concentrated using Amicon Ultra centrifugal filters 
(Millipore). Protein concentrations were determined by Bradford assay (Bio-Rad) using 
bovine serum globulin (Pierce) as standard. 
 
The BioH-BioF order of addition assay allows in vitro conversion of pimeloyl-
ACP methyl ester to DTB using pure BioH, BioF, BioA and BioD enzymes.  The assay 
was divided into two reactions.  In the first reaction, pimeloyl-ACP methyl ester was 
incubated with BioH, BioF or both plus the required substrates to give pimeloyl-ACP, 
KAPA methyl ester or KAPA as potential products.  In the second reaction, these 
products were converted to DTB by adding the other three enzymes.  The first reaction 
(50 μl) contained assay premix (50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 10 
% glycerol, 2.5 mM DTT, 10 mM L-Ala, 100 μM PLP), 10 μM pimeloyl-ACP methyl 
ester and 1 nM of either biotin-tagged BioH or biotin-tagged BioF.  The reaction was 
incubated at 37 
°
C for 1 h.  The biotin-tagged proteins were removed by incubation with 
25 μl of streptavidin agarose (Novagen, binding capacity of 2 nmol of biotin per 25 μl) on 
ice for 30 min.  The agarose bead was separated from the supernatant using a spin filter.  
The second reaction (100 μl) contained 50 μl of the supernatant, assay premix, 2 mM 
potassium bicarbonate, 2.5 mM ATP, 2.5 mM SAM, 10 nM BioA, 10 nM BioD and 1 
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nM of either BioH or BioF.  The reaction was incubated at 37
 °
C for 1 h and quenched by 
boiling for 10 min.  Twenty μl of each reaction was spotted on DTB bioassay plate using 
strain ER90 as described in Chapter 2. 
 
Synthesis of pimeloyl-ACP methyl ester   
The acylation reaction contained 50 mM Tris-HCl (pH 8.5), 10 mM MgCl2, 0.5 
mM TCEP, 5 mM ATP, 5 mM pimelate methyl ester, 1 mM ACP and 50 μM AasS.  The 
reactions were incubated at 37 °C for 1.5 h.  Pimeloyl-ACP methyl ester was purified by 
ion-exchange chromatography using Vivapure D spin columns (GE Healthcare Life 
Science).  The reaction mixture was diluted five fold in binding buffer (25 mM 4-MES, 
pH 6, 10 % (v/v) glycerol and 1 mM TCEP) containing 100 mM LiCl, and loaded into 
the column.  The column was washed with binding buffer containing 250 mM LiCl and 
the ACP was eluted in binding buffer containing 500 mM LiCl. Me-Pimeloyl-ACP was 
desalted by dialysis in binding buffer, and concentrated using Amicon Ultra centrifugal 
filter (Millipore).  The ACP product was analyzed in a conformationally-sensitive 
electrophoretic mobility shift assay in 20 % polyacrylamide gels containing 2 M urea at 
130 V for 3.5 h.  The ACP was stained with Coomassie Blue R250.  Other acyl-ACPs 
were prepared by the same method.  
 
4-Nitrophenyl acetate hydrolysis assay   
The hydrolysis of 4-nitrophenyl acetate (Sigma-Aldrich) by BioH gave rise to 4-
nitrophenol which was monitored by OD at 405 nm.  The 500-μl reaction contained 100 
mM MES (pH 6.5), 10 mM 4-nitrophenyl acetate, 10 % dimethyl sulfoxide and 10 nM 
BioH.  Kinetic analysis was performed at room temperature in a Beckman Coulter DU 
800 spectrophotometer.  The reaction was equilibrated without BioH for 1 min and 20 
sec, initiated by adding BioH and monitored continuously for a total of 7 min.  Mean 
reaction rates and standard errors were determined from three replicate experiments.   
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RESULTS 
Evidence that BioH acts prior to BioF 
The order of action of the genes in a microbial metabolic pathway can often be 
deduced by cross-feeding experiments among mutant strains.  However, in pimelate 
synthesis this approach fails because the protein-bound intermediates cannot diffuse.  To 
counter this problem the previously reported in vitro cell-free extract system
76
 that 
converted malonyl-CoA to dethiobiotin (DTB) was simplified to a coupled system where 
four enzymes convert pimeloyl-ACP methyl ester to DTB.  The design was to add either 
BioH or BioF to an in vitro system containing the substrates required for their reactions 
and then remove the enzyme by use of an affinity tag (Figure 4-1).  The second enzyme 
(either BioF or BioH) is then added with BioA and BioD and their substrates. Following 
further incubation, DTB synthesis is assayed.  The experiment with addition of BioH or 
BioF in the opposite order would be done in parallel and the results of the two orders of 
addition compared.  Assuming strict enzyme specificity addition of the enzymes in the 
correct order would give DTB whereas the incorrect order of addition would not.  
However, I expected less than “black or white” results due to the known promiscuity of 
BioH.  The results of these experiments indicated that addition of BioH before BioF gave 
about twice as much DTB synthesis as the reverse order of addition in all four 
independent trials of the experiments, one of which is shown in Figure 4-2.  Reaction 7 
established that BioH cleaves the -methyl ester of KAPA methyl ester and that BioF 
accepts pimeloyl-ACP methyl ester in place of pimeloyl-ACP, although both off-target 
reactions are slower than the physiological reactions (reaction 8).  Given these off-target 
reactions the results I obtained were perhaps as good as might be expected.  Another 
possible source of background would be inefficient removal of the first enzyme.  To deal 
with this possibility I used the tag system having the highest known affinity, biotin-
streptavidin.  The BioH and BioC proteins were expressed as fusions to an affinity tag 
(constructed by Dr. Cronan) that becomes biotinylated by the E. coli biotin-protein ligase, 
BirA.  The biotinylated proteins were purified on a monomeric avidin column before use.  
Control experiments showed that neither protein preparation contained free biotin (which 
would have scored as DTB) (Figure 4-2).  Note that the bead-conjugated streptavidin was 
added in large molar excess. 
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 Given that the order of addition experiments gave the less than ideal results we 
sought an independent means to test whether or not BioH is the gatekeeper.  The 
promiscuity of E. coli BioH raised the question of how a nonspecific enzyme can 
catalyze a specific reaction.  In the absence of other factors BioH might derail biotin 
synthesis by hydrolyzing intermediates prior to pimeloyl-ACP methyl ester and thereby 
abort the pathway.  Previously I proposed that the structure of the ACP moiety of the 
substrate could bestow the needed specificity
76
.  Early work on acyl-ACPs demonstrated 
that the protein sequesters the first 6-8 carbon atoms of the acyl chain from solvent
26
, a 
picture borne out by X-ray structures and molecular dynamics simulations
18,31,100
.  The 
protected acyl chain carbon atoms reside within a hydrophobic tunnel formed by a bundle 
of four helices.  Hence, the bundle would largely or completely protect the ester groups 
of the shorter intermediates from BioH.  Only upon chain elongation to the C7 species 
would the ester group become fully exposed to BioH such that it could enter the active 
site.  In this scenario the slow hydrolysis of glutaryl-ACP methyl ester would be due to 
the dynamic nature of ACP structure which would leave the methyl ester transiently 
unprotected.  To test this model of the putative gatekeeper reaction I collaborated with 
Vinayak Agarwal of the Satish Nair lab to obtain a complex of pimeloyl-ACP methyl 
ester with BioH Ser82Ala that lacks the catalytic serine nucleophile (Figure 4-3). 
 
Effects of BioH surface residue substitutions on esterase activity in vitro 
Based on the co-crystal structure, we identified four Arg residues (Arg138, 
Arg142, Arg155 and Arg159) in BioH that are located at the ACP binding interface 
(Figure 4-4).  To test the enzymological and physiological relevance of the ionic 
interactions between BioH and ACP-α2 helix, these Arg residues were replaced with 
alanine to assemble a library of single, double, triple and quadruple mutants.  I assayed 
the esterase activity of the BioH mutants in vitro using the cognate substrate, pimeloyl-
ACP methyl ester.  The production of pimeloyl-ACP, which migrates more slowly than 
the substrate in a destabilizing urea-PAGE system, was monitored over 20 min (Figure 4-
5).  The wild-type enzyme and the single Arg to Ala substitution mutants had comparable 
activities whereas the S82A mutant was completely inactive.  With these BioH proteins 
production of pimeloyl-ACP could be seen in as little as 30 sec and the reaction 
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approached completion in approximately 10 min.  The activities of proteins containing 
two Ala substitutions were significantly reduced.  The earliest sign of pimeloyl-ACP 
occurred at 2 min and at 20 min the reactions remained incomplete.  The activities of 
triple and quadruple Ala substitution mutants were greatly reduced producing 
significantly less pimeloyl-ACP over the same time period.  This result indicated that at 
least three Arg residues were needed to maintain a wild-type level of activity.  Given the 
crystal structure, interpretation of these data in terms of the binding affinity between 
BioH and the ACP moiety of pimeloyl-ACP methyl ester seems straightforward.  
However, it remained possible that the mutations had somehow compromised the enzyme 
active site.  To test this possibility we assayed the abilities of each of the mutant proteins 
to cleave 4-nitrophenyl acetate, a commonly used colorimetric esterase assay substrate 
(Figure 4-6).  All of the mutant proteins had wild type activity on this model substrate 
indicating that active site function remained intact in the mutant proteins (Table 4-2).  
 
Effects of BioH surface residue substitutions on biotin synthesis 
If the interactions seen in the crystal structure are of physiological relevance, 
decreased in vitro activities of the BioH proteins carrying Ala substitutions should result 
in decreased abilities to support biotin synthesis.  This was tested using an E. coli strain 
in which both the bioH and pcnB genes had been deleted and that also carried pMS421, a 
lacI
q
 plasmid.  The various BioH proteins were expressed in plasmid pET28b, a vector 
often used to express proteins from its LacI-controlled phage T7 promoter.  In this case, 
however, there was no source of phage T7 RNA polymerase and bioH transcription was 
due to recognition of the T7 promoter by E. coli RNA polymerase
107
.  The ∆pcnB 
mutation was included to decrease the copy number of the BioH plasmids by about 10-
fold
81
.  Replication of pMS421, which provided additional LacI to allow better control of 
BioH expression, is unaffected by the pcnB deletion.  These manipulations were intended 
to allow detection of BioH mutants having significant, but incomplete, losses of esterase 
activity which could be masked by high-level expression.  Successful complementation 
absolutely required the catalytic Ser82 residue and the single Arg to Ala substitutions 
only modestly affected complementation activity (Figure 4-7), although a brief lag was 
observed before exponential growth ensued.  This growth lag was further extended in the 
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double mutants and became much more prominent in the triple and quadruple mutants 
(Figure 4-7).  Since biotin is not consumed (as in most growth assays) but allows 
catalysis, the lag is explained by the time required to accumulate protein-bound biotin to 
the threshold level required for fatty acid synthesis.  As growth proceeds the levels of 
protein-bound biotin may fall below the threshold but since E. coli can grow through 
several generations on accumulated lipids before growth cessation, the growth curve 
reaches stationary phase.  In contrast, colony formation requires a much greater number 
of generations and thus provides a more stringent assay as shown by the inability of the 
triple and quadruple BioH mutants to form colonies (Figure 4-8).  This effect of the Ala 
substitutions was completely reversed by supplementation of biotin in the growth 
medium. 
 
Effects of the chain length of the dicarboxylate moiety on BioH activity 
 BioH has been demonstrated to hydrolyze the methyl ester of ω-carboxyl-ACP of 
various chain lengths (Figure 2-10b).  However, the co-crystal structure revealed a 
hydrophobic channel in BioH that might be specific to a pimeloyl chain.  The tethering of 
ACP to the entrance of BioH active site allows insertion of phosphopantetheinylated 
pimeloyl chain into a hydrophobic channel to direct the methyl ester moiety to the BioH 
catalytic triad (Figure 4-9a).  To test whether or not dicarboxylate moieties of different 
chain lengths would fit in BioH activity, I assayed BioH activity on the methyl ester of 
glutaryl (C5)-ACP, adipyl (C6)-ACP, suberyl (C8)-ACP and azelayl (C9)-ACP.  As 
expected, the activity was the highest on the pimeloyl chain; whereas, the activity on 
other chain lengths was significantly reduced (Figure 4-9b).  A pimeloyl chain has the 
optimal length to occupy the hydrophobic channel for delivery of the methyl ester moiety 
to BioH catalytic triad. 
 
DISCUSSIONS 
Through collaboration with Vinayak Agarwal of the Satish Nair lab, we obtained 
a 2.0Å resolution co-crystal structure of BioH Ser82Ala in complex with its substrate, 
pimeloyl-ACP methyl ester.  The co-crystal structure provided an independent means to 
test the fate of the esterified pimelate moiety in the biotin synthetic pathway, namely 
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through the disruption of interactions that mediate complex formation between BioH and 
ACP.  Substitution of Ala at four Arg BioH residues, designed to disrupt interactions 
between BioH and the ACP moiety of pimeloyl-ACP methyl ester, inhibited ester 
hydrolysis in vitro and compromised the ability of plasmids encoding the altered enzymes 
to complement growth of the bioH deletion strain.  When two or more BioH arginine 
residues were replaced, the enzymes lost activity in both assays and were completely 
inactivated with three or four replacements.  Indeed, the effects of the various mutations 
on in vitro enzymatic activity and in vivo biotin synthetic ability were strikingly similar.  
Moreover, all of the BioH mutant proteins retained a fully functional active site as shown 
by the ability to cleave a model esterase substrate.  These data demonstrate that pimeloyl-
ACP methyl ester is the physiological substrate of BioH and that BioH functions as the 
gatekeeper in pimeloyl moiety synthesis, by terminating elongation of the pimeloyl chain 
by the fatty acid synthetic pathway. 
 
The structure argues that substrate specificity for ACP-bound substrates has been 
engineered into BioH, such that only a pimeloyl methyl ester chain can be accepted.  To 
test this premise Vinayak Agarwal attempted to generate crystal structures of BioH with 
the methyl ester of glutaryl-ACP and azelayl-ACP.  However, the crystals obtained 
contained only BioH without ACP.  An inspection of the BioH hydrophobic substrate 
channel (Figure 4-9a), and the manner in which the phosphopantetheinylated fatty acid is 
directed into the enzyme active site, provides a rationale for these observations.  In order 
for a fatty acid chain of abnormal chain length to travel along this hydrophobic channel 
and approach the catalytic site, structural rearrangements would be necessary.  A glutaryl 
(CH2)3 chain would have to be stretched to cover the same distance as the five methylene 
carbons of the pimeloyl substrate which would disrupt methylene tetragonal geometry, 
whereas a (CH2)7 azelayl substrate would undergo steric clashes with the hydrophobic 
side chains that line the channel.  Hence, neither a shorter, nor a longer ACP-bound chain 
could efficiently reach the active site (Figure 4-9a).  We propose a model in which three 
factors- (i) positioning of the enzyme active site on top of the BioH core domain, (ii)  
placement of the ACP molecule on top of the BioH capping helices, and (iii) tethering of 
the phosphopantetheinylated pimeloyl methyl ester through the BioH capping helices 
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guided by hydrophobic interactions, together generate reaction specificity.  The known 
ability of BioH to cleave short chain (but not long chain) 4-nitrophenol esters and the 
methyl ester of dimethylbutyryl-S-methyl mercaptopropionate are consistent with the 
hydrophobicity and narrow aperture of the BioH channel, although accommodation of the 
bulky 4-nitrophenol group argues that the bottom of the channel can expand.  Expansion 
would also explain the reported hydrolysis of the ethyl, propyl and butyl esters of 
pimeloyl-ACP
76
. 
 
We previously postulated that BioC, the SAM dependent methyl transferase, 
which methylates malonyl-ACP (or malonyl-CoA) to shunt a small portion of the flux of 
the fatty acid synthetic pathway towards biotin synthesis, may be an intrinsically poor 
catalyst.  This lack of catalytic efficiency is also characteristic of the downstream 
enzymes of the pathway
2,42,44,120
, and has been attributed to the traces of biotin required 
for cellular growth
27
.  To verify this premise, we sought to determine the kinetic 
constants for the esterase reaction mediated by BioH.  A variety of in vitro assays were 
unsuccessfully trialed for this purpose.  However, an estimate for the maximal catalytic 
rate for the enzyme can be obtained from the gel shift assay employed in this study 
(Figure 4-5).  Wild-type BioH routinely hydrolyzed a 40,000 fold molar excess of Me-
pimeloyl-ACP in less than 10 minutes.  Assuming the substrate/enzyme molar ratio used 
in our in vitro experiments to be saturating for the enzyme, the kcat value for the ester 
hydrolysis by BioH can be estimated, minimally to be 60 sec
-1
.  This value is orders of 
magnitude greater than those reported for the downstream enzymes of the 
pathway
2,42,44,120
.  This mismatch of BioH catalytic activity with the other enzymes of the 
pathway and with the physiological need for only extremely modest amounts of biotin 
may indicate that the enzyme has not yet been fully integrated into E. coli biotin 
synthesis.  Other indications are that the E. coli bioH gene is not located within bio 
operon or regulated by BirA, the repressor that controls expression of the other bio genes.  
Hence the mode of substrate engagement and the model proposed for the generation of 
substrate specificity within the enzyme active site seem to be independent of genetic 
positioning of the bioH gene.  
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TABLES 
Table 4-1. Bacterial strains, plasmids and oligonucleotides. 
Strains Relevant characteristics Reference 
BL21 (DE3) ompT hsdSB (rB
-
mB
-
) gal dcm (DE3) Invitrogen 
Tuner (DE3) ompT hsdSB (rB-mB-) gal dcm lacY1(DE3) Novagen 
ER90 MG1655 ΔbioF::cat bioC bioD 21 
YFJ239 BL21 (DE3 )/ pYFJ84 
61
 
DK574 / 
pJT93 
E. coli holo-ACP over-expression strain 
29
 
STL24 MG1655 ΔbioH::FRT Chapter 2 
STL243 MG1655 ΔbioH::FRT ∆pcnB::cat a 
Plasmids Relevant characteristics Reference 
pET28b+ Kan
R
 T7 expression vector Novagen 
pSTL3 
pET28b+ encoding C-terminal His-tagged E. coli 
BioF 
This chapter 
pSTL6 
pET28b+ encoding C-terminal His-tagged E. coli 
BioH 
Chapter 2 
pSTL13 pSTL6 derivative carrying the S82A BioH mutation Chapter 2 
pCY889 
pET28b+ encoding E. coli BioF-Pep85 fusion at C 
terminus 
This chapter 
pCY890 
pET28b+ encoding E. coli BioH-Pep85 fusion at C 
terminus 
This chapter 
pCY216 
pAR13 encoding E. coli BirA under arabinose 
control  
19
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Table 4-1. (Continued) 
Oligonucleotides Sequences 5’ to 3’ 
BioF forward 
GGC AGC ATC ATG AGC TGG CAG GAG AAA 
ATC 
BioF reverse 
CAA TGG CTT GTC TCG AGA CCG TTG CCA 
TGC 
Pep85 top 
TCG AGG GAG GAC TGA ACG ACA TCT TTG 
AAG CGC AAA AAA TCG AAT GGC ATT AAG 
CTT GC 
Pep85 btm 
TCA GCA AGC TTA ATG CCA TTC GAT TTT TTG 
CGC TTC AAA GAT GTC GTT CAG TCC TCC C 
BioH R138A Top 
AGT GAT GAT TTT CAG GCT ACA GTG GAG 
CGG TTC 
BioH R138A Bottom 
CTG AAA ATC ATC ACT GAG TTG CTG CTG 
AAA TCC 
BioH R142A Top 
CAG CGT ACA GTG GAG GCG TTC CTG GCG 
TTA CAA 
BioH R142A Bottom 
CTC CAC TGT ACG CTG AAA ATC ATC ACT 
GAG TTG 
BioH R155A Top 
GGG ACT GAA ACG GCG GCC CAG GAT GCG 
CGG GCG 
BioH R155A Bottom 
CGC CGT TTC AGT CCC CAT GGT TTG TAA 
CGC CAG 
BioH R159A Top 
GCG CGC CAG GAT GCG GCG GCG TTG AAG 
AAA ACC 
BioH R159A Bottom 
CGC ATC CTG GCG CGC CGT TTC AGT CCC 
CAT GGT 
BioH R159A - R155A Top 
GGG ACT GAA ACG GCG GCC CAG GAT GCG 
GCG GCG 
BioH R142A - R138A Top 
AGT GAT GAT TTT CAG GCT ACA GTG GAG 
GCG TTC 
 
a
 To delete the pcnB gene in MG1655 ∆bioH:: FRT, the strain was transduced with P1 
phage made from MG1655 ∆pcnB::cat (constructed by Alexander Smith).  
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Table 4-2. Catalytic rate constants for the hydrolysis of 4-nitrophenyl acetate by wild 
type and mutant BioH enzymes.  Means and standard errors were calculated from three 
replicate reactions.  
 
Enzyme 
Activity ± Standard Error  
(μmol/min/mg of BioH) 
Wild-type 2.08 ± 0.03 
R138A 1.81 ± 0.06 
R142A 2.55 ± 0.07 
R155A 1.83 ± 0.03 
R159A 2.30 ± 0.03 
R138A/R142A 2.00 ± 0.02 
R155A/R159A 1.97 ± 0.01 
R138A/R155A 1.98 ± 0.02 
R138A/R159A 2.07 ± 0.01 
R142A/R155A 2.06 ± 0.09 
R142A/R159A 1.81 ± 0.03 
R138A/R142A/R155A 2.00 ± 0.04 
R138A/R142A/R159A 2.54 ± 0.01 
R138A/R155A/R159A 1.99 ± 0.06 
R142A/R155A/R159A 2.79 ± 0.05 
R138A/R142A/R155A/R159A 2.32 ± 0.03 
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FIGURES 
 
 
Figure 4-1.  Scheme of in vitro order of addition assay.  Pimeloyl-ACP methyl ester was 
the substrate for in vitro synthesis of KAPA by two putative routes, producing either 
pimeloyl-ACP or KAPA methyl ester as intermediates.  KAPA would eventually be 
converted by the BioA and BioD reactions to DTB for bioassay. BioH and BioF were 
biotin-tagged to allow their quantitative removal by binding to streptavidin agarose 
before addition of the second enzyme.  The production of DTB, via the synthesis of 
KAPA, was visualized on the bioassay plate as described in Methods. Abbreviations: 
AMTOB, S-adenosyl-2-oxo-4-methylthiobutyric acid. 
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Figure 4-2.  The synthesis of DTB in the in vitro order of addition assay was detected by 
crossfeeding to strain ER90.  The growth of ER90 was visualized by respiratory 
reduction of tetrazolium to red insoluble formazan.  The size of the red circle is 
proportional to the amount of DTB synthesized.  All four enzymes and pimeloyl-ACP 
methyl ester were required to synthesize DTB (reaction 1-4).  Small amount of DTB was 
detected when BioF was added without BioH (reaction 5); whereas no DTB was made 
when only BioH was added (reaction 6).  When BioH was added before BioF, more DTB 
was synthesized than when the two enzymes were added in the reverse order (reaction 7-
8).  
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Figure 4-3.  Overall structure of pimeloyl-ACP methyl ester in complex with BioH 
S82A.  BioH is colored in orange whereas pimeloyl-ACP methyl ester is colored in 
yellow.  The phosphopantetheine-linked pimeloyl methyl ester, which is linked to Ser 35 
residues, is shown in sphere representation.  The image was generated using UCSF 
Chimera software. 
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Figure 4-4.  The binding interaction between BioH (red) and ACP (blue) are mediated by 
residues located on the BioH capping helices (Q136-A167) and ACP helix2 (S35-F49).  
This interaction is provided predominantly by BioH Arg138 and Arg 142 residues, which 
bind to main chain amide carbonyl oxygen and side chain carboxylate oxygen atoms of 
ACP, and also BioH Arg155 and Arg159 residues, which interact with side chain 
carboxylate oxygen atoms from aspartate and glutamate residues of ACP.  The image was 
generated using UCSF Chimera software.  
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Figure 4-5.  Substitution of alanine for the BioH arginine residues at positions 138, 142, 
155 and 156 reduced in vitro cleavage of pimeloyl-ACP methyl ester.  The product is the 
slower migrating pimeloyl-ACP, which can be resolved in a destabilizing urea-PAGE 
system.  Wild-type enzyme and single Ala substitution mutant proteins demonstrated 
similar catalytic rates whereas the S82A protein was completely inactive.  Double 
mutants showed significant reductions in activity whereas the activities of the triple and 
quadruple mutants were nearly abolished.  Abbreviation: 4’-phosphopantetheine, Ppant. 
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Figure 4-6.  Hydrolysis of 4-nitrophenyl acetate by wild type and mutant BioH enzymes.  
Hydrolysis of the ester bond gives 4-nitrophenol quantitated by optical density at 405 nm.  
Different enzyme concentrations were tested and 0.1 nM was chosen for all subsequent 
assays.  Means and standard errors were calculated from three replicate reactions. 
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Figure 4-7.  Alanine substitution of residues R138, R142, R155 and R159 reduced BioH 
activity in vivo.  The effect of Ala substitutions on BioH activity was investigated by 
assaying complementation of a ∆bioH strain.  The host strain was deleted of the 
chromosomal bioH gene and required a plasmid encoded BioH to complete biotin 
biosynthesis sustain cell growth.  The strain carrying the empty vector or expressing the 
S82A mutant protein failed to grow.  Exponential growth of cultures expressing the 
single Ala substitution mutants was slightly delayed.  These cultures required more time 
to accumulate sufficient biotin to support fatty acid synthesis.  The lag became more 
apparent in the double mutants and increased to nearly 10 h in the triple and quadruple 
mutants.  
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Figure 4-8.  Complementation by BioH mutants on M9 minimal agar plates.  Wild-type 
bioH or Arg mutant gene was cloned into pET28b plasmid, and introduced into 
MG1655∆bioH∆pcnB, carrying a second plasmid pMS421.  Single Arg mutants 
complemented the chromosomal bioH equally well as the plasmid-encoded wild-type 
bioH.  The majority of double mutants also complemented well, except R142A/R155A 
(12) and R142A/R159A (13).  Triple and quadruple Arg mutants failed to complement. 
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Figure 4-9.  (a) ACP binds near to the entrance of BioH active site, allowing 
phosphopantetheinylated pimeloyl chain to insert into a hydrophobic channel and deliver 
the methyl ester moiety to the BioH catalytic residues.  The depth of hydrophobic 
channel, as highlighted in dashes, seems to match the length of a pimeloyl chain.  (b) 
BioH also acted on the methyl ester of ω-carboxyl-ACP of various acyl chain lengths.  
The carboxylesterase activity was the highest on the pimeloyl substrate.  
  
H235 
D207 
S82A 
Pimeloyl chain 
Methyl ester 
moiety 
ACP BioH 
Phospho- 
pantetheine 
 
 
a                                        b 
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CHAPTER 5 
CONCLUSIONS 
 
SUMMARY AND NARRATIVE OF FINDINGS 
 In this thesis, I describe the delineation of E. coli biotin synthetic pathway using 
genetic, biochemical and structural approaches.  Prior to my study, several important 
clues were already known about the pathway.  It was known that the pimeloyl moiety is 
synthesized asymmetrically from acetate and is attached to a carrier molecule which was 
believed to be CoA.  The synthesis was thought to involve fatty acid synthesis, BioC 
(annotated SAM-dependent methyltransferase) and BioH (carboxylesterase).  Genetic 
studies further dismissed fatty acid degradation pathway as the source of pimeloyl-CoA.  
However, these clues were disconnected and did not offer a clear picture to how BioC 
and BioH catalyze the synthesis of pimeloyl moiety. As a result, several conflicting 
hypotheses were proposed.  These hypotheses were challenging to test mainly due to 
extremely low production of biotin synthesis and miniscule accumulation of the 
intermediates, making extraction and characterization of the intermediates very difficult.   
 
My initial aim was to find evidence to show that fatty acid synthesis is involved in 
early steps of biotin synthesis, and ACP is the carrier of pimeloyl moiety.  This 
hypothesis cannot be tested genetically, because fatty acid synthesis genes are essential 
and cannot be simply deleted to create biotin auxotrophy.  I decided to take a biochemical 
approach to set up an in vitro DTB synthesis assay (Chapter 2) to circumvent the 
impermeability problem of ACP-bound biotin precursors.  The first question I wanted to 
answer was whether or not pimeloyl-ACP was a precursor of biotin.  My plan was to 
synthesize pimeloyl-ACP from pimelic acid, ACP (holo form), ATP and acyl-ACP 
synthetase AasS.  This reaction scheme seemed doubtful because dicarboxylic acids were 
never tried in AasS reaction. The hydrophobic active site of AasS would likely reject the 
second carboxyl group of pimelic acid.  Out of curiosity, I set up the reaction anyway.  
Surprisingly, the reaction was successful, yielding a new acyl-ACP product that migrated 
differently from the substrate holo-ACP in EMSA.  When added into DTB synthesis 
reaction, this putative pimeloyl-ACP was also converted into DTB.  This is the first 
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evidence that ACP, despite being a lot larger than CoA, can be the active thioester carrier 
of pimeloyl moiety.  My next logical step was to incubate the putative pimeloyl-ACP 
with BioH and CoA to determine if BioH exhibited an acyltransferase activity to transfer 
the pimeloyl moiety from ACP to CoA.  Remarkably, BioH reaction converted the 
putative pimeloyl-ACP into a new ACP product that shifted similarly to holo-ACP.   
 
It was still unclear about the true identity of putative pimeloyl-ACP because 
EMSA is not a precise measure of molecular weight.  Therefore, I submitted the putative 
pimeloyl-ACP for MALDI-MS analysis.  The detected mass was very close to the 
expected mass, but strangely, was consistently 28 Da higher.  Furthermore, the extra 
mass was removed after BioH treatment, giving a new mass that matched perfectly with 
pimeloyl-ACP.  In other words, AasS never made pimeloyl-ACP and BioH couldn’t 
produce holo-ACP.  I could have dismissed the small mass difference as a reasonable 
error from the inherently low-resolution of MALDI-MS.  However, I was determined to 
find out the cause of the extra 28 Da mass.  The pursuit to identify the source of extra 
mass took more than six months, during which I repeatedly prepared ACP samples for 
both MALDI-MS and ESI-MS analyses.  I also treated ACP with EDTA to remove any 
metal ions that might be trapped in the protein.  Despite all the effort, I consistently 
obtained the same puzzling MS result.   
 
I eventually narrowed down the cause to AasS reaction because the mass of apo- 
and holo-ACP were correct.  When Dr. Cronan began to question about the reagents I 
used in the reaction, it was then we realized that I made a serendipituous mistake in 
preparing the pimelic acid solution.  Ethanol is commonly used in the lab as a solvent to 
dissolve fatty acids.  Since pimelic acid is poorly soluble in water, I dissolved it in 
ethanol, instead of converting the free acid into a salt form.  Over time, pimelic acid 
slowly reacted with ethanol to produce a mixture of free acid, pimelate monoethyl ester 
and pimelate diethyl ester, as revealed by GC-MS.  Standard esterification reactions 
normally call for acid catalysis; however in this case, pimelic acid, which is a weak acid, 
presumably catalyzed the esterification of itself.  When a mixture of pimelate was added 
to an AasS reaction, the enzyme specifically selected the monoethyl ester for ligation 
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whereas the diethyl ester was chemically inert and pimelic acid was too hydrophilic to fit 
in the active site.  My putative pimeloyl-ACP was in fact pimeloyl-ACP ethyl ester, 
carrying an extra 28-Da ethyl ester moiety at the ω-carboxyl group.  The true pimeloyl-
ACP was obtained only upon BioH hydrolysis of the ester bond.  Since BioH also 
targeted methyl, propyl and butyl esters, we postulated that the physiological ester is a 
methyl ester, which is introduced by BioC SAM-dependent methyltransferase.  To 
understand the significance of the methyl ester moiety, we re-evaluated Lynen’s model of 
pimeloyl-CoA synthesis, and realized that the methyl ester and ACP were the two 
missing clues to complete Lynen’s scheme.  I was extremely lucky to stumble upon them 
simultaneously.  If I had prepared pimelic acid differently or dismissed the confusing MS 
results, biotin synthesis would most likely remain a mystery to me to this day. 
 
The discovery of methyl ester moiety and ACP allowed us to propose a new 
model of E. coli biotin synthesis.  In this model, BioC converts malonyl-ACP to its 
methyl ester, and initiates biotin synthesis by shunting a unique primer molecule 
malonyl-ACP methyl ester (as opposed to the canonical primer acetyl-CoA), into fatty 
acid synthesis for chain elongation.  In two cycles of fatty acid synthesis, the malonyl 
chain is extended into a pimeloyl chain, before BioH cleaves off the methyl ester moiety 
terminate chain elongation.  To test the putative acyl-ACP intermediates, I set up an in 
vivo screening assay, in which I introduced the aasS gene into E. coli to bypass the 
actions of BioC or BioH (Chapter 2).  This screening assay is sensitive and unambiguous.  
Surprisingly, the majority of compounds to be screened were commercially available, 
although some were listed under different nomenclatures.  Using this assay, I identified 
seven out of nine putative biotin acyl-ACP intermediates in our model.  Together with 
additional results from DTB synthesis assay, I determined that the methyl ester moiety is 
essential for bypassing BioC function and for chain elongation.  Moreover, BioH is 
required specifically for removal of the ester moiety.   
 
To experimentally validate the model, I knew that I must demonstrate BioC 
methyltransferase activity.  However, this was no easy task.  I spent years troubleshooting 
with E. coli BioC solubility and toxicity.  Together with Ryan E. Hanson, an 
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undergraduate researcher, we tested different growth condition, host strains, vectors, 
fusion tags and additives, and could not obtain even a slight amount of soluble protein.  I 
also co-expressed BioC with BioH in hope to improve BioC stability.  This idea was 
inspired by a natural BioC-BioG (a BioH ortholog) fusion protein in Bacteroides fragilis, 
but failed to work for E. coli enzymes.  Out of desperation, I denatured and refolded 
BioC from inclusion bodies, but could barely detect activities in DTB synthesis assay.  I 
eventually gave up E. coli BioC altogether and searched for homologs in other outlier 
bacteria.  All of BioC I tested were either very toxic to E. coli or difficult to express to 
high quanitity.  The reason for BioC toxicity, as I discovered later, is that the enzyme 
depletes malonyl-ACP, which is an essential substrate for fatty acid synthesis.  Having 
both toxicity and solubility issues, BioC just seemed impossible to obtain. 
 
After years of failed attempts, I finally succeeded in obtaining a soluble B. cereus 
BioC that was heterogeneously expressed in E. coli and readily purified (Chapter 3).  
Using 
3
H-labeled SAM as a substrate, I detected specific methylation of malonyl-ACP, 
but much weaker methylation of malonyl-CoA.  The KM for malonyl-CoA was much 
higher than its physiological concentration, hinting that ACP might play an important 
role in substrate binding and recognition.  BioC methylation reaction was also disrupted 
by SAH and sinefungin, which are two known inhibitors of SAM-dependent 
methyltransferases.  When BioC was highly expressed, phospholipid synthesis and cell 
growth quickly came to a halt, suggesting that BioC methylation depleted malonyl-ACP 
and disrupted fatty acid synthesis.  The next logical step would be to co-crystalize BioC 
with either malonyl-ACP or malonyl-ACP methyl ester.  A three-dimensional structure 
would certainly provide a clear picture of why ACP is a much better substrate than CoA.  
For this purpose, I have collaborated with the Nair lab to co-crystallize B. cereus BioC 
with malonyl-ACP.  Unfortunately, B. cereus BioC always precipitated out during the 
crystallization process. 
 
BioH, on the other hand, is a much easier protein to work with.  The protein was 
easy to express, easy to purify with a His tag fusion, was highly active and stable, and 
most impressively, co-crystallized with pimeloyl-ACP methyl ester in under a week.  
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This co-crystal structure allowed us to investigate the binding interaction of BioH to 
ACP.  Using this structure, Vinayak Agrawal identified four Arg residues at the surface 
of BioH capping helices that might provide ionic interaction necessary for binding to 
ACP, and made a collection of mutations.  My job was to assay the mutant enzymes for 
lost of carboxylesterase activity.  However, this seemingly simple hydrolysis reaction 
proved very challenging to assay kinetically.  For years I have adapted different 
approaches to assay BioH reaction, but without success.  The biggest obstacle is to 
achieve high concentrations of pimeloyl-ACP methyl ester to measure the KM.  Equally 
challenging is the fact that there is not an assay sensitive enough to measure the intial 
velocity.  I have tried but failed to measure the release of methanol by a coupled 
enzymatic assay
48
 and chemical detections
5
.  I also synthesized pimeloyl-ACP [
14
C] 
methyl ester for EMSA in attempts to monitor the disappearance of [
14
C] methyl ester, 
but the radioactivity was low.  Together with Vinayak Agrawal, we tried chemical 
derivatization of the pimeloyl methyl ester moiety for GC-MS analysis.  We also tried to 
measure the BioH-ACP binding affinity by isothermal titration calorimetry, but BioH 
could not withstand the vigorous mixing by the instrument.  In the end, I decided to 
revisit the original EMSA assay and optimize the condition to compare the wild-type and 
mutant enzymes (Chapter 4).   
 
Interestingly, Ala substitution of the Arg residues had a negative and cumulative 
effect on BioH activity in vitro.  While the activity of single mutants was slightly 
affected, the activities of triple and quadruple mutants were nearly abolished.  To verify 
that the lost of activity was not caused by misfolding of the active site, Dr. Cronan 
suggested a simple esterase assay using 4-nitrophenyl acetate as a BioH substrate.  The 
binding of 4-nitrophenyl acetate in BioH does not involve the surface Arg residues, and 
therefore the hydrolysis of 4-nitrophenyl acetate should be independent of Arg mutation.  
The simplicity of assay saved me the trouble to verify BioH structure by other 
complicated means, such as circular dichroism.  In vitro effect of Arg mutation also 
translated nicely to in vivo biotin production.  I set up a BioH complementation assay to 
see whether or not the Arg mutants would hinder biotin production, and hence 
compromise cell growth.  I suspected that the growth difference, conferred by wild-type 
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or mutant BioH, would be slight and easily masked by elevated level of the enzyme.  I 
knew the only solution was to keep BioH protein level as low as possible.  So I followed 
Alex Smith’s suggestion to knock out the pcnB gene in order to decrease the copy 
number of pET28b plasmid, which carried the bioH gene.  I took one additional step to 
further reduce BioH expression by including pMS421 plasmid carrying the lacI
q
 gene.  
This setup worked brilliantly for me.  Although I have not actually measured the protein 
concentration, I predicted that the BioH expression level in my strain to be lower than 
that of wild-type E. coli.  Under this condition, I was able to see a growth delay that 
corresponded proportionally to the number of Arg mutation.  My in vitro and in vivo 
assays provided convincing evidence to support the notion that pimeloyl-ACP methyl 
ester is the substrate of BioH and a true precursor in E. coli biotin synthesis. 
 
In summary, I have described my approaches to elucidate the functions of BioC 
and BioH in E. coli biotin synthesis.  BioC is a SAM-dependent methyltransferase that 
converts ω-carboxyl group of malonyl-ACP to a methyl ester.  The methyl ester moiety 
introduced by BioC is later removed by BioH carboxylesterase to produce the pimeloyl 
moiety for biotin ring assembly.  Interestingly, this biosynthetic scheme is analogous to 
protective groups in organic synthesis; however in biotin synthesis the disguise facilitates 
synthesis, whereas in organic synthesis the protective group prevents undesired reactions.  
I hope that my findings in E. coli biotin synthetic pathways would inspire different 
viewpoints to our understanding of biosynthesis of complex biomolecules.  I am certainly 
curious to see if similar reaction schemes exit in other biosynthetic pathways.  Perhaps 
greater metabolic efficiency and diversity are evolutionarily engineered, not by creating 
new enzymes, but by ”borrowing” existing pathways to perform new jobs.  
 
FUTURE DIRECTIONS 
Identification of 3-ketoacyl-ACP synthases required for pimelate synthesis 
There are still several key reactions, specifically those involving fatty acid 
synthetic enzymes that need to be demonstrated experimentally.  I am particularly 
interested in identifying the 3-ketoacyl-ACP synthases that are involved in pimelate 
synthesis.  Our model of pimelate synthesis calls for two condensation reactions which 
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may require two separate synthases (Figure 6-1).  The first reaction takes place 
immediately after the BioC reaction, in which malonyl-ACP methyl ester is condensed 
with malonyl-ACP to give 3-ketoglutaryl-ACP methyl ester.  The second reaction 
extends glutaryl-ACP methyl ester with another molecule of malonyl-ACP to give 3-
ketopimeloyl-ACP methyl ester.  There are three candidates from E. coli fatty acid 
synthesis: 3-ketoacyl-ACP synthase I (FabB), synthase II (FabF) and synthase III (FabH).  
FabH catalyzes the initiation of fatty acid synthesis by condensing acetyl-CoA (primer 
for fatty acid synthesis) with malonyl-ACP (elongation unit).  FabH can also elongate 
shorter-chain (less than C6) acyl-ACPs, whereas FabB and FabF have a preference for 
longer-chain (greater than C6) acyl-ACPs.  In addition, FabB is unique in elongating 3-
cis-decenoyl-ACP (C10) which is the first intermediate in unsaturated fatty acid 
synthesis; whereas FabF is able to elongate palmitoleoyl-ACP (C16).  All three enzymes 
have a malonyl-ACP binding site, and their acyl chain becomes covalently linked to the 
sulfhydryl of an active site cysteine residue.  Unlike FabH, FabB and FabF are known to 
accept acetyl-ACP as a primer. To my knowledge, these enzymes have not been studied 
with dicarboxylic ACPs.  Moreover, it is difficult to speculate which 3-ketoacyl-ACP 
synthase(s) participates in pimelate synthesis based on their known capacities. 
 
 To identify the enzymes, one should first take a genetic approach to delete 3-
ketoacyl-ACP synthases and check for biotin auxotrophy.  FabH is essential; therefore, 
deletion of the fabH gene is not viable without additional manipulations.  However, it is 
possible to delete the fabF and fabB genes, although ∆fabB strain requires the 
supplementation of oleate to grow.  To find specifically the enzyme that catalyzes the 
second condensation of C5-ACP to C7-ACP, one can introduce AasS into the deletion 
strain and supplement the growth medium with glutarate monomethyl ester (Figure 6-1).  
The combination of AasS and glutarate methyl ester would allow the bypass of the 
second condensation reaction, and restore biotin production.  Once the candidate 
synthases have been narrowed down, one can take a biochemical approach to 
demonstrate the condensation reaction.  I have described the preparation of malonyl-ACP 
methyl ester and glutaryl-ACP methyl ester in Chapter 3 and 2, respectively.  They can 
be used as substrates to study the condensation reactions using purified, recombinant 
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FabB, FabF or FabH.  The extension of malonyl-ACP methyl ester and glutaryl-ACP 
methyl ester would lead to a significant increase in mass which can be detected by 
MALDI-MS. 
 
Crystallization of BioC 
 I believe it would be worth the effect to attempt co-crystallization of BioC with 
malonyl-ACP substrate.  Unfortunately, we were unable to obtain a BioC crystal because 
B. cereus BioC always precipitated in our previous trials of crystallization.  To improve 
protein stability, one can pre-incubate BioC with malonyl-ACP and SAH to constitute an 
enzyme-substrate complex, and purify the complex for crystallization using size-
exclusion chromatography.  However, it is not known if such a complex is stable enough 
to be seen in chromatography.  An alternative approach would be to switch to a BioC 
homolog from a thermophile.   My rotation student Thomas D. Mand has cloned the bioC 
gene from Chlorobium tepidum, a phototrophic thermophilic bacterium.  He has shown 
that C. tepidum bioC gene complemented E. coli bioC gene nicely (Figure 6-2a), 
suggesting the enzyme could recognize E. coli ACP substrate.  However, the bioC gene 
was PCR amplified from genomic DNA and contains rare codons that are not optimized 
for expression in E. coli.  As a result, the expression of C. tepidum BioC in E. coli B 
strains was very poor.  Thomas screened several expression strains and found 
BL21(DE3) Codon Plus a suitable host for the expression of C. tepidum BioC.  As shown 
in SDS-PAGE, the level of BioC accumulated over an induction period of six hours 
(Figure 6-2b).  The future plan is to assay C. tepidum BioC for methyltransferase activity 
using E. coli malonyl-ACP, and to use C. tepidum BioC for crystallization.  
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FIGURES 
 
 
 
Figure 5-1. Elongation of a malonyl (C3) moiety to a pimeloyl (C7) moiety requires two 
condensation reactions, by 3-ketoacyl-ACP synthase, using malonyl-ACP as substrate.  
There are three 3-ketoacyl-ACP synthases in E. coli fatty acid synthesis: FabB, FabF and 
FabH.  The enzyme(s) involved in the elongation of malonyl or glutaryl moieties are not 
known.  AasS can be used to specifically bypass the first elongation step and to identify 
the second 3-ketoacyl-ACP synthase.  
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Figure 5-2.  (a) C. tepidum bioC, which was cloned into plasmid pET28b, complemented 
E. coli bioC gene.  MG1655∆bioC strain, carrying the C. tepidum bioC gene, grew on 
minimal medium without supplement of biotin.  In contrast, vector control was unable to 
grow without biotin.  Each plate contained four random colonies.  (b) C. tepidum bioC 
gene was poorly expressed in BL21(DE3) due to the presence of rare codons.  The 
expression improved in a different strain, BL21(DE3) Codon Plus (Stratagene), which 
carries extra copies of the argU, ileY, and leuW tRNA genes on a plasmid. These genes 
encode tRNAs that recognize the arginine codons AGA and AGG, the isoleucine codon 
AUA, and the leucine codon CUA, respectively.  Upon IPTG induction, accumulation of 
BioC could be seen in an hour.  Experiments were done by Thomas D. Mand.  
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